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CHAPTER I 
 
CURRENT UNDERSTANDING OF SPASMOLYTIC POLYPEPTIDE 
EXPRESSING METAPLASIA (SPEM) AND ITS STANDING IN THE 
PRENEOPLASTIC PROCESS 
Adapted From: Weis, V.G. and Goldenring, J.R. Current understanding of SPEM and 
its standing in the preneoplastic process. Gastric Cancer. 2009;12(4):189-97.  
 
 
Gastric adenocarcinoma is the second leading cause of cancer-related death 
worldwide (Pisani et al. 1999). Gastric resection remains the critical step in gastric cancer 
therapy. Accordingly, the early detection of early stage cancers remains a priority. 
However, the cellular mechanisms involved in the progression of preneoplastic events to 
gastric cancer remain unclear. This lack of a clear understanding of the neoplastic 
transition hampers efforts to discover better screening methods for populations at risk. 
Thus, a more extensive knowledge of the preneoplastic events could clearly reduce 
gastric cancer mortality. The following discussion reviews the emerging concepts on the 
origin of preneoplastic metaplasia and the factors that influence conversion of metaplasia 
towards neoplasia. 
 
Oxyntic Atrophy, Metaplasia, and Gastric Adenocarcinoma 
 Chronic infection of the stomach with the gram-negative bacterium, Helicobacter 
pylori, is the leading proximate cause of gastric cancer in humans (Blaser et al. 1994a). 
Chronic H. pylori infection causes global changes in the gastric mucosa which can 
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eventually lead to gastric adenocarcinoma. These global changes result from the two 
major effects of chronic H. pylori infection: parietal cell loss (or oxyntic atrophy) and 
prominent inflammation. Oxyntic atrophy has a profound affect on the gastric mucosa 
because parietal cells play an important role in differentiation of other gastric lineages. 
Parietal cells are responsible for the secretion of a number of factors including 
amphiregulin, TGF-alpha, HB-EGF, and Shh (Beauchamp et al. 1989; Murayama et al. 
1994; Abe et al. 1997; Jain et al. 2006a). Loss of parietal cell-derived signaling molecules 
disrupts the proper differentiation of other lineages such as the zymogen-secreting chief 
cells (Li et al. 1996). The second major result of chronic infection is prominent 
inflammation throughout the mucosa. Oxyntic atrophy along with prominent 
inflammation appear to be the prerequisites for progression to metaplasia and gastric 
adenocarcinoma (El-Zimaity et al. 2002). 
Oxyntic atrophy in the setting of inflammation can progress to the development of 
metaplasia. In humans, two types of metaplasia can arise from the presence of oxyntic 
atrophy and inflammation: intestinal metaplasia and spasmolytic polypeptide expressing 
metaplasia (SPEM). Both intestinal metaplasia and SPEM have been associated with the 
progression to intestinal type gastric cancer (Hattori et al. 1979; Hattori et al. 1982; 
Hattori 1986; Correa 1988; Filipe et al. 1994; Takizawa et al. 1998; Schmidt et al. 1999; 
Xia et al. 2000; Yamaguchi et al. 2002; Halldorsdottir et al. 2003). Thus, a case can be 
made for oxyntic atrophy in association with prominent inflammation laying the 
groundwork for altered gastric lineages that are involved in the development of gastric 
cancer. However, the factors mediating progression from oxyntic atrophy to gastric 
cancer remain unclear. Intestinal metaplasia is characterized by the presence of intestinal 
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goblet cells in the stomach (Morson 1955). Because intestinal goblet cells are not 
normally present in the stomach, intestinal metaplasia was originally proposed as the pre-
neoplastic metaplasia leading to intestinal type cancer (Correa 1988). Goblet cells in 
intestinal metaplasia express appropriate intestinal markers including Muc2 and Trefoil 
factor 3 (TFF3) (Ectors et al. 1986). However, investigations have identified a second 
possible pre-neoplastic metaplasia, SPEM. The mucous metaplastic lineages in SPEM 
display morphological characteristics more typical of deep antral gland cells or Brunner’s 
glands, with expression of Muc6 and Trefoil Factor 2 (TFF2) (Schmidt et al. 1999). 
Despite the similarity between SPEM and the deep antral glands, no gastrin cells are 
observed in these glands. Recent studies have suggested that both SPEM and intestinal 
metaplasia may be pre-neoplastic metaplasias. In three separate studies, SPEM was 
associated with 90% of resected gastric cancers (Schmidt et al. 1999; Yamaguchi et al. 
2001; Halldorsdottir et al. 2003). The exact influences promoting the sequential 
progression from oxyntic atrophy to metaplasia to dysplasia, however, remain unknown. 
Parietal cell loss leads to metaplasia 
The unresolved questions about the origin of oxyntic atrophy and its progression 
to gastric cancer are difficult to examine in humans, but mouse models are more 
amenable to answering these questions. As mentioned above, the most common 
predisposing factor for gastric cancer in humans is chronic H. pylori infections, resulting 
in oxyntic atrophy and prominent inflammation. The importance of both oxyntic atrophy 
and the inflammatory response has been examined in mice. Chronic infection of mice 
with H. pylori or with a different, but related, subspecies of Helicobacter felis (H. felis) 
results in profound loss of parietal cells and inflammation throughout the mucosa, similar 
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to that seen in humans (Fox et al. 1996; Wang et al. 1998; Fox et al. 2003). H. felis-
infected C57BL/6 mice develop SPEM after 6 months of infection, demonstrating that 
oxyntic atrophy and inflammation can also lead to SPEM in mice (Figure 1). After 12 
months of infection, the mice progress to gastritis cystica profunda, a dysplastic process 
in the fundic mucosa (Wang et al. 1998). Importantly, however, the infected mice never 
develop intestinal metaplasia, suggesting that SPEM is the pre-neoplastic metaplasia in 
mice. The direct cause of SPEM, however, is difficult to elucidate from this chronic 
model complicated by the presence of both of the major predisposing factors: oxyntic 
atrophy and prominent inflammation. 
To isolate the role of oxyntic atrophy from the role of inflammation in the 
development of SPEM, administration of DMP-777 has been utilized to examine the role 
of acute oxyntic atrophy. DMP-777 is a cell permeant neutrophil elastase inhibitor that 
ablates parietal cells without inciting an inflammatory response. Loss of parietal cells is 
due to the secondary activity of DMP-777 as a parietal cell-specific protonophore. After 3 
days of DMP-777 administration, mice develop oxyntic atrophy. The oxyntic atrophy 
gives rise to SPEM after 10 to 14 days of DMP-777 administration in the absence of 
inflammation (Nomura et al. 2004c). Thus, SPEM develops as a direct result of the loss 
of parietal cells (Figure 1). However, DMP-777-induced SPEM never progresses to 
dysplasia even after a year of administration (Goldenring et al. 2000). L635, another 
parietal cell-specific protonphore, lacks the neutrophil inhibition that DMP-777 possesses. 
Instead, administration of L635 results in oxyntic atrophy and a prominent inflammatory 
response that is similar to H. felis infection (Nam et al. 2010). SPEM develops after only 
3 days of L635 administration. The rapid induction of SPEM from L635 administration is 
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the result of the inflammatory response that accompanies the parietal cell loss because 
without inflammation (as in DMP-777 administration) SPEM does not develop in 3 days 
(Nam et al. 2010). Although longer administration of L635 is not currently possible, the 
similarity of L635 administration and H. felis infection has led to the use of L635 as an 
initial alternative to long infection studies. Together, these findings suggest the important 
role of inflammation in the progression to gastric neoplasia. Furthermore, 
immunodeficient mice infected with H. felis do not develop oxyntic atrophy and thus do 
not develop SPEM or progress to dysplasia (Fox et al. 1993). In the case of 
pharmacological ablation of parietal cells, no inflammation is needed for parietal cell loss. 
More importantly, the parietal cell loss is sufficient for the development of SPEM. 
 
Cellular Origin of Metaplasia 
Although oxyntic atrophy leads to the emergence of SPEM, the cellular origin of 
SPEM was only recently discovered (Figure 1). Normal gastric cell lineages such as the 
acid secreting parietal cell and mucin secreting mucous neck cell are derived from 
progenitor cells located in the upper region of the gland (Karam 1993; Karam et al. 1993b; 
Karam et al. 1993c; Karam et al. 1993d; Karam et al. 1993e; Karam et al. 2003). As the 
post-mitotic mucous neck cells migrate towards the base of the gland, they alter their 
expression profiles as well as their morphology to redifferentiate into zymogen secreting 
chief cells (Figure 1) (Karam et al. 1993d; Ramsey et al. 2007). A previous study has 
shown that the transcription factor, Xbp1 is necessary for the cessation of mucous cell 
marker expression and complete differentiation to chief cells (Huh et al. 2010). 
Furthermore, the transcriptions factor, Mist1 is expressed in the last stages of this mucous 
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to chief cell differentiation and in mature chief cells (Figure 1). Mist1 is required to 
establish the chief cell secretory machinery and thus for full maturation of chief cells 
(Ramsey et al. 2007).  Because both mucous neck cells and chief cells have 
conventionally been thought of as post-mitotic, it had originally been suggested that 
SPEM cells arise from a cryptic progenitor cell located at the base of the gastric glands. 
However, recent studies have shown that the chief cells (or a subset of chief cells) 
transdifferentiate into SPEM cells (Nam et al. 2010). Indeed, the most reliable pattern for 
the emergence of SPEM following induced oxyntic atrophy has been the identification of 
cells at the bases of fundic glands expressing both intrinsic factor (a mouse chief cell 
marker) and TFF2 in different granules within the same cells (Nomura et al. 2004c). One 
recent study demonstrated that some SPEM cells express MIST1, a chief cell 
differentiation specific marker (Nozaki et al. 2008). The development of the Mist1-Cre 
mouse has now allowed for the investigation of chief cells as the cell of origin for SPEM. 
In this study, Mist1 expressing chief cells lineage traced into SPEM regardless of the 
induction milieu (Nam et al. 2010). Oxyntic atrophy in both the absence and presence of 
inflammation results in chief cell transdifferentiation into SPEM. However, this study 
could not address the question if all chief cells or only a subset have the ability to 
transdifferentiate. The study by Nozaki et al. showed that SPEM cells located towards the 
base of the gland have an increase in the expression of minichromosome maintenance 
complex component 3 (MCM3), which is involved in initiation of genome replication. 
Occasionally, MCM3 positive cells were also observed at the bases of normal gastric 
glands in cells that co-expressed intrinsic factor, a chief cell marker in mice, suggesting 
that it may be a subset of chief cells that retain or possibly can reactivate the ability to 
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replicate (Nozaki et al. 2008). Recent studies in the intestine and gastric antrum have 
shown cells with leucine-rich repeat containing G-protein-coupled receptor 5 (Lgr5) 
transcriptional activity function like adult stem cells. Cells transcriptionally active for 
Lgr5 expressed intrinsic factor and pepsinogen and were seen scattered in the lesser 
curvature of the stomach. However, upon administration of DMP-777 or L635, this 
subset of Lgr5 expressing chief cells did not lineage map into SPEM (Nam et al.). Future 
studies are needed to investigate further the possibility that SPEM arises from a previous 
unidentified subset of chief cells as this data suggest different populations of chief cells 
exist. 
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Figure 1. Comparison of normal fundic gastric glands and metaplastic SPEM 
glands in mice. The diagram at the top depicts alterations in gland lineages between 
normal and SPEM glands with emergence of SPEM and foveolar hyperplasia following 
loss of parietal cells. Panels below show immunostaining patterns for normal and SPEM-
containing glands. TFF2 (red) expressing mucous neck cells redifferentiate into intrinsic 
factor (green) expressing chief cell at the base of normal glands. However, TFF2 
expression is expanded to the base of SPEM glands and appears within cells that show 
dual staining for intrinsic factor. Mist1 (green) is a differentiated chief cell marker in 
normal gastric glands. However, Mist1 is also expressed in some TFF2-expressing SPEM 
cells, demonstrating transdifferentiation of chief cells. Although proliferation as detected 
by BrdU (red) is normally only in the progenitor zone of the upper normal gland, TFF2-
expressing SPEM cells show clear proliferating cells also expressing intrinsic factor (IF). 
Previous studies have led to the identification of promising biomarkers of SPEM such as 
HE4. HE4 is not detected in normal chief cells or any normal fundic cells, but HE4 
staining is strongly observed in SPEM. 
 
 
The origin of intestinal metaplasia has been harder to elucidate because 
Helicobacter infection in mice does not result in intestinal metaplasia. However, H. 
pylori infection of other species, such as Mongolian gerbils, does induce intestinal 
metaplasia (Hirayama et al. 1996; Honda et al. 1998a). Moreover, H. pylori infection-
induced intestinal metaplasia evolves into gastric cancer in older Mongolian gerbils 
(Honda et al. 1998b; Watanabe et al. 1998; Yoshizawa et al. 2007). Detailed examination 
of the histological progression of oxyntic atrophy to gastric cancer in the Mongolian 
gerbil has shed some light into the origin of intestinal metaplasia and its association with 
SPEM (Yoshizawa et al. 2007). After only 3 weeks of infection, the gerbils developed 
SPEM in the presence of oxyntic atrophy. The emergence of intestinal metaplasia 
followed later at 24 and 39 weeks of infection. Importantly, the sites of intestinal 
metaplasia were surrounded by the pre-existing SPEM. Moreover, single glands 
contained both intestinal metaplasia and SPEM (Yoshizawa et al. 2007). Similar 
developmental patterns of intestinal metaplasia have also been observed in humans (El-
10 
 
Zimaity et al. 2001). The findings in these studies suggest that oxyntic atrophy results in 
the development of SPEM which in turn can then evolve into intestinal metaplasia 
(Figure 2). However, conclusive evidence of this progression has evaded researchers so 
far. Future studies in mouse models of SPEM and intestinal metaplasia are needed to 
trace this progression of metaplastic lineages to cancer. Until these studies are conducted, 
three hypotheses must be considered. First, each type of metaplasia (intestinal metaplasia 
or SPEM) may lead to a distinct type of cancer. For example, SPEM may progress to 
gastric type cancers while intestinal metaplasia proceeds to intestinal type cancers. 
Alternatively, one of the metaplasias could be the preneoplastic metaplasia, while the 
other is merely associated with cancer. The third hypothesis based on the Mongolian 
gerbil studies is that SPEM develops first, progresses to intestinal metaplasia, and finally 
evolves into gastric cancer. More extensive studies comparing both the transcript and 
protein expression patterns of metaplastic lineages to the patterns of gastric 
adenocarcinomas may provide insights into the links between metaplastic lineages and 
cancer. 
Another aspect of this progression that must be considered, though not frequently 
mentioned, is the geographical origin of these metaplastic lesions within the stomach. 
SPEM and the resulting intestinal metaplasia found in H. pylori infected Mongolian 
gerbils initiated along the lesser curvature of the stomach and expanded towards the 
greater curvature during longer terms of infections (Yoshizawa et al. 2007). This 
concentration of metaplastic lineages along the lesser curvature has also been 
documented in humans (Sugimura et al. 1982; El-Zimaity et al. 2001). Additionally, H. 
pylori preferentially colonizes the lesser curvature both in mouse models and in humans 
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(Lee et al. 1997; Misra et al. 2000). This localization of metaplastic initiation in both 
rodents and humans may be the result of Helicobacter sp. colonization patterns. However, 
there may also be an underlying factor for this convergence on the lesser curvature that 
has yet to be discovered. For example, the cellular lineage composition of the lesser 
curvature may vary from the greater curvature to account for these differences in location 
of metaplastic initiation. Interestingly, the human stomach has not yet been extensively 
mapped out. It will be interesting to know the full extent of the differences in lineage 
distributions between the two curvatures and how they correspond with H. pylori 
colonization and the origin of metaplasia. 
It is also necessary to consider the other geographical axis when examining the 
origin of metaplasias. Unlike the possible lineage differences between the two curvatures, 
there are known differences in the cell lineages between the fundus and the antrum of the 
stomach. Although parietal cells play a crucial signaling role in the fundus, they are not 
found in the antrum. Chief cells are also not located in the antrum. Instead, antral glands 
have a TFF2-expressing lineage that populates the base of the glands. The antrum also 
contains other cell lineages not found in the fundus such as gastrin expressing G-cells. 
Gastrin plays an important role in acid secretion as well as proliferation in the fundus 
(Johnson 1977; Wang et al. 1996). Knocking out gastrin creates a hypogastrinemic 
environment which results in a reduction in parietal cell mass in the fundus and chronic 
inflammation in the antrum. This antral inflammation leads to an increase in intestinal 
markers such as villin and MUC2, although goblet cell morphology is not seen. 
Eventually, tumors develop in the antrum in 12 month old gastrin-deficient mice (Zavros 
et al. 2005). Interestingly, another mouse model, the trefoil factor 1 (TFF1) knockout 
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mouse, also results in antral tumors, although more quickly. TFF1, unlike gastrin, is 
normally expressed in surface cells throughout the entire stomach. Mice lacking TFF1 
expression develop antral tumors at 5 months of age (Lefebvre et al. 1996). Both mouse 
models suggest an important role for gastrin and TFF1 in maintaining normal 
differentiation of the antrum. A third mouse model combines the effect of gastrin and 
TFF1 loss. The gp130 mouse contains a mutation that inhibits protein tyrosine 
phosphatase (SHP2) binding to the interleukin 6 (IL-6) family co-receptor gp130. This 
binding inhibition results in decreases in gastrin and TFF1 expression as well as an 
increase in signal transducer and activator of transcription 3 (STAT3) expression. These 
aberrant expression patterns result in antral tumors at 6 weeks of age, which quickly 
extend into the fundus by around 17 weeks of age. Additionally, these tumors are 
accompanied by SPEM (Judd et al. 2004). Thus, the combined effect of gastrin loss with 
TFF1 loss accelerates the development of antral tumors in mice. Moreover, this model 
resembles antral tumor development in humans. Together gastric tumor models, in mice 
and Mongolian gerbils, demonstrate how metaplasias of the stomach and gastric cancer 
may originate and progress differently depending on the geographical location and 
possibly local regulatory signals. 
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Figure 2. Current model for the origin and progression of gastric metaplasias in 
humans. Studies have demonstrated that loss of parietal cells results in chief cell 
transdifferentiation and the SPEM emergence. In the presence of chronic inflammation 
from H. pylori infection, SPEM evolves into intestinal metaplasia then progresses on to 
gastric cancer. Establishment of biomarkers of these metaplastic lineages is a priority. 
Recent studies in mice identified HE4 as a SPEM biomarker. In humans, HE4 is not 
expressed in the cells of the normal fundus. However, HE4 is detected in both SPEM and 
intestinal metaplasia, supporting the hypothesis of SPEM progression to intestinal 
metaplasia. 
 
 
 
Regulation of Metaplasia 
While oxyntic atrophy is directly responsible for the development of SPEM, the 
emergence of SPEM can be altered by endocrine or paracrine regulation. As stated above, 
parietal cells produce instructive signaling for the growth and differentiation of the other 
gastric lineages. However, parietal cells also receive signals from other cell types in the 
gastric mucosa such as the previously mentioned gastrin secreting G cells and histamine 
secreting enterochromaffin-like (ECL) cells (Zimmerhackl et al. 1993; Andersson et al. 
1998; Hinkle et al. 1999; Lindstrom et al. 2001; Samuelson et al. 2003; Chen et al. 2006a; 
Jain et al. 2006b). Gastrin stimulates ECL cell release of histamine, the primary 
stimulator of acid secretion from parietal cells (Chen et al. 2006a). Histamine secreted by 
the ECL cells also plays an important role in the differentiation of the gastric lineages 
(Appendix B) (Nozaki et al. 2009). At the same time, somatostatin cells coordinate 
inhibitory influences both on acid secretion and hormonal secretion (Chew 1983). Thus, 
parietal cells, G cells, somatostatin cells and ECL cells coordinate with each other to 
regulate the gastric mucosal milieu. Understandably then, the disruption of this balance of 
intramucosal factors affects the maturation of normal gastric lineages as well as the 
development of SPEM. For example, gastrin deficient mice develop SPEM after only one 
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day of DMP-777 administration, while it takes 10 days of DMP777 administration for the 
development of SPEM in wild type mice (Nomura et al. 2004c). Similarly, histidine-
decarboxylase (HDC) deficient mice (which lack histamine) also have an accelerated 
development of SPEM upon administration of DMP-777 (Appendix B) (Nozaki et al. 
2009). These studies highlight the complex coordination that occurs between the different 
cell lineages of the stomach. 
Additionally, other intramucosal paracrine factors such as growth factors are 
important in the regulation of metaplasia. To examine the role of the epidermal growth 
factor (EGF) signaling pathway in the development of SPEM, the waved-2 mouse was 
utilized, because it has a reduction in the EGF receptor tyrosine kinase activity. Upon 
administration of DMP-777, accelerated development of SPEM was observed in the 
waved-2 mice (Ogawa et al. 2006). Further investigations into this signaling pathway 
demonstrated that different EGF receptor ligands affected the mucosal lineages 
differently. DMP-777-induced SPEM in TGFα-deficient mice developed similarly to that 
seen in wild type mice. In contrast, loss of amphiregulin led to accelerated SPEM 
development (Nam et al. 2007). Taken together, these findings demonstrate that 
emergence of SPEM is regulated by a complex coordination of both endocrine and 
paracrine factors. While loss of a single factor may alter SPEM development, no factor 
has been found to be solely responsible for the emergence of SPEM. 
Metaplastic progression to gastric cancer 
Inflammation plays an important role in the development and progression of 
SPEM. As stated before, while SPEM can develop in the absence of inflammation, it 
does not progress to dysplasia without inflammation. Helicobacter infections in mice 
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progress to dysplasia when prominent inflammation is present (Wang et al. 2000). The 
inflammatory response observed in these mice is composed mostly of a TH1 response 
(Mohammadi et al. 1996). Interestingly, further investigation into the components of 
inflammation has led to the discovery that the type of inflammatory response appears to 
be important in the progression to gastric cancer. In mice with a TH2 dominant 
inflammatory response to H. felis infection, the SPEM did not progress to dysplasia (Roth 
et al. 1999). Thus, a TH1 dominant inflammatory response is needed for progression of 
SPEM to dysplasia in mice. Other factors involved in the progression to neoplasia such as 
the necessary immune cells have been difficult to elucidate, possibly because of gaps in 
our knowledge of progression from metaplasia to dysplasia. 
One recent study suggested a role for bone marrow derived cells (BMDCs) within 
this progression (Houghton et al. 2004a). This study found that BMDCs were recruited to 
the stomach during chronic H. felis infection. These recruited BMDCs appeared to 
engraft into the SPEM glands and progress to gastritis cystica profunda (Houghton et al. 
2004a). No engraftment was observed in models of SPEM without inflammation, such as 
DMP-777 treatment. It also remains unclear whether BMDCs adopt the SPEM phenotype 
or actually fuse with SPEM cells during engraftment. At this time, it remains uncertain 
whether this engraftment of SPEM by BMDCs is specific to infection with the H. felis 
strain and there remains no strong evidence to support a role for BMDCs in the evolution 
of metaplasia or cancer in humans. 
Another issue to consider is the concept of field cancerization and expansion of 
mutated clones. Field cancerization suggests that multiple stem cells form independent 
epithelial tumors (Slaughter et al. 1953). Application of this concept to SPEM and 
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intestinal metaplasia proposes that one of the stem cells in the gastric gland acquires a 
mutation. This mutated stem cell would then expand its mutated progeny until it 
eventually took over the gland and all the cell lineages present would have the mutation. 
The unit would then spread by gland fission creating a field of mutated gastric glands. A 
recent study applying this concept to intestinal metaplasia proposed that a gastric stem 
cell commits to the intestinal phenotype (McDonald et al. 2008). The progeny of the 
mutated stem cell would be seen mixed with normal gastric lineages as the stem cell 
proceeded to take over the gland. This could be one explanation for the mixed glands 
observed in the H. pylori infected Mongolian gerbils (Yoshizawa et al. 2007). It is 
possible that, while SPEM arises from transdifferentiation of the chief cells, intestinal 
metaplasia is derived from a mutated stem cell born in the context of SPEM. 
Alternatively, intestinal metaplasia may represent a further mucous cell metaplastic 
differentiation that predisposes to adoption and propagation lineages with genetic 
mutations. If these concepts are correct, then SPEM and intestinal metaplasia may 
represent sequential steps in the progression to gastric cancer. 
Future studies may result in biomarker discovery  
Given the clear association of metaplasias in the stomach with increased risk for 
gastric cancer, identification of markers of metaplasia and metaplastic progression to 
dysplasia is a clear priority for the development of effective screening methods that could 
identify pre-neoplasia. The discovery of preneoplastic biomarkers would be of great 
value for earlier detection and treatment of preneoplastic lesions. Recent studies have 
begun to identify a number of biomarkers that have implications for cancer outcome. For 
example, a recent study identified the secreted whey acidic protein (WAP) domain 
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protein, HE4 (WFDC2) as a putative biomarker (Nozaki et al. 2008). While there was no 
HE4 expression in normal gastric lineages, there was a prominent increase in expression 
in SPEM lineages from both DMP-777 treated and H. felis infected mice (Figure 1). 
Similarly, HE4 was expressed in metaplastic lineages in humans (Figure 2). Through 
examination of human tissue arrays, HE4 was found to have strong expression in 100% 
of both SPEM and intestinal metaplasias. Additionally, strong HE4 expression is 
maintained in a number of intestinal-type gastric cancers, making it a promising 
biomarker candidate. However, a more expansive array of biomarkers is still needed to 
increase the diagnostic specificity of metaplasias and preneoplastic events as well as 
expand our understanding of the metaplastic progression. As more biomarkers are 
established, diagnosis and treatments may be increasingly specialized based on the 
individual patient’s biomarker expression patterns. Additionally, the discovery of new 
biomarkers will lead to a greater understanding into the molecular progression of normal 
gastric lineages to metaplasia (SPEM and intestinal metaplasia) to cancer. 
Rationale and aims 
Inflammation plays an important part in the progression to gastric 
adenocarcinoma. Utilizing pharmacological agents (DMP-777 and L635), the specific 
roles of parietal cell loss and inflammation could be investigated. Loss of parietal cells 
alone is sufficient for the transdifferentiation of chief cells into SPEM, while parietal cell 
loss accompanied by inflammation exacerbates the SPEM induction and progression. 
However, the molecular mechanisms of transdifferentiation in chief cells and SPEM 
progression have been difficult to elucidate with the currently available model systems. 
In Chapter II, SPEM lineages arising in different milieu were investigated for 
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commonalities and differences of phenotypically similar SPEM lineages. Transcriptional 
expression of acute SPEM without inflammation (DMP-777) or in the presences of 
inflammation (L635) and chronic SPEM with chronic inflammation were analyzed by 
gene microarray. We hypothesized that the presence or absence of inflammation as well 
as the length of time would result in differences among the SPEM lineages. However, all 
SPEM lineages would express a subset of transcripts, regardless of the surroundings in 
which it arose. To further investigate novel markers found in Chapter II, as well as 
previously identified factors involved in the induction of SPEM, we utilized the 
Immortomouse to develop two novel in vitro cell culture systems: ImChief and ImSPEM. 
Development of these lines would provide crucial in vitro models for investigations into 
the molecular mechanisms of chief cells and metaplasia of the stomach. To understand 
the progression of metaplasia, the cell of origin must also be examined. In Chapter IV, 
Mist1 null mice were utilized to study the intrinsic characteristics of chief cells necessary 
for transdifferentiation into SPEM. Chief cells in Mist1 null mice do not completely 
mature because they cannot maintain their secretory machinery. While previous 
investigations have focused on extrinsic factors acting upon chief cells, this study focuses 
on the function of chief cells themselves in SPEM induction. Overall, the studies 
presented here broaden our current understanding of the initiation and induction of 
metaplasia in the stomach. Furthermore, these studies provide novel in vitro models to 
study the molecular mechanisms and interactions of SPEM. 
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CHAPTER II 
 
HETEROGENEITY IN MOUSE SPASMOLYTIC POLYPEPTIDE-EXPRESSING 
METAPLASIA LINEAGES IDENTIFIES MARKERS OF METAPLASTIC 
PROGRESSION 
Appears as: Weis, V.G., Sousa, J.F., Lafleur, B.J., Nam, K.T., Weis, J.A., Finke, 
P.E., Ameen, N.A., Fox, J.G., and Goldenring, J.R. Heterogeneity in mouse spasmolytic 
polypeptide-expressing metaplasia lineages identifies markers of metaplastic progression. 
Gut. In press. 
 
 
Introduction 
Helicobacter pylori infection is the major predisposing factor for human gastric 
cancer (Blaser et al. 1994a).  In humans, H. pylori infection causes a disruption in the 
gastric homeostasis by inducing prominent chronic inflammation and loss of parietal cells.  
The loss of parietal cells leads to two distinct types of mucous cell metaplasia: intestinal 
metaplasia and spasmolytic polypeptide-expressing metaplasia (SPEM).  While intestinal 
metaplasia has conventionally been considered the primary neoplastic precursor to gastric 
cancer, SPEM is associated with 90% of resected gastric cancers (Schmidt et al. 1999; 
Yamaguchi et al. 2001; Halldorsdottir et al. 2003).  Increasing evidence in humans and 
rodent models suggests that intestinal metaplasia develops in the presence of pre-existing 
SPEM, supporting the concept that SPEM is a neoplastic precursor (Yoshizawa et al. 
2007; Nam et al. 2009; Goldenring et al. 2010). 
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Chronic H. felis infection in mice is a critical model for H. pylori infection in 
humans.  After 6 months of H. felis infection, significant parietal cell loss accompanied 
by inflammation leads to the emergence of a proliferative SPEM lineage (Figure 3A).  
SPEM progresses to dysplasia after 1 year of infection without developing phenotypic 
intestinal metaplasia (Wang et al. 2000; Houghton et al. 2004a).  Thus, all present 
evidence indicates that SPEM is the direct precursor to dysplasia in H. felis-infected mice. 
Several mouse models have previously been utilized to investigate SPEM induction in the 
setting of parietal cell loss.  Of importance, an acute oxyntic atrophy model using the 
parietal cell-specific protonophore, DMP-777, allows for the separation of the roles of 
parietal cell loss and inflammation in the initiation of SPEM (Figure 3A) (Goldenring et 
al. 2000; Nomura et al. 2004c).  Oral gavage administration of DMP-777 for 14 days 
induces SPEM as a direct result of parietal cell loss.  However, DMP-777 also inhibits 
any inflammatory response because of its ability to potently inhibit neutrophil elastase 
resulting in SPEM that is less proliferative (Goldenring et al. 2000; Nomura et al. 2004c).  
DMP-777-induced SPEM fails to progress to dysplasia even after a year of administration 
(Goldenring et al. 2000).  Thus, the DMP-777 model shows that parietal cell loss is 
sufficient for SPEM initiation, but inflammation is necessary for the progression of 
SPEM to dysplasia.  In contrast, acute administration of L635, a protonophore analog of 
DMP-777 that lacks elastase inhibition, results in a prominent inflammatory response and 
induces a SPEM lineage phenotypically similar to H. felis infection (Figure 3A and 
Figure 4) (Nam et al. 2010).  Analysis of the progression to dysplasia with chronic 
administration of L635 is not currently feasible due to limited supplies of the drug.  These 
results have led to the concept that inflammatory cells drive the evolution of metaplasia 
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towards a more proliferative lineage and later to dysplasia.  However, no studies have 
investigated differences in expression among phenotypic SPEM lineages. 
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Figure 3. Models of phenotypic SPEM in mice and of metaplastic progression in 
humans.  (A) The three mouse models used in these investigations all display phenotypic 
SPEM.  DMP-777 administration is an acute model of parietal cell loss that results in 
SPEM without inflammation.  L635 administration is also an acute model of SPEM; 
however, L635-induced SPEM is accompanied by prominent inflammation.  H. felis 
infection is a SPEM model phenotypcially similar to L635 but with chronic 
inflammation.  H. felis infection induces SPEM at 6 months but progresses with chronic 
inflammation to acquire intestinal characteristics.  (B) In humans, loss of parietal cells 
leads to the emergence of SPEM.  Intestinal metaplasia arises from SPEM under the 
influences of chronic inflammation. 
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Figure 4. Expression of cytokines in the gastric mucosa of L-635–treated and H 
felis–infected mice. Transcript levels for tumor necrosis factor (TNF)-α, IL-1β, IL-4, IL-
10, and interferon-γ were determined by real-time PCR in fundic RNA samples isolated 
from untreated wild-type (WT), DMP-777–treated, L-635–treated, and H felis–infected 
mice (n = 3 for all groups). Results are expressed as a ratio of the mean expression in 
wild-type mice (±standard error of the mean). *P < 0.05 vs untreated wild-type mice. 
Adapted from (Nam et al. 2010). 
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 Recent studies have shed important light on the origins of SPEM lineages. 
Lineage mapping studies showed that SPEM arises through transdifferentiation of mature 
chief cells into mucous cell metaplasia (Nam et al. 2010).  Nevertheless, these studies 
utilizing three SPEM models have indicated that differences exist among phenotypically 
similar SPEM lineages.  H. felis infection-induced and L635-induced SPEM, both of 
which are associated with prominent inflammatory infiltrates, were derived almost 
completely from transdifferentiated chief cells.  In contrast, phenotypic SPEM arising 
from DMP-777 administration showed two distinct component lineages: 
transdifferentiated chief cells at the gland bases and mucous neck cell hyperplasia in the 
neck region (Nam et al. 2010).  Taken together, these studies suggest that 
transdifferentiation of chief cells to SPEM is common to all models, but the progression 
of metaplasia is significantly affected by the surrounding inflammatory milieu.    
To investigate the different phenotypic SPEM lineages, we have compared 
transcriptional expression profiles for microdissected chief cells from untreated C57BL/6 
mice with microdissected SPEM cells from mice after 6-12 months of H. felis infection, 3 
days of L635 administration, or 14 days of DMP-777 administration.  Specific 
comparison categories identified putative markers of SPEM emergence as well as 
metaplastic progression.  Wfdc2 (HE4), the previously reported SPEM and intestinal 
metaplasia marker,(Nozaki et al. 2008) was upregulated in all SPEM models.  
Additionally, the disulfide-linked heterodimeric glycoprotein clusterin (Clu), which is 
expressed only at low levels in the progenitor zone of the normal stomach, was 
upregulated in all of the SPEM lineages in both mice and humans.  SPEM models with 
inflammation showed upregulation of a number of biomarkers that also were previously 
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observed in human intestinal metaplasia (Lee et al. 2010).  The ATP-binding cassette 
transporter, cystic fibrosis transmembrane conductance regulator (CFTR), was not found 
in normal gastric mucosa or SPEM without inflammation, but was upregulated in 
inflammatory SPEM.  In humans, CFTR was expressed only in intestinal metaplasia, but 
not in normal mucosa or SPEM.  Together, these findings indicate that distinct 
heterogeneity is present in different animal models of phenotypic SPEM.   In addition, 
these investigations indicate that SPEM in the context of inflammation, especially with 
long-term infection with H. felis for greater than one year, acquires the expression of 
intestinal transcripts that resemble features of intestinal metaplasia in humans. 
 
Methods 
Mice 
C57BL/6 mice obtained from Jackson Laboratories (Bar Harbor, ME) were used 
for all experiments.  During the experiments, the mice were maintained with regular 
mouse chow and water ad libitum in a temperature-controlled room under a 12-hour 
light/dark cycle. The care, maintenance, and treatment of animals in these studies 
followed protocols approved by the Institutional Animal Care and Use Committee of 
Vanderbilt University. 
Drug administration and H. felis challenge 
DMP-777, a gift from DuPont Pharmaceuticals (Wilmington, DE), was 
formulated in 0.5% methylcellulose and administered orally as a gavage once daily at 350 
mg/kg/day for 14 consecutive days.  L635, dissolved in saline and orally administered as 
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a gavage once daily at 350 mg/kg/day for 3 consecutive days, was a gift from Merck & 
Co, Inc (Rahway, NJ).  H. felis was grown in brucella broth containing 5% fetal bovine 
serum overnight.  Bacteria were collected by centrifugation.  After fasting overnight, 6 
week old mice were inoculated 3 times every other day by oral gavage with 108 H. felis 
cells in 0.2 ml of brucella broth.   
Gene microarray analysis 
DMP-777 or L635 was administered by oral gavage to groups of six 7 month old 
C57BL/6 male mice.  Another group of 6 mice (2 males and 4 females) were H. felis 
infected for 6-12 months.  Untreated C57BL/6 male mice were used as controls.  Chief 
cells from control mice or SPEM lineages at the base of glands from treated mice were 
laser capture microdissected from frozen sections of fundic stomach.  Total RNA was 
isolated from microdissected cells with Picopure RNA Isolation Kit (Arcturus, Mountain 
View, CA).  The Nugen WT Pico Kit (San Carlos, CA) was used to reverse transcribe 
and amplify 25 ng of total RNA for each sample.  Fragmented and labeled samples were 
hybridized to Affymetrix Mouse Gene 1.0ST arrays (Santa Clara, CA) using standard 
Affymetrix protocols.  The raw gene expression data (.cel files) were converted to 
expression values using the Affy function in R (http://www.bioconductor.org).  Once 
expression values were obtained, we filtered the features that have at least 25% samples 
with intensities above 100 fluorescent units and inter-quartile range of at least 0.5 
(removal of outliers and non-specific intensities).  The log2-based expression levels were 
then compared on the resulting features using ebayes moderated t-tests implemented in 
the limma package.  These p-values were ranked and a candidate feature list was 
compiled, using False Discovery Rate adjusted p-value cut-offs obtained by the linear 
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step-up method described by Hochberg and Benjamini (Hochberg et al. 1990).  The 
generated candidate lists were then compared to each other to create the comparison 
categories (Table 1 and Supplemental Table 1 - Supplemental Table 5).   
Quantitative real time polymerase chain reaction  
From 3 male mice per group, total RNA was extracted from the gastric fundus 
using TRIzol (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions.  
For each sample, 1 μg of total RNA was treated with RQ1 RNase-free DNase (Promega, 
Madison, WI) and then reverse-transcribed using Superscript III reverse transcriptase 
(Invitrogen, Carlsbad, CA).  Quantitative real time polymerase chain reaction (qRT-PCR) 
was performed with EXPRESS SYBR GreenER quantitative PCR SuperMix (Invitrogen, 
Carlsbad, CA) using specific primers in an ABI StepOnePlus Real-Time PCR System 
(Applied Biosystems, Foster City, CA).  The specific primer sequences and 
concentrations are listed in Supplemental Table 6.  Each sample was run in triplicate 
following cycling conditions indicated by the SYBR Green supermix manufacturer's 
protocol.  Relative expression analysis was performed as previously reported (Nam et al. 
2010).  In short, using TATA–box-binding protein as an endogenous control and the 
mean value of the control mouse samples as a reference, the 2−ΔΔ cycle threshold method 
was used to compare samples.  Statistical significance (P < 0.05) between the groups was 
determined using the Mann-Whitney U test.   
Immunohistochemistry  
Excised stomachs from mice were frozen in liquid nitrogen or fixed in 4% 
paraformaldehyde overnight and embedded in paraffin.  For paraffin embedded samples, 
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antigen retrieval was performed using Target Retrieval solution (DakoCytomation, 
Glostrup, Denmark).  For frozen samples (for GSII lectin and CFTR antibodies), 7 μm 
thick sections were air dried then fixed in 4% paraformaldehyde (for GSII lectin) or 2% 
paraformaldehyde (for CFTR) for 10 minutes.  Immunostaining was performed using the 
following primary antibodies incubated at 4°C overnight:  mouse anti-TFF2 (1:500; a gift 
from Dr Nicholas Wright, Cancer UK, London, England), mouse anti-pan-cytokeratin 
(1:500, Abcam, Cambridge, MA), goat anti-clusterin α (1:2500, Santa Cruz 
Biotechnology, Santa Cruz, CA), rabbit anti-CFTR (1:500),(Ameen et al. 2000) and 
mouse anti-CFTR clone M3A7 (1:40, Santa Cruz Biotechnology, Santa Cruz, CA).  
Detection for immunohistochemistry was performed with 3,3-diaminobenzidine using a 
kit from Vector Laboratories (Burlingame, CA).  For immunofluorescence, Alexa594 
conjugated GSII lectin (Molecular Probes, Eugene, OR), Cy3-goat anti-mouse IgM 
antibody, Cy5-goat anti-mouse IgG antibody (Jackson ImmunoResearch, West Grove, 
PA), and Alexa488 donkey anti-goat IgG (Invitrogen, Carlsbad, CA) were used at 1:500.  
Slides were mounted with ProLong Gold Antifade Reagent with DAPI (Invitrogen).  
Sections were analyzed using Zeiss Axiophot microscope equipped with an Axiovision 
digital imaging system (Zeiss, Jena GmBH, Germany) or an Olympus FV1000 confocal 
microscope (Tokyo, Japan) and tissue arrays were analyzed using the Ariol SL-50 
automated slide scanner (Genetix, San Jose, CA).   
Statistical analysis   
A tissue array of normal gastric fundic mucosa (n=15) and metaplasias (SPEM 
and intestinal metaplasia, n=37) resected at University of Tokyo (Leys et al. 2006) was 
used for analysis of clusterin expression.  Each core was identified as having normal 
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glands, SPEM, intestinal metaplasia or a combination.  The TMA section used for 
analysis had 25 cores with normal glands, 20 with SPEM and 11 with intestinal 
metaplasia.  Samples were considered positive if the glands displayed the staining pattern 
described: progenitor region of normal glands, throughout SPEM glands, or a few cells at 
the base of intestinal metaplasia glands.  A percentage was calculated as the number of 
positive cores out of a total number of cores with SPEM or intestinal metaplasia.  For 
initial expression analysis in cancer, a tissue array comprised of 44 gastric cancers 
resected at Vanderbilt Medical Center (Leys et al. 2006) was scored as positive or 
negative using immunohistochemistry.  For this analysis, 16 intestinal-type cancer cores 
and 7 diffuse-type cancer cores were scored.  A core was considered positive if clusterin 
staining was detected in any part of the gland besides the progenitor region.  A second 
gastric adenocarcinoma tissue array with 450 patient samples resected at Seoul National 
University Hospital was used for correlation studies (SNUH-2004-GC; SuperBioChips, 
Seoul, Korea) (Lee et al. 2010).  Stained sections were scanned using the Ariol SL-50 
(Genetix, San Jose, CA).  CellProfiler (Lamprecht et al. 2007) (Broad Institute, 
Cambridge, MA) was then used to detect the percentage of epithelial cells positive for 
clusterin immunostaining using pan-cytokeratin as a reference for the total number of 
epithelial cells (Figure 5).  All counted cells had nuclei as detected by DAPI. 
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Figure 5. Representative images of tissue array cores and CellProfiler expression 
detection. Each core was individually processed with CellProfiler.  Pan-cytokeratin (red) 
was used to identify epithelial cells and DAPI for nuclei.  CellProfiler detected the 
number of clusterin (green) positive epithelial cells with nuclei.  The left panels are a 
representative TMA core images and the right panels are the CellProfiler renderings of 
the detected expression.  In the CellProfiler renderings (right panels), red represents 
epithelial cells with nuclei as detected by pan-cytokeratin staining and green is detectable 
clusterin staining.  The percentage of clusterin positive epithelial cells was used for 
correlation studies of clusterin expression. 
 
 
Cox proportional hazards models were used to evaluate the association between 
percent of clusterin positive epithelial cells and survival.  All models included pathologic 
stage as defined by American Joint Committee on Cancer (AJCC).  We transformed the 
percentage of positive clusterin staining using the square root transformation to reduce 
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variability.  Restricted cubic splices (rcs) were used to allow for more flexibility in the 
relationship between positive staining and survival.  Analysis of variance models were fit 
for clusterin levels and prognostic indicators including stage, Lauren grade, metastasis, 
and histopathology.  Pair-wise differences for all statistically significant prognostic 
indicators were performed at the 0.05 level of significance. 
 
Results 
 
Gene microarray analysis of phenotypic SPEM lineages with and without 
inflammation  
To compare the expression profiles of SPEM lineages arising in different milieus, 
we used laser capture microdissection to isolate chief cells from control untreated mice 
and SPEM cells at the bases of glands from mice treated with DMP-777, L635, or H. felis 
infection.  These SPEM models were selected based on their distinct characteristics such 
as length of treatment (acute versus chronic) and progression to dysplasia (presence 
versus absence of inflammation) (Figure 3A), so that the commonalities and differences 
among the different phenotypic SPEM lineages could be analyzed.  Levels of isolated 
mRNA transcripts from the microdissected cells were measured with Affymetrix gene 
microarrays.  Five comparison categories were established based on the SPEM model 
characteristics (as mentioned above) to analyze upregulated transcripts associated with 
either the emergence or progression of SPEM (listed in Table 1 with heat maps of each 
group shown in Figure 6).  The Pan-SPEM and Acute SPEM categories focus on 
transcripts upregulated with the induction of SPEM.  Transcripts upregulated in all SPEM 
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lineages as compared to chief cells are markers indicative of the initiation of SPEM (Pan-
SPEM).  Eight transcripts were upregulated in Pan-SPEM including the secreted 
glycoprotein, clusterin (Clu) and the previously reported SPEM marker, whey acidic 
protein 4-disulfide core domain 2 (Wfdc2, also known as HE4) (Nozaki et al. 2008).  In 
the previous study, we identified HE4 as a marker of SPEM and intestinal metaplasia that 
was not found in the normal stomach (Nozaki et al. 2008).  The Acute SPEM comparison, 
comprised of transcripts increased in acute SPEM lineages (DMP-777 and L635-induced 
SPEM) versus chief cells, revealed transcripts that initially increase in SPEM induction, 
but decrease in chronic SPEM lineages.  Acute SPEM identified 5 additional transcripts 
upregulated in the initiation of SPEM (Table 1), which included fidgetin-like 1 (Fignl1), 
a transcript previously reported as upregulated in gastrin-deficient mice treated with 
DMP-777 (Nozaki et al. 2008).   
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Figure 6. Heat map analysis of each comparison category. Heat map analysis was 
performed on each comparison category:  Pan-SPEM (A), Acute SPEM (B), SPEM with 
Inflammation (C), Specific to SPEM with Inflammation (D), and SPEM with Chronic 
Inflammation (E).  Clustering of samples is shown in each panel.   
 
 
Table 1. Upregulated transcripts in three mouse models of SPEM. Normal chief cells 
and SPEM lineages from 3 SPEM models were compared by gene microarray (6 mice per 
group).  Five comparison categories were established: Pan-SPEM (I), Acute SPEM (II), 
SPEM with Inflammation (III), Specific to SPEM with Inflammation (IV), and SPEM 
with Chronic Inflammation (V).  The linear fold change in each sample group is listed as 
compared to the column marked with a bullet point (•).  In Categories I, II, and III, fold 
changes are upregulated as compared to Chief Cells.  Category IV changes are compared 
to DMP-777.  In Category V, listed transcripts are upregulated in H. felis as compared to 
each of the other groups; thus fold changes are shown as relative downregulation in the 
respective groups.  Asterisks denote transcripts previously found upregulated in human 
metaplasias of the stomach (Lee et al. 2010). 
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  I. Pan-SPEM
Chief Cells DMP-777 L635 H.felis
*Ccnb2 ● 2.01 2.55 1.82
*Cenpk ● 1.35 2.60 1.27
 Clu ● 1.04 1.58 1.38
 Cxcl17 ● 1.50 1.81 1.56
 Slfn9 ● 1.33 2.18 1.33
*Top2a ● 1.95 2.92 2.11
 Traf4 ● 1.75 2.18 1.59
 Wfdc2 ● 1.62 1.50 3.12
II. Acute SPEM
Chief Cells DMP-777 L635
 Chek2 ● 1.23 1.42
 Fignl1 ● 1.19 1.93
 Mmp12 ● 1.91 2.79
 Tmem48 ● 0.78 1.76
 Ube2c ● 1.61 2.88
III. SPEM with Inflammation
Chief Cells L635 H.felis
*Cftr ● 3.14 5.78
*Ctss ● 1.24 2.03
*Dmbt1 ● 2.72 2.77
 Etv5 ● 2.01 3.13
*Gpx2 ● 2.36 3.00
*Mad2l1 ● 2.12 1.78
*Prom1 ● 0.73 1.44
IV. Specific to SPEM with Inflammation
DMP-777 L635 H.felis
 Arhgap9 ● 0.84 0.77
 Cd14 ● 1.53 2.72
 Ceacam10 ● 0.36 2.17
 Glipr1 ● 0.98 0.84
 Gpr171 ● 1.89 2.17
 Ly6a ● 0.75 1.26
 Lyz2 ● 2.53 1.97
 Ms4a6b ● 1.45 1.94
 Ms4a6c ● 2.13 2.03
 Tyrobp ● 1.47 1.15
V. SPEM with Chronic Inflammation
Chief Cells DMP-777 L635 H.felis
*Casp1 -4.10 -4.45 -4.32 ●
*Ceacam1 -3.44 -3.05 -2.28 ●
*Gpa33 -2.93 -2.74 -3.60 ●
*Il18r1 -3.09 -1.66 -1.99 ●
*Itga2 -2.87 -2.61 -2.81 ●
*Muc4 -3.74 -3.34 -3.77 ●
*Pigr -5.37 -3.29 -3.16 ●
*Vil1 -2.59 -2.26 -2.60 ●
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Because previous studies have indicated that SPEM cannot progress to dysplasia 
in the absence of inflammation,(Goldenring et al. 2000; Oshima et al. 2005) transcripts 
putatively involved in the progression of SPEM were identified with comparisons 
focusing on SPEM accompanied by inflammation (L635- and H. felis-induced SPEM).  
Transcripts increased in L635- and H. felis-induced SPEM versus chief cells are listed as 
“SPEM with Inflammation,” whereas the comparison of inflammatory SPEM to non-
inflammatory SPEM (DMP-777-induced SPEM) identified “Specific to SPEM with 
Inflammation” transcripts.  The “SPEM with Chronic Inflammation” category compares 
H. felis-induced SPEM to acute SPEM models (with and without inflammation) and chief 
cells.  Ten transcripts were upregulated in the Specific to SPEM with Inflammation 
comparison.  The SPEM with Inflammation and SPEM with Chronic Inflammation 
categories yielded numerous upregulated transcripts (43 and 131, respectively) (selected 
transcripts listed in Table 1).  Pathway analysis of the comparison categories only 
identified an increase in interferon-γ associated genes in SPEM with Chronic 
Inflammation (Figure 7).  As a whole, these gene microarray studies demonstrated that 
phenotypic SPEM lineages did indeed demonstrate distinct differences in transcript 
expression. 
 To narrow the lists for further investigation, we compared the upregulated 
transcripts to transcripts previously reported as upregulated in microdissected human 
metaplasias of the stomach (SPEM or intestinal metaplasia) by gene microarray (Lee et 
al. 2010) (Table 1).  Nine transcripts from SPEM with Inflammation, including the 
chloride transporter, cystic fibrosis transmembrane conductance regulator homolog 
(CFTR), were also upregulated in human metaplasia, while 17 common transcripts were 
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found for SPEM with Chronic Inflammation.  Only 3 other transcripts from the other 
comparison categories, topoisomerase (DNA) IIα (Top2a), cyclin B2 (Ccnb2), and 
centromere protein K (Cenpk), were also upregulated in the human metaplasia 
microarrays.  Thus, we found considerable overlap in transcripts associated with SPEM 
with Inflammation in mice and those associated with metaplasias in humans. 
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Figure 7. Pathway analysis of SPEM with Chronic Inflammation. Pathway 
characteristics were analyzed by examining WIKIpathways database for transcripts in 
each of the comparison categories using WebGestalt.  The SPEM with Chronic 
Inflammation category was enriched with interferon-γ associated genes. 
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Quantitative PCR analysis of upregulated transcripts  
Quantitative real-time PCR (qRT-PCR) was used to evaluate further selected 
upregulated transcripts from each of the comparison categories (Figure 8 and Figure 9 - 
Figure 13).  H. felis-induced SPEM was divided into two time points (6 and 12 months) 
to distinguish between the earlier stages of SPEM and chronic SPEM.  In these studies, 
regions of whole gastric fundus were used for qRT-PCR, rather than microdissected 
samples.  While this approach failed to validate all transcripts from the categories, it 
allowed for analysis of and insight into upregulation on a more global scale.  The poorly 
understood gene, schlafen 9 (Slfn9), from the Pan-SPEM category was significantly 
upregulated in all SPEM models versus normal gastric mucosa (Figure 8A).  HE4 
expression showed an increasing trend in all SPEM models, but failed to reach statistical 
significance in all individual comparisons.  Clusterin was significantly upregulated in 
acute SPEM models, and there was a trend towards upregulation in 12 month H. felis 
infection-induced SPEM (Figure 8A).  All five Acute SPEM transcripts were 
significantly increased in DMP-777- and L635-induced SPEM versus normal mucosa 
(Figure 8B and Figure 10).  The six transcripts in SPEM with Inflammation that were 
upregulated in human metaplasias of the stomach were tested along with a selected 
transcript, ets variant gene 5 (ETV5), which was the only transcription factor found in the 
category (Figure 8C and Figure 11).  Many of the transcripts, including CFTR and ETV5, 
were validated as significantly upregulated in SPEM with inflammation as compared to 
normal mucosa.  CFTR expression increased over 100-fold in 12 month H. felis 
infection-induced SPEM.  Notably, ETV5 was significantly upregulated in L635- and 6 
month H. felis infection-induced SPEM, but decreased to near normal levels after 12 
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months of H. felis infection.  Similar to Pan-SPEM transcripts, not all of the Specific to 
SPEM with Inflammation transcripts followed the trend found in the microarray data with 
statistical significance (Figure 8D and Figure 12).  Expression of carcinoembryonic 
antigen-related cell adhesion molecule 10 (Ceacam10) and TYRO protein tyrosine kinase 
binding protein (Tyrobp) expression was significantly increased in inflammatory SPEM 
models as compared to the non-inflammatory SPEM model.  While others such as glioma 
pathogenesis-related 1 (Glipr1) and the two members of the membrane-spanning 4-
domains subfamily A, member 6B and member 6C (Ms4a6b and Ms4a6c), followed the 
trend, but did not achieve statistical significance.  Five transcripts from SPEM with 
Chronic Inflammation that were also upregulated in human metaplasias of the stomach 
(Nomura et al. 2004c) were selected for qRT-PCR analysis (Figure 8E and Figure 13).  
Four of these transcripts, including villin 1 (Vil1), were significantly upregulated in the 
12 month H. felis infection-induced SPEM model compared to the other sample groups 
(acute SPEM models and control).  Together, these results provide a consistent profile of 
the alterations in the expression of the transcripts in each comparison category, and thus 
classify gene expression characteristics of SPEM with and without inflammatory 
influence.   
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Figure 8. Quantitative Real Time PCR assay of selected upregulated transcripts 
from each comparison category. Expression of selected upregulated transcripts from 
each category was assessed by qRT-PCR in RNA isolated from the whole fundic stomach 
(3 mice per group).  Pan-SPEM (A) and Acute SPEM (B) transcripts were associated 
with the emergence of SPEM, while SPEM with Inflammation (C), Specific to SPEM 
with Inflammation (D), and SPEM with Chronic Inflammation (E) relate to the 
progression of SPEM lineages.  Results are shown as fold change as compared to the 
mean value of the control group (labeled WT).  Single asterisks in A, B, and C signify 
significant upregulation as compared to WT.  Double asterisks in D are significant as 
compared to DMP-777-induced SPEM.  Significance in E (+) is noted as compared to 12 
month H. felis infection. All values are shown as means +/- standard error of the mean, 
SE. (p < 0.05 by Mann-Whitney U test). 
 
 
 
Figure 9. Quantitative Real Time PCR of transcripts in the Pan-SPEM category. 
Global expression of upregulated transcripts from each category was assessed by qRT-
PCR as in Figure 2.  The SPEM models were compared to WT (n=3, mean+/- standard 
error of the mean, SE). (*p < 0.05 by Mann-Whitney U test).   
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Figure 10. Quantitative Real Time PCR of transcripts in the Acute SPEM category. 
Global expression of upregulated transcripts from each category was assessed by qRT-
PCR as in Figure 2.  The acute SPEM models (DMP-777 and L635) were compared to 
WT (n=3, mean +/- standard error of the mean, SE). (*p < 0.05 by Mann-Whitney U 
test).   
 
 
 
Figure 11. Quantitative Real Time PCR of transcripts in the SPEM with 
Inflammation category.  Global expression of upregulated transcripts from each 
category was assessed by qRT-PCR as in Figure 2.  The inflammatory SPEM models 
(L635 and H.felis) were compared to WT (n=3, mean +/- standard error of the mean, SE). 
(*p < 0.05 by Mann-Whitney U test). 
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Figure 12. Quantitative Real Time PCR of transcripts in the Specific to SPEM with 
Inflammation category. Global expression of upregulated transcripts from each category 
was assessed by qRT-PCR as in Figure 2.  The inflammatory SPEM models (L635 and 
H.felis) were compared to the non-inflammatory SPEM model (DMP-777)  (n=3, mean 
+/- standard error of the mean, SE). (**p < 0.05 by Mann-Whitney U test). 
 
 
 
 
Figure 13. Quantitative Real Time PCR of transcripts in the SPEM with Chronic 
Inflammation category.  Global expression of upregulated transcripts from each 
category was assessed by qRT-PCR as in Figure 2.  Each group is compared to 12 month 
H.felis infection-induced SPEM (n=3, mean +/- standard error of the mean, SE). (+p < 
0.05 by Mann-Whitney U test). 
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Clusterin expression is increased in all SPEM lineages   
Based on antibody availability, we selected clusterin from the Pan-SPEM 
category to investigate protein expression profiles of the induction of SPEM.  Clusterin is 
a ubiquitously expressed secreted glycoprotein thought to be involved in a variety of 
cellular processes such as tissue remodeling, differentiation, cytoprotection, and anti-
apoptosis (Collard et al. 1987; Aronow et al. 1993; Ahuja et al. 1994; McLaughlin et al. 
2000; Lee et al. 2011; Fjeldbo et al. 2012).  In untreated mice, clusterin staining was 
observed at low levels only in cells in the isthmus of the oxyntic glands (Figure 14).  
Some clusterin positive cells co-labeled with the first few TFF2-expressing mucous neck 
cells.  In all SPEM models, clusterin was strongly expressed throughout the SPEM 
lineages (Figure 14).  Differences in the upregulation of clusterin mRNA versus 
detectable protein suggests clusterin mRNA is processed differently between the SPEM 
lineages.  Together, these results demonstrate that clusterin protein expression is a marker 
of SPEM regardless of the causation or surrounding milieu of chief cell 
transdifferentiation to SPEM.   
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Figure 14. Expression of Clusterin in normal murine gastric mucosa and SPEM 
models. Sections of C57BL/6 mouse fundic mucosa were immunostained with antibodies 
against clusterin (top panels, red) and TFF2 (middle panels, green).  In WT mice, 
clusterin was expressed in cells located in the isthmus and co-labeled with TFF2 in a 
small number of cells (arrowheads and higher magnification inset).  Clusterin expression 
was detected throughout all SPEM lineages (14 day DMP-777 administration, 3 day 
L635 administration, and 12 month H. felis infection) (arrowheads and higher 
magnification insets).  DAPI (blue).  Bar = 20 μm. 
 
 
Upregulation of CFTR expression is observed only in SPEM with inflammation   
To investigate possible markers for the progression of SPEM lineages, we 
examined the expression of CFTR, the most upregulated transcript in SPEM with 
inflammation as detected by qRT-PCR.  CFTR is an ATP-gated chloride channel that is 
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found on the apical membrane of epithelial cells including intestinal crypt cells (Ameen 
et al. 2000).  As assessed by immunohistochemistry, CFTR was not detected in the 
normal gastric fundus (Figure 15) confirming previous investigations (McDaniel et al. 
2005).  Although CFTR mRNA was increased in all SPEM lineages, DMP-777-induced 
SPEM lineages lacked detectable CFTR protein expression.  However, expression of 
CFTR protein was observed in the apical membranes of the inflammatory SPEM lineages 
induced by either L635 administration or H. felis infection, which both have large 
increases in CFTR mRNA expression (Figure 15).  Similar expression was seen 
following 6 months and 12 months of H. felis infection (data not shown).  These results 
show a difference in expression patterns between the inflammatory and non-
inflammatory SPEM lineages and suggest that CFTR is a marker of advanced 
proliferative SPEM that may possess the ability to progress towards dysplasia.   
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Figure 15. Expression of CFTR in normal murine gastric mucosa and SPEM 
models. Frozen sections of C57BL/6 mouse fundic mucosa were immunostained with 
either GSII lectin (a mucous neck cell and SPEM marker) or an antibody against CFTR 
to investigate CFTR protein expression in SPEM. Top Panel: GSII (green) labels mucous 
neck cells in WT stomach mucosa and SPEM at the bases of glands in each of the SPEM 
models.  Middle and Bottom Panels: Frozen sections immunohistochemical staining for 
CFTR showed no CFTR expression was detected in either WT mucosa or non-
inflammatory SPEM (DMP-777-induced SPEM).  The inset shows magnification of the 
bases of glands.  CFTR expression was detected on the apical membranes of SPEM cells 
accompanied by inflammation (3 day L635 administration and 12 month H. felis 
infection).  Scale bars = 20 μm. 
 
Clusterin and CFTR expression in human metaplasias of the stomach and gastric 
cancer  
Based on the murine data, we examined the expression of clusterin and CFTR in 
human gastric tissues.  Clusterin was expressed in a pattern similar to that observed in 
murine tissue.  In normal human gastric mucosa, clusterin was detected in the isthmus 
region of fundic glands (Figure 16A).  Some dual-labeling with TFF2 was observed in 
cells near the upper neck region of oxyntic glands, similar to our observations in mouse.  
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In metaplasias of the stomach, clusterin had a robust granular pattern throughout SPEM 
glands, but was limited to a few cells at the base of glands when detected in intestinal 
metaplasia (Figure 16B).  These clusterin positive intestinal metaplasia cells did not 
express TFF2.  In a tissue array of metaplasias from the human gastric fundus, 90% of 
cores with SPEM and 46% with intestinal metaplasia (18/20 and 5/11, respectively) were 
positive for the respective clusterin staining patterns.  In a small cohort of gastric 
adenocarcinomas collected at Vanderbilt, clusterin was expressed in 56.5% of cancers 
(9/16 intestinal-type and 4/7 diffuse-type).  A second cohort of 450 Korean patient 
samples, predominately early stage cancers, was used to assess clusterin as a prognostic 
biomarker.  Clusterin staining was quantified by calculating the percentage of keratin-
staining epithelial cells in each sample that were clusterin positive (Figure 16C and 
Figure 5).  There was a statistically significant association between percent of clusterin 
positive epithelial cells and stage.  Specifically, there were pairwise differences between 
all comparisons except stage 1 versus 3, and stage 3 versus 4 (Figure 16D).  Both positive 
clusterin staining and stage were associated with survival (p-values of .0232 and < 0.0001, 
respectively).  Clusterin was modeled using a restricted cubic spline with 4 knots.  While 
the second knot (consisting of 23-43% clusterin positive epithelial staining) correlated 
with longer survival time, the 43-95% staining group was associated with shorter survival 
time (Figure 16E).  Further, the model including both stage and percent clusterin staining 
had a c-index of 0.86, which is essentially equivalent to an area under the ROC curve 
(demonstrating good prediction). 
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Figure 16. Clusterin expression in human normal gastric mucosa, metaplasia of the 
stomach, and gastric cancer. (A) In normal glands, clusterin (green) was detected in the 
isthmus and in a few cells dual-labeled with TFF2 (red) as seen in the inset (arrowheads 
in top right panel).  The sample shown was taken from the University of Tokyo 
metaplasia array.  (B) Clusterin was prominently expressed throughout SPEM glands as 
marked by TFF2 in red.  In intestinal metaplasia, clusterin was limited to a few cells at 
the base of glands (designated by arrowheads in bottom right panel).  These staining 
patterns were found in 90% of SPEM samples and 45% of intestinal metaplasia samples 
on the University of Tokyo metaplasia tissue array.  Left panel scale bar = 100 μm.  Inset 
panel scale bar = 50 μm.  (C) Representative images from a human gastric cancer TMA 
show clusterin (green) expression in gastric cancer cells in each stage.  Pan-cytokeratin 
staining (red) marks epithelial cells.  Clusterin expression was present in all stages of 
cancer (I-IV) with averages of 27.75%, 21.82%, 31.32%, and 37.94% clusterin positive 
epithelial cells, respectively.  DAPI (blue). Bar = 100 μm.  (D) The percentage of 
clusterin positive epithelial cells was statistically significantly related to tumor stage by 
analysis of variance (p = 0.05).  There were significant differences in clusterin staining 
between stage 1 compared to stages 2 and 4 (labeled with *) and stage 2 versus stages 3 
and 4 (labeled with +).  (E) Estimated survival curves of clusterin by staining percentage 
categorized into 4 quartiles.  The highest staining quartile (43-95% clusterin positive 
epithelial cells) correlated with the worst survival outcome.   
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CFTR expression was also investigated to understand the correlation between 
murine and human gastric metaplasias.  Similar to murine expression patterns, CFTR was 
undetectable in normal gastric mucosa (Figure 17).  Conversely, CFTR was not observed 
in human SPEM even though it was accompanied by prominent inflammation.  
Nevertheless, intestinal metaplasia showed strong CFTR expression in the apical 
membranes throughout the glands.  An analysis of CFTR expression in adenocarcinomas 
using tissue arrays was not possible because all available antibody reagents only perform 
well in frozen sections.   Nevertheless, taken together with the murine tissue data, these 
results suggest a correlation between SPEM with inflammation in mice and intestinal 
metaplasia in humans, supporting the hypothesis that murine SPEM with inflammation is 
more advanced and acquires intestinal characteristics. 
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Figure 17. CFTR expression in human normal gastric mucosa and in metaplasia of 
the human stomach. Frozen sections of human stomach were immunostained with an 
antibody against CFTR (bottom panels).  Top panels are H&E staining of sections for 
orientation and morphology.  CFTR was absent from normal mucosa (bottom left) and 
SPEM lineages (designated by arrowheads in right panels).  The diffuse cytoplasmic 
immunoreactivity seen in surface cells is nonspecific as CFTR is localized to apical 
membranes.  However, expression was observed in intestinal metaplasia (bottom right).  
Due to limitations of the CFTR antibody and the lack of availability of frozen 
adenocarcinoma samples, CFTR expression was not evaluated in cancers.   Bar = 100 
μm. 
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Discussion 
 Chronic H. pylori infection in humans results in the loss of parietal cells 
accompanied by prominent inflammation.  Loss of parietal cells from the gastric mucosa 
results in a disruption of the homeostasis that, under normal conditions, promotes orderly 
differentiation and maturation of oxyntic gland lineages.  Our previous data have shown 
that parietal cell loss without inflamamtion (DMP-777 treatment) results in the 
transdifferentiation of chief cells into SPEM (Nam et al. 2010), possibly as a transient 
and local injury response mechanism.  However, when SPEM becomes chronic, under 
the continuing influence of chronic inflammation as in the setting of H. pylori infection, 
SPEM progresses to dysplasia. Although SPEM alone is not sufficient for progression to 
dysplasia, it is necessary for the initiation of carcinogenesis cascade.  Thus, metaplastic 
cell lineages such as SPEM and intestinal metaplasia are considered neoplastic precursors.  
Intestinal metaplasia arises in the presence of pre-existing SPEM (Yoshizawa et al. 2007; 
Goldenring et al. 2010) suggesting a progression from SPEM to intestinal metaplasia and 
then to neoplasia.  The mechanisms of the induction and progression of metaplasias in the 
stomach remain poorly understood.  A number of investigators have utilized chronic H. 
felis infection in mice as a major model for the development of metaplasia in the stomach 
and progression to dysplasia (Lee et al. 1990; Wang et al. 2000; Houghton et al. 2004a; 
Nam et al. 2010; Oshima et al. 2011; Varon et al. 2011).  H. felis infected mice do not 
develop phenotypic intestinal metaplasia, but instead SPEM progresses directly to 
dysplasia (Wang et al. 2000; Houghton et al. 2004a).  The present investigation indicates 
that, while phenotypic intestinal metaplasia may not develop from SPEM in H. felis-
infected mice, over time the SPEM lineages do begin to express intestinal transcripts, 
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including CFTR and villin.  Thus, while these lineages may not display all of the 
characteristics of goblet cells and absorptive cells as in human intestinal metaplasia, they 
do represent further alterations towards more intestinal characteristics that correlate with 
susceptibility to the development of dysplasia (Figure 3).  
 Studies using DMP-777 and L635 have shown that parietal cell loss is sufficient 
to induce SPEM, but the presence of inflammation is necessary for the progression of 
SPEM to a more proliferative metaplasia as well as to gastritis cystica profunda/dysplasia 
(Fox et al. 1993; Goldenring et al. 2000; Nam et al. 2010).  Differences in the timescale 
for SPEM emergence as well as proliferation and dysplastic potential suggest that the 
surrounding milieu significantly affects the SPEM lineages.  Previously, differences 
among phenotypically similar SPEM lineages have not been investigated.  In this study, 
we analyzed the transcriptional expression of three SPEM models, establishing 
expression profiles for each lineage model.  Specific comparisons of these profiles 
identified commonalities and differences among the SPEM lineages arising in different 
milieus.  Thirteen transcripts were upregulated in two comparison categories (Pan-SPEM 
and Acute SPEM) indicative of SPEM initiation.  Two of these, the secreted glycoprotein 
Wfdc2/HE4 and the poorly characterized ATPase Fignl1, were previously reported as 
upregulated in SPEM from gastrin null mice after only 1 day of DMP-777 treatment 
(Nozaki et al. 2008).  Another secreted glycoprotein, clusterin, was also upregulated in 
SPEM.  Similar to HE4, clusterin was prominently expressed in all SPEM lineages.  A 
recent study has shown that clusterin upregulation may in part be induced by gastrin 
(Fjeldbo et al. 2012), which is elevated in our mouse models of SPEM.  However, 
clusterin is also upregulated in SPEM from DMP-777 treated gastrin null mice (data not 
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shown), indicating that gastrin-independent pathways exist for clusterin upregulation.  
Although the mechanisms for clusterin upregulation are unclear, clusterin represents a 
specific marker of SPEM induction in the gastric oxyntic mucosa.   
 Comparisons of expression profiles of the inflammatory SPEM models identified 
putative markers of advanced SPEM.  In particular, prominent upregulation of CFTR was 
observed in both inflammatory SPEM models, but was undetectable in normal glands and 
in the non-inflammatory DMP-777-induced SPEM lineages.  This represents the first 
definite expression difference among phenotypic SPEM lineages.  Along with the other 
changes in intestinal transcripts such as villin, these findings suggest that inflammation 
elicits upregulation of genes, such as CFTR, which are more characteristic of the 
duodenum.  As inflammation is required for progression of metaplasia to dysplasia, it 
follows that SPEM accompanied by prominent inflammation acquires intestinal 
metaplastic markers.  Moreover, a recent study from Varon et. al. suggested 
Helicobacter-induced metaplasia advances after 75 weeks to express Muc2, an intestinal 
metaplasia marker, in the upper portions of glands (Varon et al. 2011).  The comparisons 
in the present study represent expression profiles that can be used to distinguish 
differences among phenotypic SPEM lineages such as the more advanced SPEM with 
intestinal characteristics (SPEM-IC) that is susceptible to progression to dysplasia.  It 
remains unclear at this time whether proteins such as clusterin and CFTR represent 
markers of the metaplastic process or whether they directly contribute to the progression 
of disease.  Direct analysis of these questions remains problematic because there are no in 
vitro models of normal chief cells and metaplastic lineages (SPEM and IM).  
Nevertheless, we anticipate that the rapid induction of metaplasia following L635 
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treatment will aid future examination of candidate protein influences using mouse strains 
with targeted gene disruption. 
Taken together, the identification of differences among the expression profiles of 
phenotypic SPEM lineages illustrates the need to characterize in greater detail SPEM 
lineages found in the various models of metaplasia of the stomach and gastric cancer.  
Although SPEM was initially underappreciated as a preneoplastic lesion, recent 
investigations have illustrated the high prevalence of SPEM in numerous mouse models 
of gastric homeostasis and gastric cancer (Oshima et al. 2004; Katz et al. 2005; Oshima et 
al. 2006; Jain et al. 2008; Keeley et al. 2010; Ito et al. 2011).  The loss of Klf4 in 
glandular tissues results in the development a SPEM phenotype in the absence of 
inflammation (Katz et al. 2005).  Similar to DMP-777- induced SPEM, SPEM in Klf4-
deficient mice does not acquire intestinal characteristics (such as Muc2 or villin 
expression) nor does it progress to dysplasia.  Samuelson et. al. reported that the loss of 
Hip1r in parietal cells resulted in apoptotic loss of parietal cells and chief cells (Jain et al. 
2008; Keeley et al. 2010).  A SPEM lineage accompanied by inflammatory infiltrates 
emerged at 5 weeks of age (Jain et al. 2008; Keeley et al. 2010).  Expression of intestinal 
features such as Muc2 and villin is unknown in this SPEM model; however, this model is 
of interest for comparison to L635-induced SPEM (an acute SPEM model with 
inflammation).  K19-C2mE transgenic mice, which overexpress COX-2 and microsomal 
prostaglandin E synthase-1 (mPGES-1), develop SPEM at 12 weeks of age and then 
progress to tumors at 48 weeks (Oshima et al. 2004).  The addition of WntI expression 
(K19-WntI/C2mE or Gan mice) resulted in SPEM at 5 weeks of age progressing to 
dysplastic tumors at 20 weeks (Oshima et al. 2006).  In these models, development of 
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mucosal lesions was associated with prominent macrophage infiltrates similar to H. felis-
induced SPEM.  In contrast to all SPEM models utilized in this study, mice deficient for 
Runx3 develop a SPEM phenotype without prominent inflammation and without loss of 
parietal cells.  Although there is no inflammatory infiltrate, cells at the base of some 
SPEM glands expressed intestinal markers, Muc2 and CDX2 (Ito et al. 2011), which are 
not seen in our metaplasia models.  This model is of interest for comparison because of 
the progression of SPEM to acquire intestinal characteristics without the presence of 
inflammation or loss of parietal cells.  The markers identified in our present 
investigations should provide reference points for analysis of the metaplastic lineages that 
arise in these other mouse models. 
 By establishing commonalities and differences in the expression patterns in our 
three murine SPEM models, we were able to find novel potential biomarkers of 
metaplasia in the human stomach (Clusterin and CFTR).  While all SPEM lineages in 
mice expressed clusterin, we found that 90% of SPEM and 46% of intestinal metaplasia 
in humans expressed clusterin.  In human intestinal metaplasia, clusterin localized to a 
few cells at the base of the intestinal metaplasia, which is the region suggested as a 
transitional and proliferative area of intestinal metaplasia arising from SPEM (Goldenring 
et al. 2010).  Clusterin may be acting in an anti-apoptotic or cytoprotective manner to 
help maintain this transitional niche.  Clusterin upregulation was maintained in the 
majority of intestinal-type and diffuse-type cancers.   Correlation between clusterin 
expression and stage was U-shaped suggesting clusterin functions differently in the 
different stages of cancer, a pattern previously observed in other types of cancers (Rizzi 
et al. 2010).  Adverse patient outcome was associated with the highest percentage of 
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clusterin expression, which was more frequently seen in late stage cancers.  This study 
supports the recent findings that high clusterin expression in late stage gastric cancers 
correlated with a poor outcome (Bi et al. 2010). Therefore, clusterin is a useful biomarker 
for SPEM and an adverse prognostic marker for adenocarcinomas.  Conversely, CFTR 
expression was absent in human SPEM, but was upregulated in intestinal metaplasia.  
These findings show that expression profiles in murine SPEM with inflammation 
(SPEM-IC) overlap with human intestinal metaplasia, suggesting that SPEM-IC is a more 
advanced SPEM lineage (Figure 3).  Further investigation of murine SPEM lineages will 
provide greater insight into the heterogeneity of SPEM as well as the progression of early 
stage SPEM to SPEM-IC in mouse and, by analogy, to the progression of SPEM to 
intestinal metaplasia in humans. 
 In summary, we have established distinct expression profiles of SPEM with or 
without inflammation that illustrate similarities among all SPEM lineages and differences 
in SPEM lineages with the potential for progression to dysplasia in mice.  From these 
profiles, clusterin upregulation was verified as a biomarker of SPEM and poor patient 
outcome.  Additionally, CFTR was identified as a biomarker of SPEM with inflammation 
in mice and intestinal metaplasia in humans.  The expression profiles of SPEM lineages 
with inflammation, especially H. felis infection-induced SPEM, identified a more 
advanced SPEM lineage in mice that has adopted some intestinal characteristics.  These 
studies support a model of metaplastic progression in mice that begins with the induction 
of SPEM and advances to SPEM with intestinal characteristics (SPEM-IC) that may have 
dysplastic potential.  The studies also indicate that the mouse model of chronic H. felis 
infection does mimic the analogous human condition of H. pylori infection suggesting a 
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progression of parietal cell loss to initiation of SPEM to further metaplastic progression 
towards intestinalizing metaplasia in the presence of inflammatory influences. 
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CHAPTER III 
 
NOVEL IN VITRO CHIEF CELL AND SPEM CULTURES PROVIDE A MODEL 
FOR CHARACTERIZATION OF METAPLASIA IN THE STOMACH 
Appears as: Weis, V.G., Petersen, C.P., Mills, J.C., Drapkin, R.I., Tuma, P.L., Whitehead, 
R.H., and Goldenring, J.R. Novel in vitro chief cell and SPEM cultures provide a model 
for characterization of metaplasia in the stomach. Manuscript in preparation. 
 
 
Introduction 
 Homeostasis in the stomach relies on a balance of the production and maintenance 
of multiple cell lineages, such as the acid-producing parietal cells, mucous-secreting neck 
cells, and zymogen-secreting chief cells. In the normal stomach, mucous neck cells 
transdifferentiate into chief cells as they progress towards the base of the gastric glands 
(Karam et al. 1993d; Ramsey et al. 2007).  Parietal cells are thought to secrete factors that 
control this maturation of chief cells (Beauchamp et al. 1989; Murayama et al. 1994; Abe 
et al. 1997; Jain et al. 2006a) because the absence of parietal cells results in loss of chief 
cells (Li et al. 1996). However, the specific factors responsible for chief cell maturation 
and homeostasis of are unclear. Studies using in vivo models and in vitro primary culture 
models to investigate these specific factors show the effects of a specific factor on the 
whole tissue level. Using these techniques, several studies have attempted to elucidate 
such factors and have determined various aspects of chief cell function, such as signals 
that regulate zymogen secretion (Langley 1882; Hirschowitz 1967; Koelz et al. 1982; 
Raufman et al. 1983; Berger et al. 1985; Sutliff et al. 1986; Raufman et al. 1987). The 
molecular pathways that regulate zymogen secretion were established further with 
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pharmacological agents that activate specific steps of recognized signaling pathways, 
such as elevation of cAMP or Ca2+ levels (Muallem et al. 1986; Raufman et al. 1986; 
Brown et al. 1987; Matozaki et al. 1988; Tsunoda et al. 1988). However, the trafficking 
pathways involved in secretion are still unknown. The majority of these studies utilized 
isolated primary chief cells, which precludes molecular studies. Therefore, it has proven 
difficult to elucidate the molecular pathways and interactions of the factors involved in 
the maturation and function of chief cells due to the lack of an in vitro model that can be 
easily manipulated.  
 In damage or disease, the homeostasis of the stomach is disrupted and chief cells 
trandifferentiate into spasmolytic polypeptide-expressing metaplasia (SPEM) (Nomura et 
al. 2004a; Nomura et al. 2004c; Nozaki et al. 2008; Nam et al. 2010). Acute SPEM is 
thought to be a protective mechanism for repairing local damage; however, in the 
presence of inflammation, SPEM progresses to more advanced metaplasia (Fox et al. 
1993; Goldenring et al. 2000; Wang et al. 2000; El-Zimaity et al. 2001; Houghton et al. 
2004a; Oshima et al. 2005; Yoshizawa et al. 2007; Nam et al. 2010; Varon et al. 2011). In 
humans, SPEM gives rise to intestinal metaplasia which can progress to cancer (Hattori et 
al. 1979; Hattori et al. 1982; Hattori 1986; Correa 1988; Filipe et al. 1994; Takizawa et al. 
1998; Schmidt et al. 1999; Xia et al. 2000; Yamaguchi et al. 2002; Halldorsdottir et al. 
2003). In mice, however, SPEM does not progress to phenotypic intestinal metaplasia. 
Instead, SPEM progresses to “SPEM with intestinal characteristics” (SPEM-IC), which is 
the mouse version of intestinal metaplasia (Weis et al. 2013). Administration of DMP-
777, an elastase inhibitor and protonophore, results in parietal cell loss without 
inflammation (Nomura et al. 2004c), and SPEM develops after 10-14 days. Even after 
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two years of daily DMP-777 administration, SPEM never progresses to dysplasia 
(Goldenring et al. 2000). In contrast, administration of L635, a protonophore analogue of 
DMP-777 that lacks elastase inhibition, results in SPEM with a prominent inflammatory 
response after three days (Nam et al. 2010). In contrast to DMP-777, L635-induced 
SPEM begins to acquire some intestinal transcripts (Weis et al. 2013). Furthermore, H. 
felis-infected mice develop SPEM with chronic inflammation that expresses even more 
intestinal transcripts (SPEM-IC) (Varon et al. 2011; Weis et al. 2013). After 
approximately 12 months of infection, SPEM-IC progresses to dysplasia (Wang et al. 
1998; Wang et al. 2000; Houghton et al. 2004a; Nam et al. 2010; Varon et al. 2011). 
These three models have been used to elucidate expressional changes in the induction of 
SPEM and the progression to SPEM-IC and dysplasia. 
Numerous studies have identified a variety of putatively important factors in chief 
cell homeostasis and function or induction and progression of SPEM. However, no in 
vitro models of chief cells or metaplasia of the stomach currently exist, which has 
significantly hindered specific investigations into the molecular mechanisms of the 
numerous factors identified in a multitude of studies. In vitro models are desperately 
needed to elucidate such mechanisms. The availability of the Immortomouse (Jat et al. 
1991), makes the establishment of such in vitro models now possible (Whitehead et al. 
1994; Whitehead et al. 2008; Kohn et al. 2010). The Immortomouse is a transgenic 
mouse that has an interferon-γ (IFNγ) inducible expression of a temperature sensitive T-
antigen (Jat et al. 1991). The presence of IFNγ induces expression of the immortalizing 
T-antigen. At the permissive temperature of 33°C, the T-antigen folds correctly and 
immortalizes the cells. However, at the non-permissive temperature of 39°C, IFNγ is 
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removed and residual T-antigen misfolds, returning the cultures to a more ‘primary-like’ 
state. The Immortomouse has been successfully used to establish cell lines from various 
tissues, including the stomach (Whitehead et al. 1994; Allen et al. 2000; Whitehead et al. 
2008; Whitehead et al. 2009; Kohn et al. 2010). However, these stomach cell lines do not 
express any chief cell or SPEM cell characteristics, but more closely resembles gastric 
surface cells (Whitehead et al. 2009), while another is a gastric stromal cell line 
(Whitehead, R.H., unpublished). In this study, we have developed and characterized the 
first in vitro models of chief and SPEM cells that are invaluable to expanding our 
understanding of the molecular mechanisms of chief cell homeostasis and the metaplastic 
process.  
Using a modified protocol previously used for chief cell isolation (Tashima et al. 
2009), our cell isolates were enriched for either chief cells or SPEM cells to remove 
contamination of other cell types. We established a chief cell line (ImChief) from 
untreated Immortomice and a SPEM cell line (ImSPEM) from L635-treated 
Immortomice. ImChief and ImSPEM cells expressed only the appropriate cell lineage 
markers. Additionally, ImSPEM cells polarize on transwells and form cystic structures 
when grown in Matrigel. Utilizing our two novel in vitro cell culture models, gene 
expression comparisons reveal a novel subapical marker of SPEM, MAL2. As a protein 
necessary for transcytosis, MAL2 is the first trafficking protein identified as upregulated 
in SPEM.  
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Methods 
Animals and cell isolation buffers 
Immortomice (tsA58SV40 T antigen transgenic; (Jat et al. 1991) Charles River 
Laboratories, Wilmington, MA, USA) were maintained on a C57- BL/6 background. 
Mice were euthanized at 12-16 weeks of age. Chief cells were isolated from four 
untreated female Immortomice. For SPEM cell isolation, L635 dissolved in saline was 
orally administered as a gavage once daily at 350 mg/kg/day for three consecutive days to 
three female Immortomice. L635 was a gift from Merck & Co, Inc (Rahway, NJ). All 
procedures were performed under Vanderbilt IACUC-approved animal protocols. 
Solutions for cell isolation were made from a basic buffer of 0.5 mM NaH2PO4, 1 mM 
Na2HPO4, 20 mM NaHCO3, 70 mM NaCl, 5 mM KCl, 50 mM HEPES, and 11 mM 
glucose in water. Medium A is 2 mM EDTA and 2% BSA (fraction V and globulin free 
A-9418; Sigma-Aldrich, St. Louis, MO) in basic buffer. Medium B is 1 mM CaCl2, 1.5 
mM MgCl2 and 2% BSA (fraction V and globulin free) in basic buffer. 
Cell isolation and culture 
Chief cells and SPEM cells were isolated by sequential digestions as described 
previously by others (Tashima et al. 2009). Stomachs were excised, inverted, washed in 
ice cold 1X PBS, and tied off at the antrum and the forestomach. Unwanted tissue from 
the antrum and the forestomach were then removed. Medium A containing 2.5 mg/mL of 
protease type XIV (Sigma-Aldrich) was injected into the stomach until fully inflated 
(500-800 µl). The inflated stomachs were incubated in a series of solutions for 30 
minutes each in a 37°C shaking water bath (Fractions 1-5). First, they were submerged in 
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Medium A without protease (Fraction 1) followed by three changes of Medium B 
(Fractions 2-4). For fraction 5, stomachs were incubated in Medium B with 0.5 mg/mL of 
DNase I (Sigma-Aldrich) and then vigorously shaken by hand for 30 seconds. A 500 μL 
aliquot from each fraction was fixed with 4% paraformaldehyde at 4°C for 20 minutes to 
verify cell types in each fraction. To confirm cell isolation from the mucosa, stomachs 
were fixed in 4% paraformaldehyde and paraffin embedded for immunohistochemical 
analysis. 
Chief cells and SPEM cells were found to be enriched in fractions 4 and 5. To 
remove tissue clumps, fractions 4 and 5 were filtered through a 100 μm cell strainer. 
These fractions were centrifuged for 5 minutes at 1000 rpm and resuspended in a 1:1 
mixture of Ham’s F-12 and Dulbecco’s minimum essential medium containing 10% heat-
inactivated FBS, 8 μg/mL ITS, 1 μg/mL hydrocortisone, 100 U/mL penicillin and 
streptomycin, 100 μg/mL MycoZap Plus-PR (Lonza, Rockland, ME), 1 ng/mL EGF, 1 
ng/mL bFGF, 10 ng/mL HGF, and 5 U/mL interferon-γ (IFNγ). Growth factors and IFNγ 
were purchased from PeproTech (Rocky Hill, NJ). Cells were plated on collagen 
(PureCol; Advanced BioMatrix, San Diego, CA) coated 96-well and 24-well plates at 
varying densities (10,000-60,000 cells for 96 well plates and 50,000 to 200,000 cells for 
24 well plates) and incubated at 33°C with 5% CO2. Cells were passaged at a 1:2 dilution 
as needed using trypsin with EDTA. Various cellular morphologies were observed and 
further purified by sequential higher dilution passages (1:3-5) or with trypsin-soaked 
cloning disks. Each morphology was analyzed by qPCR to verify cell type. Colonies with 
the desired expression profile were selected. Cells were maintained at 33°C in the media 
described above.   
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For immunostaining analysis, cells were plated at confluency on collagen-coated 
coverslips or transwell filters and cultured at 39°C for 1 week. For 3D culture 
experiments, 25,000 cells were suspended in 1:1 mixture of media (without IFNγ) and 
Matrigel (9.9 mg/mL stock; Sigma-Aldrich) and grown in 48-well plates at 39°C for 3-5 
weeks. IFNγ was removed from the media for all experiments at 39°C. 
Transfections of cells  
For transfection of ImChief cells, Amaxa Nuclefactor (Lonza, Allendale, NJ), 
FuGene 6 (Promega, Madison, WI),  TurboFect (Thermo Scientific, Glen Burnie, MD), 
and Effectene (Qiagen, Valencia, CA) were tested (Table 2). For the Amaxa 
Nucleofactor System, 500,000 cells were transfected with 2 µg of an EGFP plasmid 
according to manufacturer’s protocol using Kit T and program T-030. Cells were 
incubated at 33°C and media was changed after 24 hours. Transfection efficiency was 
calculated 48 hours after transfection. For FuGene 6, TurboFect, and Effectene, cells 
were grown to approximately 70% confluency at 33°C overnight. Cells were then 
transfected with an EGFP plasmid according to manufacturer’s protocols and incubated 
at 33°C. Again, media was changed after 24 hours and efficiencies were calculated after 
48 hours. Efficiencies were calculated as the number of GFP positive cells out of the total 
number of cells. For Mist1 transfections, 2 µg of an MIST1-EGFP plasmid (Bredemeyer 
et al. 2009) was transfected using the Amaxa  Nucleofactor System as stated above.  
After transfection, cells were incubated at 39°C for 3 days. 
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Table 2. Transfection efficiency of ImChief cells by various transfection methods. 
ImChief cells were transfected with an EGFP plasmid via different transfection methods 
to test transfection capabilities. After 48 hours of transfection, GFP expression was 
examined. Efficiency was calculated by the number of GFP-expressing cells out of the 
number of cells counted (>850 cells). The Amaxa Nucleofactor method resulted in the 
highest transfection efficiency. 
 
RNA extraction, reverse transcription and real time PCR 
For characterization experiments, cells were plated on collagen coated dishes and 
incubated at 39°C for one week. Initial ImSPEM characterization used cells grown at 
33°C. Final characterization (Table 3) used cells incubated at 39°C for one week. Cells 
were washed with 1X PBS and RNA was extracted with TRIzol (Invitrogen, Carlsbad, 
CA) according to the manufacturer's instructions. The RNA (1 µg) was treated with RQ1 
RNase-free DNase (Promega, Madison, WI) and then reverse-transcribed using the 
Advantage RT-for-PCR kit (Clontech, Palo Alto, CA). Advantage 2 PCR kit (Clontech) 
was used for all PCR amplifications (unless stated otherwise) using gene specific primers 
and the following protocol: denature for 5 minutes at 94°C, amplification for 40 cycles of 
20 seconds at 94°C, 20 seconds at 60°C, and 20 seconds at 68°C, and final extension for 
5 minutes at 68°C. Reactions were then visualized on a 2% agarose gel. For quantitative 
RT-PCR, 1 μg of total RNA was treated with RQ1 RNase-free DNase (Promega, 
Madison, WI) and then reverse-transcribed using Superscript III reverse transcriptase 
(Invitrogen, Carlsbad, CA).  Quantitative real time polymerase chain reaction (qRT-PCR) 
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was performed with EXPRESS SYBR GreenER quantitative PCR SuperMix (Invitrogen, 
Carlsbad, CA) using specific primers in an ABI StepOnePlus Real-Time PCR System 
(Applied Biosystems, Foster City, CA). Each sample was run in triplicate following 
cycling conditions indicated by the SYBR Green supermix manufacturer's protocol. 
TATA–box-binding protein (TBP) was used as an endogenous control and reference for 
verification of sufficient cDNA in the reaction. 
Immunofluorescence analysis  
The following primary antibodies were used in this study:  sheep anti-Pepsinogen 
II (1:1000; Abcam, Cambridge, MA), rabbit anti-RAB3D (1:50; ProteinTech Group Inc, 
Chicago, IL), rabbit anti-HE4 (1:2000) (a gift from Dr. Ronny Drapkins, Harvard 
Medical School, Boston, Massachusetts), mouse IgM anti-TFF2 (1:1000; Abcam), mouse 
anti-E-cadherin (1:200; BD Tranduction Laboratories, Lexington, KY), mouse anti-p120 
(1:200; BD Transduction Laboratories), rat anti-ZO1 (1:400; Developmental Studies 
Hybridoma Bank, University of Iowa, Iowa City, IA), and rabbit anti-MAL2 (1:1000) (In 
et al. 2010). Fluorescent secondary antibodies (Cy3 and Cy5; Jackson ImmunoResearch 
Laboratories, West Grove, PA and Alexa-488, -594, and -647; Invitrogen, Carlsbad, CA) 
were used at 1:500 to visual primary antibodies. For coverslips and transwells, cells were 
washed with PBS and fixed with 4% paraformaldehyde for 20 minutes at room 
temperature. Cells were blocked/extracted with 10% normal donkey serum (Jackson 
ImmunoResearch Laboratories) and 0.3% Triton X-100 for 30 minutes at room 
temperature. Primary antibodies were diluted in 1% serum and 0.05% Tween-20 and 
incubated overnight at 4°C. Cells were washed three times with PBS and incubated with 
secondary antibodies in 1% serum for one hour at room temperature. After three washes 
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with PBS, coverslips or transwells were mounted with ProLong Gold plus 4′,6-
diamidino-2-phenylindole (DAPI; Invitrogen). Matrigel plugs were moved to 0.5 mL 
microcentrifuge tubes, washed 3 times with PBS to remove media from the plug, and 
fixed in 4% paraformaldehyde for one hour at room temperature. After three washes with 
PBS, plugs were blocked/extracted with 10% normal donkey serum and 0.3% Triton X-
100 rotating for one hour at room temperature. Plugs were washed twice with PBS and 
0.05% Tween-20 and then rotated overnight at 4°C with primary antibodies. After two 
washes with PBS and Tween-20, plugs were incubated with secondary antibodies for four 
hours rotating at room temperature. They were then washed four times with PBS and 
Tween-20, washed twice with PBS, and mounted in Prolong Gold plus DAPI on a glass 
slide with a coverslip. For all Matrigel plugs, tubes were centrifuged for one minute at 
6000 rpm between each step to collect all fragments of the Matrigel. All primary and 
secondary antibodies used for Matrigel plugs were diluted in 1% normal donkey serum. 
All images of cells were captured with an Olympus FV1000 confocal microscope (Cell 
Imaging Shared Resource, Vanderbilt University, Nashville, TN). 
For immunostaining in tissue, human and mouse stomachs were obtained as 
previously reported (Leys et al. 2006; Weis et al. 2013). For mouse tissue, 4% 
paraformaldehyde-fixed paraffin-embedded stomachs from untreated control mice, 14-
day DMP-777 treated mice, three-day L635 treated mice, and 6-12-month Helicobacter 
felis infected mice were used. A tissue array of metaplasias (SPEM and intestinal 
metaplasia, n=19) resected at University of Tokyo (Leys et al. 2006) was used for 
analysis of MAL2 expression. A tissue array comprised of 44 gastric cancers resected at 
Vanderbilt Medical Center Sections was used for analysis of expression in gastric cancer 
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(Leys et al. 2006). Eleven intestinal-type cancer cores were analyzed. Sections were 
heated at 60°C for 30 minutes, allowed to cool to room temperature, deparaffinized in 
Histo-Clear (National Diagnostics, Atlanta, GA), and rehydrated. Antigen retrieval was 
performed using Target Retrieval solution (DakoCytomation, Glostrup, Denmark). Slides 
were blocked overnight at 4°C with serum-free protein block (DakoCytomation). Primary 
antibodies were incubated overnight at 4°C in antibody diluent with background reducing 
components (DakoCytomation). Sections were washed in PBS and incubated with 
secondary antibodies for one hour at room temperature. After washing in PBS, sections 
were mounted in Prolong Gold plus DAPI. Images of tissue were captured with a Zeiss 
Axio Imager M2 microscope (Jena GmBH, Germany) outfitted with a Spot Xplorer 
camera (SPOT Imaging Solutions, Sterling Heights, Michigan) using either a 20X NA 
0.8 or 40X NA 0.95 Plan-Apochromat objective (Zeiss). 
Western blot analysis 
Cells were plated at confluency and incubated at 39°C for one week. For analysis 
of media, cells were washed and fresh media was added for 24 hours. After 24 hours on 
the cells, media was collected and stored at -80°C. For analysis of cell lysates 
corresponding to the media analysis, protein was isolated from the plated cells with 
TRIzol according to the manufacturer's instructions. For overexpression experiments, 
protein was isolated in a lysis buffer of 50 mM Tris (pH 8.0), 150 mM NaCl, and 0.5% 
SDS in PBS plus phosphatase inhibitors. Lysates were rocked for 30 minutes at 4°C and 
then centrifugated for 15 minutes at 4°C. The protein-containing supernatants were 
transferred to new tubes. The protein concentration of the cell lysates was measured by 
bicinchoninic acid (BCA) method using the Pierce BCA protein assay reagent (Pierce, 
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Rockford, IL). A total protein amount of 20 µg of each cell lysate sample and an aliquot 
of 15 µL of media was suspended in 1X SDS sample buffer. Samples were resolved in a 
10% Bis-Tris NuPAGE Novex 1.0 mm gel (Life Technologies, Carlsbad, CA) and 
transferred to an Immobilon-P PVDF membrane (Millipore, Billerica, MA). Blots were 
blocked with 5% dry milk powder in Tris-buffered saline and 0.05% Tween-20 (TBS-T). 
Primary antibodies were diluted in 2.5% dry milk powder/TBS-T and incubated 
overnight at 4°C. After four washes in TBS-T, blots were incubated with horseradish 
peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch) for one hour at 
room temperature. Blots were then washed four times with TBS-T and once with TBS 
only. Specific labels were detected with enhanced chemiluminescence reagents (Pierce, 
Rockford, IL) and BioMax ML film (Kodak, Rochester, NY). For sequential probing, 
blots were washed with TBS-T and stripped with ReBlot Plus Strong Antibody Stripping 
Solution (Millipore) for 20 minutes at room temperature. After two washes of TBS-T, 
blots were again blocked and probed as described. Cell lysate bands were normalized to 
the control bands of either rabbit anti–voltage-dependent anion-selective channel protein 
1 (VDAC1)/porin (1:1000; Abcam) or β-actin (1:1000; Sigma-Aldrich).  
Gene microarray analysis  
ImChief cells and ImSPEM cells were plated at approximately 80% confluency 
on collagen coated flasks and incubated at 39°C for one week. Cells were detached with 
Trypsin and EDTA and washed twice with PBS. Total RNA was isolated with the 
mirVana miRNA Isolation Kit (Life Technologies) following manufacturer’s protocol. 
cDNA was reverse transcribed from 130 ng of RNA using the Ambion WT Expression 
Kit (Life Technologies). Standard Affymetrix protocols were used to fragment and label 
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5.5 µg of cDNA. Samples were then hybridized to the Affymetrix mouse gene 1.0ST 
array (Santa Clara, California). Data was analyzed on an Affymetrix Expression Console 
v. 1.1 using a RMA normalization to produce log base 2 values. Statistical significance 
was determined by unpaired Student's t-tests (p ≤ 0.05) with GeneSpring software 
(Agilent Technologies, Wilmington, DE) using Benjamini-Hochberg MTC (Hochberg et 
al. 1990). Fold changes of the top 25 increased genes are listed in Table 4. 
 
Table 3. Transcriptional expression of lineage specific markers in ImChief and 
ImSPEM cells. ImChief cells and ImSPEM cells were cultured at 39°C for one week. 
Both cultures express the epithelial markers Krt8 and Krt18. ImChief cells express all 
chief cell markers except Gif. Other lineage markers are not expressed, demonstrating the 
specificity of the ImChief cell line. Similarly, ImSPEM cells express SPEM markers and 
some SPEM-IC markers (Cftr and PigR), but lack markers of other lineages. 
Additionally, the ImChief and ImSPEM cell lines did not express intestine and antral-
specific markers (Pdx1 and Cdx2) showing the cultures were not contaminated with 
intestinal or antral cells. 
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Results 
Establishment of an immortalized chief cell line (ImChief) 
Stomachs from four female Immortomice were digested in serial fractions to 
obtain an enriched population of chief cells. As previously reported (Tashima et al. 
2009), chief cells were found predominately in fractions 4 and 5. Chief cells constituted 
73% of the cells found in the enriched fractions (Figure 18). To establish a chief cell line, 
these Immortomouse chief cells enriched fractions were cultured on collagen-coated 
plates at the permissive temperature (33°C) in the presence of IFNγ, which induces 
expression of the temperature sensitive T antigen transgene. At the permissive 
temperature, the T antigen protein folds correctly and causes in ‘immortalization’ of the 
cells. Colonies with an epithelial-like morphology (a cobblestone appearance) appeared 
after several passages. These colonies were further purified using sequential higher 
dilution passages and isolation with cloning disks. Although stromal cells could not be 
completely removed, detection of epithelial markers cytokeratins 8 and 18 (Krt8 and 
Krt18) confirms epithelial cells are predominantly present in the culture (Figure 19). The 
transcriptional profile of the cell line was analyzed by PCR to verify the composition of 
the gastric cell types in the culture. Lineage markers for the various cell types of the 
stomach were examined in cells cultured at the non-permissive temperature (39°C) for 
one week. Transcriptional analysis of the cell culture reveals the expression of the chief 
cell-specific markers Mist1, pepsinogen C (Pgc), amylase 2 ( Amy2), and Rab3d, but not 
gastric intrinsic factor (Gif) (Figure 19). However, the cells do not express the mucous 
neck cell markers Muc6 and Tff2, thus ruling out the presence of mucous neck cells, 
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which normally differentiate into chief cells in vivo. Furthermore, markers of foveolar 
cells, parietal cells, and endocrine cells were not detected (Figure 19). The expression of 
chief cell markers and lack of all other lineage markers demonstrates the predominance 
of chief cells and the absence of other gastric cell lineages; thus the culture was 
appropriately designated ImChief (Im-Immortomouse, Chief-Chief cells). This 
expression pattern was retained for at least 50 passages suggesting the chief cell 
phenotype is stable. A previous report from in vivo murine stomach showed that upon the 
loss of parietal cells, chief cells transdifferentiate into SPEM cells and begin expressing 
HE4 (Nozaki et al. 2008). Of note, although parietal cells are not present in the in vitro 
cell culture, ImChief cells do not transdifferentiate, as determined by the lack of He4 
transcriptional expression (Figure 19).  
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Figure 18. Cell type composition of fractions 4 and 5 of stomach digestion. An aliquot 
from fractions 4 and 5 of the cell isolate were fixed with 4% PFA and spun down onto a 
slide using a cytospin centrifuge. After drying the slides, cells were immunolabeled with 
H/K-ATPase (parietal cell marker), TFF2 (mucous neck cell marker), PGC (chief cell 
marker), and DAPI (nuclei). Fraction 4 had the highest enrichment of chief cells at 
79.9%, while fraction 5 had 69.7%. The percentage of parietal cells increased between 
fraction 4 and 5 (from 10.5% to 21.4%). Although fraction 5 had an increase in parietal 
cells, fractions 4 and 5 (together 73.3% chief cells) were both used for plating and 
culturing of chief cells. This allowed for a higher total number of chief cells for plating 
and presumably, parietal cells would not survive in culture over time. 
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Figure 19. Expression of gastric cell lineage markers in ImChief cells. ImChief cells 
were grown at 39°C for one week. cDNA made from an H. felis-infected stomach was 
used for a positive control. ImChief cells expressed the epithelial markers, Krt8 and 
Krt18. They also expressed all chief cell markers except Gif. Although the expression is 
low, the chief cell specific marker, Mist1, is expressed. ImChief cells did not detectably 
express markers for other gastric cell types (surface cells, parietal cells, mucous neck 
cells, endocrine cells, or SPEM cells). The lack of He4 shows ImChief cells do not 
transdifferentiate into SPEM in this culture system. This expression pattern shows 
ImChief cells have a similar expression pattern to in vivo chief cells. 
 
 
In vivo chief cells produce and secrete vesicles that contain zymogens, such as 
pepsinogen. Recent studies have shown RAB3D co-localizes with these secretory 
vesicles, suggesting a role in exocytosis of the zymogens (Tang et al. 1996). To examine 
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whether ImChief cells possess the secretory components found in vivo, cells at both the 
permissive and non-permissive temperatures were probed for pepsinogen (PGC) and 
RAB3D. Immunostaining revealed that ImChief cells produce pepsinogen vesicles at 
both temperatures (Figure 20). Furthermore, RAB3D co-labeled these pepsinogen 
vesicles. These findings confirm that ImChief cells produce the necessary secretory 
components. The localization of RAB3D predominately on pepsinogen vesicles suggests 
that ImChief cells may also actively secrete zymogen vesicles, however more studies are 
needed. Additionally, ImChief cells appear to express more RAB3D and pepsinogen co-
positive vesicles at the non-permissive temperature (39°C) than at the permissive 
temperature (33°C) (Figure 20). At 39°C, the temperature sensitive T antigen misfolds 
and thus no longer immortalizes the cells, significantly decreasing proliferation of 
ImChief cells after approximately three days at 39°C whereby cells cannot be passaged 
(data not shown). Although further validation of increased vesicle production at 39°C is 
needed, these observations indicate that ImChief cells cease proliferation and 
subsequently may become more differentiated and ‘primary-like’ at the non-permissive 
temperature. Taken together, these data demonstrate that ImChief cells retain significant 
characteristics of in vivo chief cells. 
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Figure 20. RAB3D and PGC expression in ImChief cells at the permissive and non-
permissive temperatures. ImChief cells were plated on collagen-coated coverslips and 
incubated at either 33°C (permissive) or 37°C (non-permissive) for one week. Cells were 
immunolabeled with RAB3D (top row and red in merged panel) and PGC (middle row 
and green in merged panel). RAB3D and PGC co-labeled vesicles in ImChief cells at 
both temperatures (bottom row). However, at the non-permissive temperature, ImChief 
cells express more co-labeled vesicles, suggesting they become more differentiated. 
DAPI (blue). 
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Mist1 overexpression demonstrates the utility of the ImChief cell line 
We sought to determine the utility of ImChief cells as a tool for investigating 
molecular mechanisms of chief cells. First, the ability of ImChief cells to be transfected 
was tested with multiple established transfection protocols. As seen in Table 2, ImChief 
cells were sucessfully transfected by multiple transfection methods with varying 
transfection efficiencies. Although the transfection efficiency for all methods was low, an 
electroporation transfection method (Amaxa Nucleofactor) resulted in the highest 
efficiency (29%). To further establish the utility of ImChief cells as an in vitro chief cell 
model, we chose to perform preliminary studies examining the function of Mist1, a chief 
cell-specific transcription factor. Previous studies in both mouse stomach and human 
gastric cancer cell lines have shown that Mist1 is required for the formation of 
pepsinogen granules (Ramsey et al. 2007; Tian et al. 2010). To examine if ImChief cells 
would function in a similar manner, cells were transfected with a human Mist1 plasmid 
(Tian et al. 2010). A preliminary western blot suggests that Mist1 overexpression in 
ImChief cells induces an increase in endogenous pepsinogen (PCG) levels (Figure 21). 
Furthermore, the metaplasia marker, HE4, remained undetectable upon Mist1 
overexpression (Figure 21). The lack of HE4 upregulation indicates ImChief cells will 
not readily become metaplastic from simple manipulations such as transfection. These 
preliminary results suggest the ImChief cell line functions similarly to in vivo chief cells 
and can be used for the investigation of specific molecular mechanisms in chief cells. 
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Figure 21. PGC and HE4 expression in protein lysates from ImChief cells 
overexpressing MIST1. ImChief cells were transfected with a Mist1-EGFP plasmid or a 
control EGFP plasmid and cultured at 39°C for three days (n=1). 20 µg of protein lysate 
was probed for PGC or HE4. β-actin and VDAC were used as loading controls. 
Overexpression of MIST1 increased PGC expression. HE4 expression was not detected, 
showing that simple manipulation of ImChief cells does not cause them to 
transdifferentiate into SPEM. 
 
Immortalized SPEM cell line (ImSPEM) retains in vivo SPEM characteristics 
 A recent study profiling multiple human gastric cell lines showed that the KatoIII 
cell line retained expression of some metaplastic markers (Tan et al. 2011). However, the 
KatoIII line expresses a mixture of SPEM and intestinal metaplasia markers, and 
therefore cannot be appropriately used as an in vitro cell culture model for studying the 
signaling pathways and molecular mechanisms of SPEM. Accordingly, we developed and 
characterized a more definitive in vitro model of SPEM. To establish a SPEM cell line, 
the successful approach used for the establishment of the ImChief line was again utilized. 
SPEM was induced in three female Immortomice by oral gavage of L635 for three days. 
Stomachs were inverted and digested in serial fractions.  Again, fractions 4 and 5 were 
enriched with the cell type of interest. Cells were plated on collagen-coated plates at 
33°C with IFNγ and passaged (at 1:2) as needed. Multiple epithelial-like morphologies 
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emerged in the culture. Each morphology was purified individually by sequential higher 
dilution passages. Unlike the ImChief cell purification, cloning disks were not needed 
because the epithelial-like cells in the SPEM cell enriched cultures expanded more 
quickly than the contaminating stromal-like cells. Epithelial origin was confirmed by 
transcriptional expression of Krt8 and Krt18 (Figure 22). Additionally, all cultures were 
negative for Pdx1 expression, verifying the cells as derived from the fundus of the 
stomach and not the antrum or duodenum (Table 3). Expression of specific cell lineage 
markers was investigated to identify the cell types present in each culture. Differences in 
the expression of the differentiated gastric cell markers were detected among the different 
purified cultures. All cultures expressed the SPEM lineage markers Tff2 and He4; 
however, a few cultures expressed other differentiated gastric cell markers as well (data 
not shown). This type of expression profile may result for a multitude of reasons. For 
example, these cultures may contain multiple differentiated gastric cell types that are 
proliferating, or a progenitor cell with the ability to give rise to multiple lineages. For the 
present study, we focused on the cell cultures that expressed SPEM markers, but lacked 
expression of other lineage markers, as they represented purified SPEM cell cultures. The 
expression levels of the SPEM markers varied among the different SPEM cultures (data 
not shown). Therefore, from the different SPEM cultures, the culture with the most 
prominent expression of the SPEM markers Tff2 and He4 (Figure 22) as compared to the 
other cultures was selected and designated ImSPEM (Im-Immortomouse, SPEM-
Spasmolytic Polypeptide Expressing Metaplasia).  
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Figure 22. Transcript expression of SPEM markers in ImSPEM cells. Cells were 
cultured at 33°C for one week for initial expression characterization. Expression of the 
SPEM markers He4 and Tff2 was analyzed in ImSPEM cells. ImSPEM cells express the 
epithelial markers (Krt8 and Krt18) and the SPEM markers. 
 
 
Multiple in vivo SPEM characterististics were evaluated in order to fully validate 
the newly established ImSPEM line. One distinct property of in vivo SPEM cells is re-
entry into the cell cycle. Although chief cells are post-mitotic, upon transdifferentiation to 
SPEM, SPEM cells begin to proliferate. Aptly, upon return to a more primary-like culture 
at 39°C without IFNγ, ImSPEM cells continue to proliferate. ImSPEM cells can be 
maintained and passaged at 39°C without IFNγ for at least one month, signifying that 
ImSPEM cells possess an intrinsic proliferative property similar to in vivo SPEM cells. 
Another characteristic of L635-derived SPEM is the acquisition of intestinal transcripts. 
Previously, we have shown transcriptional heterogeneity among SPEM lineages from 
different murine models of SPEM (Weis et al. 2013). Briefly, SPEM lineages derived in 
the presence of inflammation progress to SPEM-IC (SPEM with Intestinal Characteristics) 
by acquiring intestinal transcripts such as Cftr, Dmbt1, and eventually Vil1 and PigR. To 
characterize the metaplastic state of ImSPEM cells, expression of selected previously 
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reported SPEM (by real time PCR) and SPEM-IC (by qRT-PCR) markers were evaluated 
at the non-permissive temperature (39°C). ImSPEM cells expressed all SPEM markers 
that were tested by real time PCR (Table 3). The SPEM-IC markers Cftr and PigR were 
expressed at low levels while Vil1, Dmbt1, and Cdx2 were not expressed at all (Table 3) 
as tested by qRT-PCR. This expression profile matches that of SPEM-IC cells in vivo.  
 Although ImSPEM cells retain the transcriptional profile of in vivo SPEM, we 
further characterized the ImSPEM line by analyzing protein expression of key SPEM 
markers. When chief cells transdifferentiate into SPEM, SPEM cells begin producing 
TFF2 vesicles and HE4 vesicles. To date, HE4 expression is the most prominent and 
specific marker of SPEM induction in vivo. Thus, TFF2 and HE4 expression in ImSPEM 
cells was investigated. Immunostaining revealed ImSPEM cells expressed both TFF2 and 
HE4 that localized to cytoplasmic vesicles (Figure 23). To confirm HE4 expression in 
ImSPEM cells, western blots of protein lysates were probed for HE4. Replicate protein 
lysates show HE4 expression in ImSPEM cells, but not ImChief cells (Figure 23). 
Moreover, because HE4 is known to be secreted in vivo, we tested for HE4 detection in 
the conditioned media as a measure of functional secretory machinery in the ImSPEM 
line. ImSPEM cells were grown at 39°C for one week. ImChief cells were used as a 
negative control as they do not express HE4. After one week at 39°C, fresh media was 
incubated on the cells for 24 hours. Western blot analysis of the 24 hour conditioned 
media reveals HE4 detection in ImSPEM media, but not ImChief media, showing 
ImSPEM cells have functional secretory machinery (Figure 23). Taken together, these 
data demonstrate ImSPEM cells possess many of the characteristics displayed by in vivo 
SPEM lineages and provides a novel in vitro model of this metaplastic cell type. 
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Figure 23. Expression of SPEM protein markers, TFF2 and HE4. Immunolabeling of 
ImSPEM cells (A), ImSPEM protein lysate (B), and conditioned media (C) reveal 
expression and secretion of SPEM markers. (A) Cells were grown on collagen-coated 
coverslips at 39°C for one week. ImSPEM cells express individual TFF2 and HE4 
vesicles similar to in vivo SPEM. (B) Cells were transfected with a Mist1-EGFP or GFP 
control plasmid and grown at 39°C for three days. 20 µg of protein lysate was 
immunolabeled for HE4 and VDAC (loading control). ImSPEM protein lysates confirm 
HE4 expression. Furthermore, MIST1 overexpression does not cause SPEM to revert 
back to chief cells, as there is no change in HE4 expression. (C) ImChief and ImSPEM 
cells were grown on collagen-coated transwells at 39°C for one week. Fresh media was 
added for 24 hours. The 24 hour conditioned media from ImChief cells and ImSPEM 
cells show secretion of HE4 from ImSPEM cells. Replicates for ImChief and ImSPEM 
cells are shown. Ponceau S staining is shown as a loading control.  
 
 
Gene microarray comparison of ImChief and ImSPEM identifies Mal2 as a novel 
subapical marker of metaplasia 
 Gene microarray analysis was used to compare the complete transcriptional 
profiles of ImChief cell and ImSPEM cells grown at 39°C without IFNγ for one week. 
Cells grown at 39°C were selected because of more primary-like (and possibly more 
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‘differentiated’) state. Additionally, effects from the T-antigen-induced immortalization 
are minimized, as it is no longer active at this temperature. Levels of mRNA transcripts 
from triplicates of each cell line were measured with Affymetrix gene microarrays. 
Comparison of ImChief and ImSPEM expression profiles identified new putative markers 
of the metaplastic process. Table 4 lists the top 25 transcripts upregulated in ImSPEM 
cells as compared to ImChief cells. Mal2, the third most upregulated transcript in 
ImSPEM, is increased by 113 fold. Previous reports have shown that MAL2 protein is 
required for the transcytosis pathway and is normally localized to the subapical 
compartment in polarized cells (de Marco et al. 2002; Marazuela et al. 2004a; Marazuela 
et al. 2004b; Marazuela et al. 2004c; de Marco et al. 2006; Ramnarayanan et al. 2007; In 
et al. 2010; Ramnarayanan et al. 2011). We chose to further validate the upregulation and 
localization of MAL2 in the mouse stomach due to its potential as a novel subapical 
marker of SPEM. 
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Table 4. Gene microarray comparison of ImChief and ImSPEM cells. ImChief cells 
and ImSPEM cells were incubated at the non-permissive temperature (39°C) for one 
week. Transcriptional expression was analyzed by gene microarray. The top 25 
transcripts upregulated in ImSPEM cells compared to ImChief cells reveal putative new 
markers of SPEM. The normalized expression level in the respective cell line is shown as 
well as the fold change. 
 
  
 
First, we examined the expression of MAL2 in normal murine gastric glands. In 
untreated control mice, MAL2 immunoreactivity was detected in the subapical 
compartment of mucous neck cells and surface cells (Figure 24).  A diffuse cytoplasmic 
staining pattern was also detected in parietal cells (co-stain with H/K-ATPase not shown) 
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and there was low MAL2 expression in chief cells (Figure 24). To thoroughly investigate 
MAL2 expression in SPEM, we utilized three models of SPEM: 14 days DMP-777 
treatment, three days L635 treatment, and 12 month H. felis infection. As previously 
reported, acute SPEM without inflammation is induced by DMP-777 treatment, while 
L635 administration results in SPEM with prominent inflammation (Nomura et al. 2004c; 
Nam et al. 2010). H. felis infection was used as a model of chronic inflammation and 
SPEM that progresses to SPEM-IC (Varon et al. 2011; Weis et al. 2013). As shown in 
Figure 24, MAL2 expression is increased and located subapically in SPEM lineages from 
all three models as well as gastritis cystica profunda in 12 month H. felis-infected mice. 
These findings not only validate MAL2 as a new marker of SPEM, but also as a novel 
marker of polarized vesicle trafficking in SPEM. Although several studies have 
elucidated the expression profile of SPEM (Lee et al. 2003; Judd et al. 2004; Nomura et 
al. 2004b; Nomura et al. 2004c; Ogawa et al. 2006; Nam et al. 2007; Nozaki et al. 2008; 
Nozaki et al. 2009; Lee et al. 2010; Weis et al. 2013), the discovery of MAL2 provides 
the first insight into the possible factors and mechanisms involved in transcytosis and 
secretion in SPEM cells.  
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Figure 24. Expression of MAL2 in normal murine gastric mucosa and SPEM 
models. Sections of C57BL/6 mouse fundic mucosa were immunostained with MAL2 
(top panel and red in bottom merged panel) and GSII lectin (a mucous neck cell and 
SPEM marker) (green). MAL2 images were taken at the same exposure for each sample 
(top row). MAL2 was expressed most strongly in parietal cells, which demonstrated a 
dispersed cytoplasmic localization. Weaker subapical staining was observed in mucous 
cells (surface and neck cells and to a lesser extent chief cells in the normal mucosa 
(arrows). In all SPEM models (DMP-777, L635, and H. felis), MAL2 expression was 
increased in the SPEM models as compared to the chief cells in the normal mucosa and 
localized to the subapical compartment in SPEM cells marked by GSII lectin. A region of 
dysplasia (gastritis cystica profunda) in the H. felis infected mouse also showed strong 
expression of MAL2. All images were taken with a 20X objective. DAPI (blue). 
 
 
To investigate MAL2 expression in human metaplasias of the stomach, a tissue 
microarray with mixture of SPEM and intestinal metaplasia samples was probed for 
MAL2 (Figure 25). MAL2 was expressed in SPEM and localized to the subapical region. 
In intestinal metaplasia, MAL2 was localized to the same subapical compartment. In 
human, 12 out of 12 samples of SPEM and 7 out of 7 samples of intestinal metaplasia 
expressed MAL2 (Figure 25). A gastric cancer tissue microarray was also immunostained 
to investigate MAL2 expression in intestinal type gastric cancers (Figure 25). Subapical 
expression of MAL2 was found in 9 out of 11 intestinal type gastric cancers (Figure 25). 
Overall, in both mouse and human, MAL2 is a novel marker of metaplasia in the stomach 
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and understanding its role in transcytosis could provide valuable knowledge about the 
mechanisms involved in the metaplastic process. 
 
 
Figure 25. MAL2 expression in normal human gastric mucosa, metaplasia, and 
cancer. A tissue microarray of normal gastric mucosa (A), SPEM (B), and intestinal 
metaplasia (B) and a microarray of gastric cancer (C) was labeled with MAL2 (red, first 
panel), GSII lectin (green), and DMBT1 (an intestinal metaplasia marker) (white). All 
images were taken with a 10X or 20X (insets shown in upper left corners) objective. The 
second panels are the merged images. (A) MAL2 was expressed in the subapical 
compartment of mucous cells and chief cells in the normal mucosa Parietal cells 
expressed MAL2 in a diffuse cytoplasmic pattern. (B) SPEM (GSII-green) and intestinal 
metaplasia (DMBT1-white) displayed subapical localization of MAL2. MAL2 expression 
was increased in SPEM and intestinal metaplasia (IM). (C) A representative image of 
intestinal type cancer from the gastric cancer tissue microarray. In cancer, MAL2 was 
subapically expressed. (D) The percentage of samples of normal chief cells, SPEM, 
intestinal metaplasia, and intestinal type cancer samples that expressed MAL2 was 
calculated. 100% of chief cells (13/13), SPEM (12/12) and intestinal metaplasias (7/7) 
expressed MAL2. MAL2 expression was found in 82% of intestinal type gastric cancers 
(9/11). DAPI (blue). 
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ImSPEM cells polarize and form cystic structures 
 The microarray and MAL2 data suggest transcytosis plays an important role in 
metaplasia. Therefore, we assessed the polarization ability of ImSPEM cells. ImSPEM 
cells were plated near confluency on collagen-coated transwells and incubated at 39°C 
for one week. On transwell filters, ImSPEM cells remain very flat (approximately 5 µM 
tall) and vary between forming a monolayer and a bilayer of cells. In bilayers, the bottom 
layer consists of numerous smaller cells, while the upper layer has fewer, but distinctly 
larger and flatter cells. Adherens junction proteins p120 and E-cadherin localized to the 
lateral membranes of all cells in both cell layers. However, the lower layer of cells had 
jagged and irregular junctions, while the top layer displayed a smooth and continuous 
pattern (Figure 26). Additionally, F-actin is concentrated at the membrane of the cells in 
the top layer. In the bottom layer, distinct lateral membrane expression was detected, as 
well as lower intensity apical localization (Figure 27). This pattern suggests differences 
in polarization within the ImSPEM cells. Cells in the monolayer have similar patterning 
to the cells in the bilayer. To investigate the extent of polarization, tight junctions were 
examined with ZO1 immunostaining (Figure 26). Because of varying cell heights and the 
complications of two cell layers, ZO1 staining was unclear in bilayers. However, in the 
monolayer regions, ZO1 was localized to the top of the lateral membranes of the cells 
(Figure 26), demonstrating that ImSPEM cells polarize and possibly establish a transition 
between the lateral and apical membrane. Overall, these data show ImSPEM cells on 
transwells vary between forming a monolayer and a bilayer of two distinct layers that 
establish adherens and tight junctions. In the bilayer, the bottom layer of cells appears to 
polarize and becomes taller, while the top layer of cells establishes more continuous and 
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distinct junctions. Furthermore, cells in the monolayer establish tight junctions showing 
polarization. 
 Determining the degree of polarization of ImSPEM cells proved difficult as there 
are no reported apical markers in SPEM. Without the discovery of MAL2 as a subapical 
SPEM marker, studies of ImSPEM polarization would have been impeded. However, we 
are able to utilize the newly validated SPEM marker, MAL2, to determine if ImSPEM 
cells designate an apical side for transcytosis. Again, ImSPEM cells were grown on 
collagen-coated transwells at 39°C for one week. MAL2 expression was limited to the 
upper layer of cells and the monolayer (Figure 27). Furthermore, MAL2 localized to the 
subapical regions of the cells. This specific subapical localization of MAL2 demonstrates 
that ImSPEM cells define an apical side. As described above, HE4 is secreted from 
ImSPEM cells and can be detected in the media by western blot analysis. To determine 
directionality of HE4 secretion and further confirm polarization of the cells, ImSPEM 
cells were grown on collagen-coated transwells at 39°C for one week. Fresh media was 
added for 24 hours to the apical and basal sides of the transwells. Media from both sides 
was collected separately and 15 µL was probed for HE4 by western blot; HE4 secreted 
protein was only detected in the apical conditioned media (Figure 27). These findings 
show ImSPEM cells delineate an apical membrane for secretion, thus confirming the 
ability of ImSPEM cells to polarize when grown on transwell filters. 
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Figure 26. Polarization of ImSPEM cells on transwells. ImSPEM cells were grown on 
collagen-coated transwell at 39°C for one week. Cells were immunolabeled for E-
cadherin (A), p120 (B), and ZO1 (C). Expression patterns were analyzed using Z-stacks 
of the transwells. ImSPEM cells grew in either a monolayer (C) or bilayer of cells (A-C). 
Serial images taken 1 µm apart are shown. (A) ImSPEM cells in a bilayer displayed 
lateral staining for E-cadherin. Cells on the top layer exhibited more continuous 
adherence junction staining while cells in the bottom layer had more jagged staining. The 
specific lateral membrane expression can be seen in the Z-axis (first panel). (B) p120 was 
also localized to the lateral membrane in a similar pattern to E-cadherin. (D) ZO1 
staining was examined in an area of monolayer growth because the varying thickness and 
size of cells in the bilayer made localization of ZO1 staining ambiguous. In the 
monolayer, cells expressed ZO1 on the upper edge of the lateral membrane 
demonstrating the establishment of tight junctions in the correct location. DAPI (blue). 
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Figure 27. Apical polarization in ImSPEM cells. ImSPEM cells were grown on 
collagen-coated transwell at 39°C for one week. (A) Cells were immunolabeled with 
MAL2 (green) and actin (phalloidin) (white). Expression patterns were analyzed using Z-
stacks of the transwells. Serial images taken 1 µm apart are shown. MAL2 was localized 
to the subapical region of ImSPEM cells. In the bilayer of cells, MAL2 was only detected 
in the cells of the top layer. DAPI (blue). (B) After one week at 39°C, fresh media was 
added for 24 hours to apical and basal compartments of the transwells. Media was 
collected and cell debris was removed. 15 µL of the 24 hour conditioned media was 
probed for HE4 by western blot. HE4 was detected only in the apical media, 
demonstrating directional secretion. Ponceau S staining is shown as a loading control. 
 
 
Utilizing the 3D culture model of suspension in Matrigel, the extent of growth and 
polarization of ImSPEM cells was examined. ImSPEM cells were suspended in Matrigel 
at a 1:1 dilution with media. Cells were then incubated at 39°C until large structures were 
apparent. This varied from three to six weeks. By light microscopy, spherical cellular 
structures can be identified. While some strictly proliferating cells form multicellular 
spheroids, other structures appear to be cup-shaped or exhibit hollowed interiors (Figure 
28). The ability to form indentions and hollowed areas further confirms the polarization 
capacity of ImSPEM cells. The size and shape of the hollowed areas varied. Initial 
attempts to retrieve intact Matrigel plugs for immunofluorescent studies failed because 
the plugs were no longer polymerized enough to hold their shape. Therefore, the semi-
liquid contents of each well were gently centrifuged to collect all cells and fragments of 
the Matrigel. The structures in the Matrigel held together during the centrifugation such 
that immunostaining analysis could be performed, however they may have been slightly 
flattened. As seen by F-actin immunolabeling, the cystic structures consist of various 
layers of cells with some areas having only one cell layer while others have multiple 
layers (Figure 28). Serial images from Z-stacks of these structures reveal areas of open 
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cavities that are void of actin staining and nuclei. These findings reveal that ImSPEM 
cells not only grow but can form cystic structures in Matrigel.  
 
 
Figure 28. ImSPEM cystic structures in 3D Matrigel culture. ImSPEM cells were 
suspended in Matrigel and grown at 39°C. Cystic structures appeared at three to six 
weeks. Cells were immunostained for actin (phalloidin). Serial images through the cysts 
(0.5 µm apart) are shown. An opening inside the structures is clearly evident from the 
lack of actin staining and nuclei. This shows ImSPEM cells polarize to form cystic 
structures in 3D Matrigel cultures. DAPI (blue). 
 
 
Discussion 
 The stomach maintains homeostasis through a complex network of both cell 
autonomous and nonautonomous signaling pathways. Numerous studies have been 
conducted on specific signaling molecules and how their alterations affect the normal 
stomach cell types (Beauchamp et al. 1989; Murayama et al. 1994; Li et al. 1996; Abe et 
al. 1997; Nomura et al. 2004a; Nomura et al. 2004c; Jain et al. 2006a; Nozaki et al. 2008; 
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Nam et al. 2010). Recent studies have shown that damage or disease in the stomach can 
cause chief cells to transdifferentiate into SPEM. Thus, a new focus has been placed on 
understanding the molecular mechanisms involved in chief cell homeostasis and 
metaplastic transdifferentiation. After the discovery of the chief cell secretory mechanism 
(Langley 1882; Hirschowitz 1967; Koelz et al. 1982; Raufman et al. 1983; Berger et al. 
1985; Muallem et al. 1986; Raufman et al. 1986; Sutliff et al. 1986; Brown et al. 1987; 
Raufman et al. 1987; Matozaki et al. 1988; Tsunoda et al. 1988), progress toward 
understanding other molecular events and signals in chief cell homeostasis and function 
has been slow. Studies into the mechanisms that underlie this homeostasis, as well as 
transdifferentiation into SPEM have been hampered by the sole reliance on in vivo mouse 
models. While in vivo models are important for studying complex signaling networks and 
the role of specific genes or signaling pathways on a whole tissue scale, it is difficult to 
identify specific molecular interactions or gene dynamics on a cellular level. Therefore, 
in vitro cell culture studies are greatly needed to help uncover such phenomena. There is 
currently one established cell line of a normal gastric epithelial cell type called ImSt (also 
developed from the Immortomouse); however, this cell line does not express lineage 
specific markers for parietal cells, mucous neck cells, or chief cells and thus is 
presumably a cell culture model of gastric surface cells (Whitehead et al. 2009). 
Currently, human gastric cancer cell lines are used in the majority of gastric in vitro 
studies (Bredemeyer et al. 2009; Wei et al. 2010; Chaturvedi et al. 2011; Fujii et al. 2012; 
Noto et al. 2013). However, these lines have inherent disadvantages for use in 
understanding the role of genes in gastric homeostasis or the metaplastic process. For 
example, previous studies investigating the function of the chief cell specific transcription 
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factor Mist1 in vesicle maturation used human gastric cancer cell lines (Tian et al. 2010) 
because of the lack of in vitro models of normal chief cells. As Mist1 is typically lost 
early in the progression to gastric cancer (Lennerz et al. 2010), the cancer cell lines used 
do not express Mist1, therefore a Mist1 stably expressing cell line had to be established 
and pepsinogen, a significant component of secretory vesicles, also had to be transfected 
into the cells in order to study the regulation of vesicle formation in these cells (Tian et al. 
2010). The establishment of the novel ImChief cell line now allows such studies to be 
conducted in an in vitro chief cell model that closely resembles in vivo chief cells. 
ImChief cells become more differentiated and primary-like at the non-permissive 
temperature of 39°C, allowing study of endogenous proteins and differentiation and 
secretion mechanisms. Additionally, for overexpression or knockdown experiments, we 
have shown that ImChief cells can be transfected effectively with a plasmid of interest. 
Thus, the ImChief cell line is an essential in vitro chief cell model that allows for the 
study of factors (endogenous and exogenous) that are difficult to study using currently 
available resources, such as mouse models and gastric cancer cell lines.  
When parietal cells are lost, chief cells transdifferentiate into SPEM possibly as a 
protective mechanism (Nomura et al. 2004a; Nomura et al. 2004c; Nozaki et al. 2008; 
Nam et al. 2010). In the presence of chronic inflammation, SPEM can progress to 
intestinal metaplasia in the human (El-Zimaity et al. 2001); however, the mechanisms of 
induction or progression of SPEM are unknown. Due to the absence of SPEM cell culture 
models, there is currently a lack of in vitro methods to study the metaplastic process in 
the stomach. A recent study profiled the transcriptional expression of several gastric 
cancer cell lines. KATOIII cells retained a more metaplastic profile than the other cell 
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lines as measured by expression of several SPEM and intestinal metaplasia markers (Tan 
et al. 2011). While KATOIII cells are a better in vitro model for metaplasia than other 
cancer cell lines, expression of intestinal metaplasia markers prohibits separation of 
studies of SPEM from intestinal metaplasia. The establishment of the novel ImSPEM cell 
line fills this void of a SPEM-specific in vitro cell culture model. Numerous studies in the 
mouse of either loss or overexpression of specific genes have identified multiple proteins 
that result in the development of SPEM (Judd et al. 2004; Nomura et al. 2004c; Oshima 
et al. 2004; Katz et al. 2005; Ogawa et al. 2006; Oshima et al. 2006; Nam et al. 2007; Jain 
et al. 2008; Nozaki et al. 2008; Nozaki et al. 2009; Keeley et al. 2010; Lee et al. 2010; Ito 
et al. 2011). Moreover, Helicobacter infection studies have revealed roles for the 
immunological response that is important in the metaplastic progression. Upon infection, 
the gastric mucosa is infiltrated with immune cells, such as macrophages and neutrophils, 
and the expression of secreted cytokines (most notably, IL-1β and TNF-α) are increased. 
However, specific molecular interactions and cellular effects of specific genes, cytokines, 
or immune cells are obfuscated in complex in vivo models. Such effects on SPEM can 
now be investigated in this novel ImSPEM cell culture model. For example, our lab is 
currently utilizing ImSPEM cells to investigate the capacity of the transcription factor 
Mist1 to initiate SPEM reversal back to chief cells. Preliminary data indicates there is no 
change in HE4 expression in cell lysates, suggesting Mist1 alone is not capable of 
reversing SPEM (Figure 23). Moreover, purified cytokines or isolated immune cells can 
also be co-cultured with ImSPEM cells to study their role in metaplasia. Similar to 
investigations of the role of extrinsic factors, ImSPEM cells can also be used to study the 
intrinsic properties and mechanisms of SPEM. The evidence that ImSPEM cells function 
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similarly to their in vivo counterparts allows for targeted mechanistic studies of 
previously identified intrinsic proteins putatively important in the metaplastic process. 
For instance, since ImSPEM cells secrete HE4, one of the few specific markers of SPEM, 
elucidation of its secretory mechanisms are now possible. Additionally, in previous 
studies, we have identified transcriptional upregulation of Mmp12, a secreted elastase, in 
acute SPEM (Weis et al. 2013). Disintegration of the 3D Matrigel plugs suggests that 
ImSPEM cells actively secrete a factor (or multiple factors) that is capable of 
extracellular matrix degradation. Therefore, it is possible that MMP12 may be an 
essential secreted protein involved in this matrix degradation.  Such extrinsic and 
intrinsic studies into the mechanisms of SPEM are now possible with the development of 
the novel in vitro cell culture model, ImSPEM.  
 Several gene microarray studies by our lab and others have yielded numerous 
insights into the induction and progression of SPEM in both the mouse and human 
(Nomura et al. 2004a; Nozaki et al. 2008; Lee et al. 2010). Based on these previous 
successes, we compared the ImChief cell line to the ImSPEM cell line with gene 
microarray analysis. From this analysis, we established a list of putative markers of 
SPEM. MAL2 immunostaining in murine tissue revealed an increase in subapical 
expression in SPEM cells. A previous study from our lab has characterized a progression 
of SPEM to acquire intestinal characteristics (SPEM-IC) in the mouse (Weis et al. 2013). 
Although further validation is necessary, immunostaining of murine SPEM models 
suggests H. felis-induced SPEM (SPEM-IC) expresses the highest levels of MAL2 in our 
three SPEM models. Our previous study concluded that SPEM-IC is the mouse version of 
intestinal metaplasia that is found in humans (Weis et al. 2013). Accordingly, both SPEM 
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and intestinal metaplasia in the human express MAL2 with the highest expression in 
intestinal metaplasia. Furthermore, 82% of intestinal type gastric cancers (9/11) 
expressed MAL2. MAL2 is a multispan transmembrane protein that is necessary for 
transcytosis in polarized epithelial cells. In ImSPEM cells, MAL2 was localized to the 
subapical compartment, confirming the ability of ImSPEM cells to polarize on transwells. 
Because of its known role in transcytosis, studies of MAL2 in ImSPEM cells will provide 
unique insights into the little known trafficking mechanisms of SPEM. Understanding the 
trafficking machinery and other molecular mechanisms of SPEM will broaden our 
understanding of the metaplastic progression and may lead to areas of clinical 
intervention in the future. Moreover, while we have identified a new SPEM marker from 
the microarray analysis, investigation of other putative genes may also provide novel 
insights into the molecular machinery of SPEM. 
 An underlying concern of cell culture models is that the majority of studies are 
conducted in 2D cultures, which may not be relevant to the in vivo system. However, in 
the case of the ImChief cell line, many characteristics of the chief cells will remain 
obscure without the use of an in vitro model system. Due to the predominant reliance on 
in vivo models throughout the literature, numerous animal model systems exist to validate 
potential findings from the ImChief cell line. Recent advances made in propagating 
enteroids from the intestine (Sato et al. 2009), have generated considerable interest in 
culturing enteroids or gastroids from the stomach. However, propagation techniques for 
gastric enteroids or gastroids have not been refined. In contrast, the ImSPEM cell line 
consists of a known and thoroughly characterized cell type that has the ability to grow as 
a 3D culture in Matrigel, forming polarized cystic structures. Thus, ImSPEM cells in 3D 
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culture can be used to assess a wide array of traits, such as proliferation, polarization, and 
cyst or gland formation. Overall, we have established and thoroughly characterized two 
novel in vitro cell lines: chief cells (ImChief) and SPEM cells (ImSPEM). These studies 
have shown the utility of ImChief and ImSPEM cell lines as vital model systems for 
studying intrinsic and extrinsic factors involved in both gastric homeostasis and the 
metaplastic process. 
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CHAPTER IV 
 
LOSS OF MIST1 IMPEDES CHIEF CELL TRANSDIFFERENTIATION INTO 
SPEM 
Appears as: Weis, V.G., Petersen, C.P., Mills, J.C., and Goldenring, J.R. Loss of Mist1 
impedes chief cell transdifferentiation into SPEM. Manuscript in preparation. 
 
 
 
Introduction 
 Gastric glands consist of multiple cell lineages that are derived from progenitor 
cells that reside in the isthmus region of the glands. The cells emerge from the progenitor 
region and differentiate as they migrate away (Karam et al. 1993a; Karam et al. 1993c; 
Karam et al. 1993d). Acid-secreting parietal cells migrate downward towards the base 
and reside in the neck region of the gland (Karam et al. 1992). Mucous neck cells also 
migrate towards the base of the glands. As they exit the neck region of the gland, mucous 
neck cells switch their secretory machinery and transdifferentiate into zymogen-secreting 
chief cells that continue to mature until they reach the base of the gland (Karam et al. 
1993d). During this transdifferntiation, the cells begin to expand their rough endoplasmic 
reticulum (rER) and extend their apical membranes to establish a more pyramidal shape 
(Karam et al. 1993d; Ramsey et al. 2007; Bredemeyer et al. 2009). This 
transdifferentiation is accompanied by the replacement of mucous filled vesicles with 
zymogen containing vesicles (Karam et al. 1993d; Ramsey et al. 2007). Approximately 
two transition cells (GSII lectin and intrinsic factor dual positive) are observed per gastric 
gland (Karam et al. 1993d; Ramsey et al. 2007). The transcription factor, XBP1, is 
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required for establishment of the rER and termination of the mucous neck cell vesicles 
(Huh et al. 2010). Accordingly, without XBP1 expression, cells retain mucous neck cell 
markers and thus do not fully differentiate into chief cells. XBP1 also induces expression 
of the chief cell specific transcription factor, MIST1 (Huh et al. 2010). MIST1 is 
involved in the expansion of the apical membrane and generation of secretory vesicles 
(Ramsey et al. 2007). While XBP1 is required for chief cells to differentiate from mucous 
neck cells, MIST1 is necessary for chief cells to fully mature as they migrate to the base 
of the gland. When MIST1 expression is lost, chief cells still cease expression of mucous 
neck cell markers (GSII lectin) but retain fewer and smaller zymogen vesicles as well as 
have defects in apical expansion (Ramsey et al. 2007). Thus, without MIST1, chief cells 
cannot maintain their secretory machinery and do not fully mature. 
 Disruptions in the homeostasis of these lineages are associated with the 
metaplastic process in the stomach. Metaplasias and gastric malignancies are associated 
with Helicobacter infections (Blaser et al. 1994b; Correa et al. 2010). Helicobacter 
infections result in oxytnic atrophy (parietal cell loss) and a prominent inflammatory 
response. In humans, two types of metaplasias arise: spasmolytic polypeptide expressing 
metaplasia (SPEM) and intestinal metaplasia (Correa 1988; Schmidt et al. 1999). Recent 
studies have shown that SPEM develops initially and then gives rise to intestinal 
metaplasia (Yoshizawa et al. 2007; Goldenring et al. 2010). Helicobacter infected mice 
develop SPEM after 6 months of infection and progress to dysplasia after 12 months 
(Wang et al. 2000; Houghton et al. 2004b). However, the mice do not develop phenotypic 
intestinal metaplasia (no goblet cells are present). Instead, in the presence of chronic 
inflammation, SPEM evolves to a more proliferative and advanced state designated 
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“SPEM with intestinal characteristics” (SPEM-IC) (Weis et al. 2013). SPEM-IC 
expresses intestinal transcripts and appears to be the mouse analog to intestinal 
metaplasia in humans (Weis et al. 2013). However, the mechanisms involved in this 
metaplastic progression are unclear.  
Our lab has developed two acute SPEM induction models in animals to analyze 
the initiation of SPEM in the absence or presence of inflammation. Administration of the 
protonophore, DMP-777, results in parietal cell loss without an inflammatory response, 
presumably because DMP-777 inhibits elastase (Nomura et al. 2005b). After 14 days of 
treatment, two zones of mucous cells appear: mucous neck cell hyperplasia (GSII lectin 
expression) and SPEM that has transdifferentiated from chief cells (GSII lectin and 
intrinsic factor expression) (Nam et al. 2010). This model demonstrates that loss of 
parietal cells is sufficient for SPEM induction. However, DMP-777 induced SPEM never 
progresses to dysplasia, even after a year of administration (Goldenring et al. 2000). 
Taken together, the DMP-777 and Helicobacter (H. felis) SPEM models demonstrate the 
necessity of inflammation for progression to dysplasia. However, the lengthy time (at 
least 6 months) required for H. felis to induce SPEM is prohibitive to studying SPEM in 
the presence of inflammation in multiple mouse models. Our lab has characterized an 
acute SPEM model with a prominent inflammatory response (Nam et al. 2010). 
Administration of L635, a DMP-777 analog that lacks elastase inhibition, induces chief 
cell transdifferentiation into SPEM accompanied by prominent inflammation in three 
days. L635 induced SPEM expresses some intestinal transcripts, such as Cftr and Dmbt1, 
at levels similar to 6 month H. felis induced SPEM (Weis et al. 2013). Furthermore, L635 
induced SPEM exhibits increased proliferation, resembling H. felis induced SPEM (Nam 
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et al. 2010). This demonstrates a more advanced SPEM induction by L635 over DMP-
777. These two acute SPEM models, DMP-777 and L635 administration, can be used to 
efficiently investigate the initiation and progression of SPEM.  
Chronic inflammation has been shown to be an important extrinsic signal in the 
metaplastic progression of the stomach. Investigations of Helicobacter infections have 
determined elevations of inflammatory cytokines (Nam et al. 2010; Quiding-Jarbrink et al. 
2010); however the complex signaling networks as well as the individual effects of these 
cytokines is unclear. Among chronic inflammation induced SPEM models, such as 
Helicobacter infection or Hip1r null mice, currently only the pro-inflammatory cytokine 
interferon-γ (IFNγ) has been shown to be necessary for the induction of SPEM 
(Yamamoto et al. 2004; Tu et al. 2011; Liu et al. 2012). Additionally, investigations of 
normal gastric homeostasis regulators have failed to identify the necessity of a specific 
gene for the development of SPEM (Mulder et al. 1991; Nomura et al. 2005b; Ogawa et 
al. 2006; Nam et al. 2007). All of these studies (including the study detailed in Appendix 
B) focus on the necessity of extrinsic signals and factors that act upon ‘passive’ chief 
cells for transdifferentiation into SPEM. However, studies of the required native intrinsic 
mechanisms and gene expression of the chief cell for SPEM induction are severely 
lacking. Here, we suggest a more active role for chief cells through an intrinsic secretory 
contribution to the complex signaling involved in the metaplastic progression of the 
stomach. 
As Mist1 is necessary for the development of fully mature chief cells, in this study, 
Mist1 null mice are used to investigate the necessity of mature chief cells with fully 
established secretory machinery for the initiation of SPEM. DMP-777 and L635 were 
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administered to Mist1 null mice and control mice. DMP-777 treated Mist1 null mice 
exhibited an increase in GSII lectin and intrinsic factor (GIF) dual positive cells. These 
cells resembled ‘neck to chief’ transition cells found in the normal stomach. However, 
focal areas displayed some characteristics of SPEM, such as a small increase in 
proliferating GSII lectin and GIF dual positive cells. Significant parietal cell loss and 
inflammation occurred with L635 administration of Mist1 null mice, similar to L635 
treated control mice. Proliferation in L635 treated Mist1 null mice was similar to DMP-
777 treatment of null mice in both quantity and localization. No increase in GSII lectin 
and GIF co-positive cells was found in the L635 treated Mist1 null mice. Instead, the 
majority of glands in L635 treated Mist1 null mice retain chief cells along the base of the 
glands, indicating that Mist1 null mice do not develop SPEM from parietal cell loss or 
inflammation as readily as control mice. 
 
Methods 
Mice 
C57BL/6 mice obtained from Jackson Laboratories (Bar Harbor, ME) were used 
as controls. Mist1 null mice were maintained on a C57BL/6 background. During the 
experiments, the mice were maintained with regular mouse chow and water ad libitum in 
a temperature-controlled room under a 12-hour light/dark cycle. The care, maintenance, 
and treatment of animals in these studies followed protocols approved by the Institutional 
Animal Care and Use Committee of Vanderbilt University. 
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Drug Administration 
DMP-777, a gift from DuPont Pharmaceuticals (Wilmington, DE), was 
formulated in 0.5% methylcellulose and administered orally as a gavage once daily at 350 
mg/kg/day. Control mice (n=3) and and Mist1 null mice (n=5) were treated for 14 
consecutive days. L635, dissolved in saline and orally administered as a gavage once 
daily at 350 mg/kg/day, was a gift from Merck & Co, Inc (Rahway, NJ). Control mice 
(n=3) and Mist1 null mice (n=3) were treated for three consecutive days. 
Immunofluorescence   
Excised stomachs from mice were fixed in 4% paraformaldehyde overnight and 
embedded in paraffin. Sections were heated at 60°C for 30 minutes and then cooled to 
room temperature for 30 minutes. Tissue was deparaffinized and rehydrated. Antigen 
retrieval was performed using Target Retrieval solution (DakoCytomation, Glostrup, 
Denmark). Slides were blocked using protein block serum-free (DakoCytomation) for 
one hour at room temperature. Immunostaining was performed using the following 
primary antibodies incubated at 4°C overnight: goat anti-intrinsic factor (1:1000, a 
gift from Dr David Alpers, Washington University, St. Louis, Missouri, USA) and rat 
immunoglobulin G (IgG) anti-Ki-67 (1:50, Dako). Detection was performed using 
fluorescent secondaries or fluorescent conjugated GSII lectin (Molecular Probes, Eugene, 
OR) for 1 hour at room temperature. Slides were mounted with ProLong Gold Antifade 
Reagent with DAPI (Invitrogen).  Sections were analyzed using Zeiss Axiophot 
microscope equipped with an Axiovision digital imaging system (Zeiss, Jena GmBH, 
Germany) or using the Ariol SL-50 automated slide scanner (Genetix, San Jose, CA). 
Quantification of the average number of cells immunostaining for Ki67, GSII lectin, and 
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intrinsic factor per gland was done by manual counts. All counted cells had nuclei as 
detected by DAPI. The number of dual positive cells (Ki67 and GSII lectin or GSII lectin 
and intrinsic factor) was counted only in well oriented glands in which the entire length 
of the gland was visible and void of any tangential cross sectioning. On average, five 
glands were counted from one representative mouse in each sample group. Due to the 
complexity of the calculations, the counts presented in this study are representative 
quantifications of the observations made from multiple mice in each group.  
 
Results 
Acute SPEM induction in the absence of inflammation in Mist1 null mice 
 DMP-777, a protonophore with elastase inhibition, was administered by oral 
gavage to control mice and Mist1 null mice for 14 days. Parietal cell loss and presence of 
the various gastric cell lineages was analyzed by PAS staining. In PAS stained sections of 
untreated control mice, parietal cells are light pink, chief cells are blue, and mucous neck 
cells are a dark magenta color (data not shown). SPEM cells also stain as a dark magenta 
color similar to mucous neck cells, though SPEM cells are predominately located at the 
base of glands in regions of parietal cell loss. The patterning of cells in untreated Mist1 
null mice differs slightly from control mice. As previously reported (Ramsey et al. 2007), 
Mist1 null mice have a small increase in transition cells (mucous neck to chief cells), an 
increase of parietal cells localized near the base, and aberrant chief cell structure. 
However, the cell types stain the same as control mice by PAS (Figure 29). Control mice 
treated with DMP-777 had significant parietal cell loss (Figure 29). Loss of blue stained 
chief cells from the base of glands can also be seen. The chief cells are replaced with 
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magenta colored cells at the base of the glands, indicative of SPEM cells (Figure 29). 
Previous reports have shown these as SPEM cells derived from transdifferentiated chief 
cells (Nam et al. 2010). DMP-777 treatment of Mist1 null mice also results in a reduction 
of parietal cells as compared to untreated control and Mist1 null mice. However, fewer 
parietal cells are lost in treated Mist1 null mice as compared to treated control mice 
(Figure 29). The amount of parietal cell loss varied throughout the fundus of Mist1 null 
mice, suggesting a more focal effect of DMP-777. Mucous neck cells increase in number 
and extend further down the gland, although not to the base. Furthermore, while the 
number of chief cells decreases, treated Mist1 null mice still retain some chief cells at the 
base of most glands in the fundus, suggesting a failure of fully induced SPEM (Figure 29).  
 Quantification of the cell lineages throughout the fundus of control and Mist1 null 
mice was performed to show differences of the lineages between treated and untreated 
mice. Although at least 3 mice from each group were manually examined, counts 
represented here are from one representative mouse from each group. GSII lectin 
(mucous neck cell and SPEM marker) and intrinsic factor (GIF) were utilized to examine 
the cell lineages in the fundus of control and Mist1 null mice. GSII lectin labels mucous 
neck cells and SPEM cells, while GIF is a chief cell specific marker that persists in early 
SPEM lesions. In untreated control mice, as mucous neck cells migrate towards the base 
of glands, they quickly switch from expression of mucins (detected by GSII lectin) to 
GIF expression during transdifferentiation into chief cells (Figure 30). Approximately 
two transition cells that co-express mucous neck cell and chief cell markers can be found 
in a normal gastric gland. GIF expression continues to increase as the chief cells mature 
towards the base (Figure 30). As previously reported (Ramsey et al. 2007), Mist1 null 
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mice have an increase in transition cells (5-6 per gland) corresponding to a delay in 
transdifferentiation to chief cells (Figure 30). Furthermore, emerging from the transition 
zone, chief cells have a sudden decrease in GIF expression (Figure 30) (Ramsey et al. 
2007). This loss of expression is due to the inability of chief cells to establish the 
secretory machinery in the absence of MIST1 (Ramsey et al. 2007). 
 
Figure 29. PAS staining of untreated and DMP-777 treated control and Mist1 null 
mice. DMP-777 was administered to control mice and Mist1 null mice for 14 days to 
induce SPEM. Images in top row were taken with a 20X objective. Black box highlights 
area imaged with 40X objective for the bottom row. DMP-777 treatment in control mice 
causes significant parietal cell loss. Magenta colored SPEM cells replace the blue stained 
chief cells at the base of glands. While magenta staining is extended closer to the base in 
Mist1 null mice, small blue stained chief cells remain at the base of glands.  
 
 
112 
 
 
113 
 
Figure 30. Proliferation of SPEM (GSII lectin positive) cells after DMP-777 
administration. Sections were immunostained for Ki67, GSII lectin, and GIF. For GIF 
images, the exposure was equal in all captured images. Untreated controls and Mist1 null 
mice have low levels of proliferation localized only to the progenitor region and distinct 
separate regions of GSII lectin and GIF immunolabeling. DMP-777 treated control mice 
have an increase in the number of GSII lectin and GIF dual positive cells at the base of 
glands representing the induction of SPEM. Moreover, these mice had an increase in 
proliferation that was predominately located in the mucous neck cell hyperplasia (GSII 
lectin positive cells in the middle of the glands). However, occasional triple positive cells 
can be found at the base of glands. DMP-777 treated Mist1 null mice have a similar 
expression pattern as the DMP-777 treated control mice. Of note, GIF expression levels 
at the base of glands in DMP-777 treated Mist1 null mice appear higher than found in 
DMP-777 treated control mice and thus more closely resemble transition cells (GSII 
lectin and GIF dual positive cells) in the untreated Mist1 null mouse. DAPI (blue). 
 
 
DMP-777 administration to control mice results in an increase of GSII lectin and 
GIF co-labeling cells at the base of glands (Figure 30). When chief cells transdifferentiate 
into SPEM, they begin to re-express mucous neck cell markers (Nozaki et al. 2008; Nam 
et al. 2010), accounting for the increase in dual positive cells (~3.5 fold increase). DMP-
777 treated Mist1 null mice also have an increase in co-expressing cells compared to 
untreated null mice (Figure 30). However, it is a smaller increase (~2.3 fold) than found 
in control mice treated with DMP-777. Additionally, the co-expressing cells in the DMP-
777 treated Mist1 null mice have high GIF expression, resembling the transition cells in 
untreated null mice (Figure 30). If these dual positive cells were SPEM cells from 
transdifferentiated Mist1 null chief cells, they would presumably lack the machinery for 
such high GIF expression because lack of Mist1 results in loss of high GIF in chief cells. 
These findings suggest Mist1 null mice predominately have an accumulation of transition 
cells instead of the induction of SPEM in the setting of acute parietal cell loss.  
Another characteristic of the induction of SPEM is an increase in proliferation of 
GSII lectin positive cells. Tissue was immunostained for Ki67 (proliferation), GSII lectin 
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(mucous neck cell and SPEM), and GIF (chief cell and early SPEM lesions). Untreated 
control mice had less than one Ki67 and GSII dual positive cell per gland (Figure 30). 
When present, the co-positive cell was located at the junction of the progenitor and neck 
zone. Thus, this dual labeling cell is an emerging immature mucous neck cell. Upon the 
induction of DMP-777 induced SPEM, there is a 22.1 fold increase of proliferating GSII 
lectin labeled cells (Figure 30). This increase appears to predominately come from the 
mucous neck cell hyperplasia zone of DMP-777 treated glands (GSII lectin positive, GIF 
negative). However, there is also an increase in GSII lectin positive SPEM cells at the 
base that label with Ki67 (Figure 30). Similarly to control mice, untreated Mist1 null 
mice have approximately one proliferating immature mucous neck cell per gland. 
Conversely, Ki67 and GSII lectin dual positive cells only increase 5.2 fold in DMP-777 
treated Mist1 null mice. While SPEM cells at the base of glands (GSII lectin and GIF 
positive) have a small increase in proliferation, this increase is again mainly in the 
mucous neck cell hyperplasia (Figure 30). Although further spatial quantification of GSII 
lectin and Ki67 labeling is needed, the increase in number of dual positive cells between 
untreated and DMP-777 treated is considerably less in Mist1 null mice than in control 
mice. Together, these findings suggest Mist1 null mice are resistant to the development of 
SPEM.  
Effects of parietal cell loss and prominent inflammation in Mist1 null mice 
 Loss of Mist1 appears to impede the induction of SPEM initiated by the loss of 
parietal cells in the absence of inflammation. Previous studies have shown L635 
administration, a DMP-777 analog without elastase inhibition, induces parietal cell loss 
accompanied by a prominent inflammatory response. SPEM derived from L635 treatment 
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for only three days expresses some intestinal transcripts, suggesting that it is a more 
advanced SPEM subtype (also called SPEM-IC). Therefore, control and Mist1 null mice 
were treated with L635 for three days to investigate the induction of SPEM or SPEM-IC 
in Mist1 null mice in the presence of inflammation. As seen by PAS staining, L635 
treated control mice have significant parietal cell loss with a prominent inflammation 
response (Figure 31). The normal gastric cell lineages are replaced with SPEM cells 
transdifferentiated from chief cells (Nam et al. 2010). In contrast to DMP-777 induced 
SPEM, the entire region below the progenitor zone is composed of SPEM cells in L635 
treated mice (Nam et al. 2010). Mist1 null mice treated with L635 also show significant 
parietal cell loss and inflammation (Figure 31). However, prominent magenta staining at 
the base of the glands, indicative of SPEM, was not seen; instead, small blue stained cells 
resembling chief cells were present (Figure 31). 
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Figure 31. PAS staining of L635 treated control and Mist1 null mice. L635 was 
administered to control mice and Mist1 null mice for three days to induce SPEM. Images 
in top row were taken with a 20X objective. Black box highlights area imaged with 40X 
objective for the bottom row. L635 administration caused significant parietal cell loss in 
both control and Mist1 null mice. Magenta colored SPEM cells replace the blue stained 
chief cells at the base of glands. Note that L635 induced SPEM cells do not stain as 
bright magenta as DMP-777 induced SPEM cells. However in Mist1 null mice, small 
blue stained chief cells were still found at the base of glands, suggesting a failure to 
transdifferentiate into SPEM. PAS staining of untreated control and Mist1 null mice is 
previously shown in Figure 29. 
 
 
 The cell lineages in L635 treated control and Mist1 null mice were then analyzed 
by immunostaining for GSII lectin and GIF. In L635 treated control mice, GSII 
immunolabeling extends to the base of glands. L635 induced SPEM is completely 
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comprised from transdifferentiated chief cells (Nam et al. 2010). GIF expression is 
significantly decreased and then lost from the SPEM cells due to the advanced stage of 
L635 induced SPEM (Figure 32). Even with this rapid GIF loss, L635 treated control 
mice have a 2.98 fold increase in GSII lectin and GIF dual positive cells (Figure 32). 
Conversely, although L635 treated Mist1 null mice also have a significant decrease in 
parietal cells, GSII lectin is not found at the base of all glands in the fundus, and GIF 
expression is still found at the base (Figure 32). In fact, it appears there are fewer glands 
with GSII lectin at the base in L635 treated Mist1 null mice than null mice treated with 
DMP-777. Quantification verified no change in GSII lectin and GIF dual positive cells 
between untreated and L635 treated Mist1 null mice. The short time course of treatment 
(3 days) may account for the lack of a change in co-positive cells in L635 treated Mist1 
null mice as compared to DMP-777 treated null mice. 
 L635 induced SPEM in control mice displays a 16.2 fold increase in proliferation 
of the GSII lectin positive SPEM cells as seen by Ki67 immunostaining (Figure 32). In 
contrast to DMP-777 induced SPEM, proliferation is seen throughout the entire length of 
L635 induced SPEM glands in control mice (Figure 32). Mist1 null mice also have an 
increase in proliferation when treated with L635. While there is a small increase in 
proliferation of GSII lectin and GIF dual positive cells, the majority of the 4.7 fold 
increase is in the upper GSII lectin positive cells similar to DMP-777 induced 
proliferation (Figure 32). These findings suggest the presence of inflammation during 
parietal cell loss does not exacerbate SPEM induction or progression to SPEM-IC in 
Mist1 null mice.  
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Figure 32. Proliferation of L635 induced SPEM (GSII lectin positive) cells. Sections 
were immunostained for Ki67, GSII lectin, and GIF. For GIF images, the exposure was 
the same in all captured images. Untreated controls and Mist1 null mice are previously 
shown in Figure 30. L635 administration induces a proliferative SPEM lineage in control 
mice. As seen in the first column, proliferation is seen throughout the length of the SPEM 
glands. While L635 treated Mist1 null mice also had an increase in proliferation, these 
cells were predominately localized in the upper regions of GSII lectin staining. 
Occasional triple positive cells were also observed. Additionally, the number of GSII 
lectin and GIF dual positive cells did not change in L635 treated Mist1 null mice as 
compared to untreated null mice. DAPI (blue). 
 
 
Discussion 
 Disruption of the homeostasis of the stomach leads to changes in the cell lineages 
in the glands. Loss of the acid-secreting parietal cells results in chief cell 
transdifferentiation into SPEM cells (Nomura et al. 2005b; Nozaki et al. 2008; Nam et al. 
2010). The presence of inflammation during oxyntic atrophy advances SPEM to SPEM 
with intestinal characteristics (SPEM-IC) ,which is the mouse analog of the progression 
of SPEM to intestinal metaplasia in humans (Weis et al. 2013). Because SPEM gives rise 
to intestinal metaplasia in the progression to gastric cancer in humans, SPEM is 
considered a preneoplastic lesion (Goldenring et al. 2010). However, the mechanisms 
necessary for this metaplastic progression are unclear. Several studies have attempted to 
elucidate factors involved; however, most have focused on the role of extrinsic influences 
such as immune cells and other signaling molecules (Mulder et al. 1991; Nomura et al. 
2005b; Ogawa et al. 2006; Nam et al. 2007; Tu et al. 2011). While these studies broaden 
our understanding of the complex networks in the progression to SPEM, the involvement 
of the native intrinsic chief cell mechanisms and gene expression are unknown. In this 
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study, we have investigated the necessity of mature chief cells with properly functioning 
secretory machinery.  
 Chief cells in Mist1 null mice fail to establish their secretory machinery resulting 
in immature chief cells that have decreased GIF and pepsinogen expression (Ramsey et al. 
2007). Initially, one may expect Mist1 null mice to develop SPEM faster, as aberrant 
chief cells may more readily transdifferentiate into reparative SPEM cells. However from 
the studies presented here, Mist1 null mice display a decrease in SPEM induction 
potential (Figure 33). Distinguishing between ‘neck to chief’ transition cells and SPEM 
cells is difficult because they both co-label with GSII lectin and GIF (Ramsey et al. 2007; 
Nozaki et al. 2008). For this reason, we also examined proliferation of GSII lectin 
positive cells because transition cells have not been shown to proliferate (Karam et al. 
1993d; Ramsey et al. 2007). DMP-777 treatment of null mice did increase the number of 
proliferating GSII lectin positive cells as well as cells co-labeled with GSII lectin and 
GIF. The majority of the proliferating cells were located in the mucous neck cell 
hyperplasia region of GSII lectin labeling. Furthermore, the GIF expression levels in the 
dual positive cells (GSII lectin and GIF) resembled the levels found in the ‘neck to chief’ 
transition cells found in untreated Mist1 null mice. If Mist1 null chief cells at the base of 
glands differentiated into SPEM, the cells would presumably lack the secretory 
machinery for such levels of GIF expression. Additionally, because GIF decreases and is 
eventually lost in SPEM, there is no rationale for the cells to setup the necessary 
secretory machinery through alternative pathways. There are two explanations for the 
potential origin of these cells. The reduction of parietal cells may cause a failure of ‘neck 
to chief’ transition cells to completely differentiate into chief cells, thus resulting in an 
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accumulation of transition cells that express mucous neck cell markers (GSII lectin) and 
chief cell markers (GIF). However, triple positive cells (Ki67, GSII lectin, and GIF) can 
still be found at the base of glands, demonstrating that SPEM is capable of developing in 
Mist1 null mice, albeit to a lesser degree. A second possibility is that only a subset of 
chief cells in the Mist1 null mouse has the ability to transdifferentiate into SPEM. The 
newly differentiated chief cell just emerging from the transition zone (before it has lost its 
secretory abilities) may give rise to the proliferating SPEM cells found in DMP-777 
treated null mice. Overall, our data shows Mist1 null mice are capable of developing 
SPEM but not as readily as control mice.  
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Figure 33. Diagram of expression patterns in untreated and treated control mice 
and Mist1 null mice. This model depicts the staining pattern for Ki67 (red), GSII lectin 
(green), and GIF (black). DMP-777 and L635 treated Mist1 null glands are depicted with 
a SPEM gland only to show a loss of parietal cells (not the induction of SPEM). DMP-
777 treated control mice have increased proliferation in the mucous neck cell hyperplasia 
region while dual labeled SPEM cells (GSII lectin and GIF) are present at the base of the 
glands. Proliferation is seen in SPEM cells throughout the length of the gland in L635 
treated control mice. In Mist1 null mice treated with DMP-777, proliferation is increased 
the upper GSII lectin region. Dual positive cells (GSII lectin and GIF) that resemble 
transition cells found in the untreated Mist1 null mouse are found at the base of the 
glands. L635 administration to Mist1 null mice results in an increase proliferation similar 
to that seen in DMP-77 treatment. Furthermore, there was no change in the number of 
dual positive cells (GSII lectin and GIF).  
 
 
 Parietal cell loss in the presence of inflammation can induce a more proliferative 
and advanced SPEM in only three days (Nam et al. 2010; Weis et al. 2013). L635 was 
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administered to Mist1 null mice to determine if the additional stimulus of inflammation 
accompanied with parietal cell loss could induce SPEM or SPEM-IC. Administration of 
L635 in null mice increased the number of proliferating GSII lectin positive cells but not 
GSII lectin and GIF dual positive cells. Additionally, many glands retained distinct 
separation of GSII lectin labeled neck cells and GIF expressing chief cells. While 
proliferating GSII lectin and GIF positive cells towards the base of glands could be seen, 
proliferation in L635 treated null mice was predominately observed in the upper GSII 
lectin positive region, similar to DMP-777 treatment. It is possible that the proliferating 
GSII lectin labeled cells in the upper neck region represents mucous neck cell hyperplasia 
as seen in DMP-777 treated mice. Overall, parietal cell loss by either drug induced a 
similar level and localization of proliferation in null mice, but it appears that dual positive 
(GSII lectin and GIF) cells do not increase after only three days of parietal cell loss even 
under the influence of inflammation. Even if only a subset of chief cells is capable of 
transdifferentiation, more SPEM cells (labeled by GSII lectin and GIF) would be 
expected from L635 treatment because of the influence of inflammation. This data further 
supports that the increase of dual positive cells in DMP-777 treated null mice may 
predominately arise from an accumulation of transition cells that fail to become chief 
cells instead of chief cells transdifferentiating into SPEM. Thus, our data suggests Mist1 
null mice are resistant to developing SPEM. However, when parietal cells are lost, a 
small subset of newly differentiated chief cells may become SPEM. After three days, 
even in the presence of inflammation, the majority of chief cells remain unchanged, 
suggesting that the loss of chief cells after 14 days of parietal cell loss is replaced by an 
accumulation of transition cells.  
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 The studies presented here focus on the necessary intrinsic properties and 
characteristics of chief cells for SPEM induction. Without Mist1, chief cells cannot 
properly maintain their secretory machinery. The current investigations show Mist1 null 
mice are resistant to SPEM induction. Because Mist1 is exclusively expressed in chief 
cells in the stomach, this resistance is solely due to their defects. Of note, Mist1 is also 
expressed in mature plasma cells, however recent studies have shown loss of Mist1 does 
not cause defects in these cells (Capoccia et al. 2011). The prevailing assertion of studies 
in the stomach literature is that the signaling networks from other cell types (e.g. immune 
and parietal cells) are the driving force of the metaplastic progression and chief cells are 
merely passive participants. However, Mist1 null mice with aberrant maturation and 
secretion are resistant to SPEM induction suggesting that normal chief cells secrete 
signals to help coordinate the transition to SPEM. Overall, these studies demonstrate the 
first intrinsic characteristic of chief cells necessary for the induction of SPEM. 
Furthermore, chief cells are not purely passive participates but instead contribute to the 
complex signaling involved in the metaplastic progression of the stomach. 
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CHAPTER V 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
Conclusions 
Aberrations of gastric homeostasis are associated with various gastric diseases, 
such as ulcers and adenocarcinomas. Helicobacter pylori (H. pylori) infections are a 
common cause of these aberrations in humans (Blaser et al. 1994b; Correa et al. 2010). 
Chronic inflammation and loss of the acid-secreting parietal cells (oxyntic atrophy) 
results from H. pylori infections. Without the differentiation signaling pathways from the 
parietal cells, chief cells transdifferentiate into SPEM, possibly as a localized repair 
mechanism (Nomura et al. 2004a; Nomura et al. 2004c; Nozaki et al. 2008; Nam et al. 
2010). However, under chronic inflammatory influences, SPEM gives rise to intestinal 
metaplasia (Yoshizawa et al. 2007; Goldenring et al. 2010). In this milieu, gastric 
adenocarcinomas can develop. Similar to humans, Helicobacter infections in mice lead to 
oxyntic atrophy with a prominent inflammatory response, and SPEM develops after six 
months of infection (Wang et al. 2000; Houghton et al. 2004b). Phenotypic intestinal 
metaplasia does not develop in mice; instead, SPEM progresses directly to dysplasia after 
12 months of infection (Wang et al. 2000; Houghton et al. 2004b). Previous studies 
comparing expression profiles of normal chief cells and Helicobacter induced SPEM 
have identified upregulated genes (Nomura et al. 2004b; Nam et al. 2010; Quiding-
Jarbrink et al. 2010). Other manipulations of gastric homeostasis, such as disruptions of 
the EGFR signaling pathway and drug induced oxyntic atrophy can also cause SPEM 
(Goldenring et al. 2000; Nomura et al. 2004c; Nam et al. 2010). However, the 
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mechanisms involved in the development of SPEM are unclear. The work presented here 
has lead to novel discoveries and tools that have expanded our understanding of SPEM. 
Investigations into both the heterogeneity of SPEM lineages and Mist1 null mice have led 
to a new model of metaplastic progression in the mouse as well as the novel concept that 
chief cells are active participants that require secretory machinery for transdifferentiation 
into SPEM. Additionally, novel in vitro chief cell and SPEM cell models were developed 
and now provide necessary tools to elucidate molecular mechanisms of chief cells and 
SPEM. These studies have also revealed novel metaplasia markers. 
Heterogeneity of phenotypic SPEM lineages  
Differing expression patterns and characteristics have been reported for SPEM 
lineages from different settings(Weis et al. 2013). These differences have confounded our 
understanding of SPEM induction. In the first study presented here, three models of 
SPEM induction (DMP-777 administration, L635 administration, and H. felis infection) 
were chosen for transcription expression analysis. These three distinct models were 
chosen based on their distinct characteristics, such as length of treatment (acute versus 
chronic) and progression to dysplasia (presence versus absence of inflammation). DMP-
777 treatment initiates SPEM in only 14 days without inducing an inflammatory response. 
Acute SPEM accompanied by prominent inflammation is induced by L635 administration. 
Lastly, H. felis infection was utilized as a chronic SPEM induction method with chronic 
inflammation. Gene microarray analysis revealed an expression profile common to all 
SPEM lineages, as well as a profile specific to SPEM with inflammation, indicative of 
progression towards more advanced SPEM. Eight transcripts were upregulated in all 
SPEM lineages regardless of the surrounding milieu. A previously reported (Nozaki et al. 
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2008) SPEM marker, whey acidic protein 4-disulfide core domain 2 (Wfdc2, also known 
as He4), was found to be upregulated in all SPEM lineages. Clusterin (Clu) was also 
upregulated in all SPEM lineages. In normal gastric glands, CLU protein was expressed 
at low levels in the progenitor zone. Upon SPEM induction, CLU expression was 
upregulated in SPEM in all three murine models. In humans, upregulated CLU protein 
expression as compared to normal glands was found in SPEM (18/20) and intestinal 
metaplasia (5/11). In intestinal metaplasia, CLU labeled small cells near the SPEM to 
intestinal metaplasia transition. Clusterin expression was retained in 56.5% of gastric 
cancers (9/16 intestinal-type and 4/7 diffuse-type). Furthermore, highest expression of 
CLU (43-95% of epithelial cells positive for CLU) correlated with shorter survival time. 
Thus, the comparison of SPEM lineages identified a novel SPEM marker. Additionally, 
we compared SPEM developed in the presence of inflammation to normal chief cells. 
Cftr transcription was upregulated in L635 and H. felis induced SPEM. CFTR protein 
was expressed only in murine SPEM accompanied by inflammation. In humans, CFTR 
was expressed in intestinal metaplasia, but not SPEM. Moreover, intestinal associated 
transcripts, such as Muc4, Vil1, and PigR were upregulated in 12 month H. felis infected 
mice. These findings identified a more advanced SPEM that acquires intestinal transcripts, 
which could potentially progress to dysplasia. This lineage has been denoted SPEM-IC 
(SPEM with intestinal characteristics). Thus, this study has led to a shift in the 
metaplastic paradigm in the stomach. SPEM is induced upon parietal cell loss, but under 
the influence of chronic inflammation, SPEM progresses to SPEM-IC, which is a more 
advanced and proliferative metaplasia. Because dysplasia arises directly from SPEM in 
mice, SPEM-IC represents the mouse equivalent of intestinal metaplasia in humans. The 
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transcriptional profiles established in this study can now be utilized to better characterize 
the stage of SPEM lineages found in other murine metaplasia models. Furthermore, the 
categories of transcripts identified in these expressional comparisons provide putative 
factors for future investigations.  
Establishment of in vitro models of chief cells and SPEM cells 
While we, along with others, have identified putative factors and signaling 
pathways involved the induction and progression of SPEM (as described above)(Nomura 
et al. 2004a; Nozaki et al. 2008; Lee et al. 2010; Nam et al. 2010; Weis et al. 2013), 
mechanistic studies of their roles have been limited to the utilization of in vivo models. 
Previously, normal gastric chief cell or metaplasia cell lines did not exist. Most in vitro 
studies use human gastric cancer cell lines with inherent disadvantages or isolated 
primary cells that lack manipulation capabilities (such as overexpression) (Bredemeyer et 
al. 2009; Wei et al. 2010; Chaturvedi et al. 2011; Fujii et al. 2012; Noto et al. 2013). 
Utilizing the Immortomouse (Jat et al. 1991), we developed two cell lines to fill this 
deficit. A chief cell line, ImChief, was established and characterized. Immortomice were 
also treated with L635 to establish the SPEM cell line, ImSPEM. ImChief cells express 
all chief cell markers except intrinsic factor (Gif) and lack expression of all other gastric 
lineage markers. Pepsinogen C and RAB3D containing vesicles are produced in ImChief 
cells. At the non-permissive temperature, the number of these vesicles appears to increase 
and proliferation ceases, showing that ImChief cells become more differentiated.  
ImSPEM cells express the SPEM markers, Tff2 and He4, but not other stomach specific 
lineage markers. TFF2 vesicles and HE4 vesicles are seen in ImSPEM cells. In fact, HE4 
is apically secreted into the conditioned media of the cells, demonstrating that ImSPEM 
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cells establish secretory machinery that traffics to the specified apical membrane. 
Immunostaining of junctional markers (p120, E-CAD, and ZO1) validates the 
polarization of ImSPEM lines grown on transwells. Furthermore, ImSPEM cells form 
cystic structures with hollow centers when grown in Matrigel at the non-permissive 
temperature. Gene microarray comparison of ImChief and ImSPEM cells has revealed 
several genes putatively upregulated in SPEM. Protein expression of the third most 
increased transcript, Mal2 (a transcytosis protein), was examined in tissue and the cell 
lines. MAL2 expression was increased in murine and human metaplasias of the stomach. 
82% of intestinal type gastric cancers also expressed MAL2. MAL2 localized to the 
subapical region of SPEM cells in tissue. Additionally, MAL2 was localized to the 
subapical zone of ImSPEM cells. MAL2’s known role in transcytosis may help elucidate 
trafficking mechanisms in SPEM. Overall, both ImChief and ImSPEM exhibit 
characteristics of their respective in vivo counterparts and thus are indispensible in vitro 
models. These cell lines can be utilized for a multitude of studies, such as: chief cell 
homeostasis, roles of extrinsic factors in the metaplastic progression, or molecular 
mechanisms of SPEM, such as vesicular trafficking.  
Loss of Mist1 impedes SPEM induction 
Culture of ImChief cells has already led to a new route of investigation in SPEM 
induction. Although loss of parietal cells in the mouse is sufficient to induce SPEM, 
ImChief cells removed from their niche (and associated signals from parietal cells) do not 
readily transdifferentiate into SPEM in culture. During analysis of transcriptional 
expression of ImChief cells, low expression of the transcription factor Mist1 was 
observed. We hypothesized that this low expression resulted in immature chief cells as 
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previously reported in Mist1 null mice (Ramsey et al. 2007) and that mature chief cells 
were necessary for transdifferentiation into SPEM. To test this theory, Mist1 null mice 
were treated with DMP-777 or L635. Null mice treated with DMP-777 had an increase in 
proliferating GSII lectin positive cells as well as GSII lectin and GIF dual positive cells. 
The proliferating GSII lectin cells predominately localized to the mucous neck cell 
hyperplasia zone, although proliferating GSII lectin and GIF co-labeled cells were 
occasionally observed at the base of glands. The majority of GSII lectin and GIF dual 
positive cells found at the base of the glands resembled ‘neck to chief’ transition cells 
found in untreated mice. L635 treatment of null mice also increases proliferating GSII 
lectin positive cells. Although proliferation is seen throughout the glands in L635 treated 
control mice, localization in treated null mice was similar to patterning observed in the 
DMP-777 treated null mice. Furthermore, there was no change in the number of GSII 
lectin and GIF co-labeled cells. Instead, distinct regions of chief cells remained. These 
data indicate that Mist1 null mice are resistant to the induction of SPEM, although SPEM 
is not completely inhibited. Taken together, these studies suggest a model in which only 
the newest differentiated Mist1 null chief cell just emerging from the transition zone has 
the ability to transdifferentiate. These may be the origin of the proliferating GSII lectin 
and GIF co-positive cells. However, the majority of chief cells do not trandifferentiate 
because they quickly lose their secretory machinery in the absence of Mist1. The increase 
in GSII lectin and GIF dual labeled cells in DMP-777 treatment of null mice may indicate 
an accumulation of transition cells. This accumulation is not seen in L635 treatment, as it 
may take longer than three days for the resident chief cells to be replaced by the transition 
cells. These findings show that chief cells are not passive participants in the induction of 
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SPEM, because without their secretory machinery they exhibit a decrease in SPEM. Thus, 
chief cells are an active contributor in the development of SPEM.  
Overall, these studies have significantly expanded our understanding of the 
induction and progression of SPEM. Comparison of the heterogeneity among SPEM 
lineages has elucidated novel markers of metaplasia as well as identification of a mouse 
analog to intestinal metaplasia in humans (SPEM-IC). Additionally, indispensible and 
novel in vitro chief cell and SPEM cell models were established and are now available 
for future studies. These cell lines have already led to the discovery that mature chief 
cells with functional secretory machinery are necessary for the induction of SPEM. Thus, 
this body of work has made great strides in furthering our understanding of metaplasia in 
the stomach. 
 
Future directions 
Characterization of SPEM lineages in other murine models 
 As detailed above, the studies presented here have significantly enhanced our 
understanding of SPEM induction and progression. Many exciting directions for future 
studies have emerged from them. Of note, the identification of SPEM-IC as a more 
advanced metaplasia in the murine stomach has led to a new model for studying 
metaplastic progression in the mouse. Future in vivo studies can more accurately report 
the stage of metaplasia that arises from various manipulations. One important future 
study to expand this model is to characterize additional SPEM lineages that arise from 
different mouse models. Of note, gastrin null mice develop SPEM after only three days 
of DMP-777 (Nomura et al. 2004c). Another distinctive mouse model that develops 
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SPEM is the Runx3 null mouse. Runx3 null mice have a prominent inflammatory 
infiltration in the gastric mucosa and develop what appears to be SPEM at the base of 
glands. However, they retain parietal cells throughout the fundus (Ito et al. 2011). The 
expressional profile of this SPEM lineage may help identify SPEM transcripts 
upregulated because of inflammation but not parietal cell loss. Furthermore, Varon et. al. 
recently reported on several Helicobacter infections in mouse (Varon et al. 2011) that 
would be of interest for further characterization utilizing the transcript profiles 
established in our studies. Together, these studies would further our understanding of the 
induction of SPEM and progression to SPEM-IC. The findings would directly relate to 
the progression to intestinal metaplasia in humans. With the recent increase in attention 
given to SPEM in various mouse models, characterizing each SPEM lineage using the 
profiles established here would help unify the understanding of SPEM characteristics as 
well as pinpoint the stage of metaplastic progression in each mouse model. 
 Using ImChief and ImSPEM cells to study homeostasis and the metaplastic process 
As alluded to in the Mist1 null mouse studies, the necessity of mature chief cells 
in the induction of SPEM could focus future studies to the intrinsic properties of chief 
cells. ImChief cells can be used to study this requirement. While one would expect this 
transdifferentiation to happen in culture in the absence of parietal cell signals, ImChief 
cells did not transdifferentiate de novo. As noted in Chapter 3, overexpression of Mist1 to 
drive ImChief cells towards further maturity also did not induce SPEM. However, 
another more powerful transcription factor such as Xbp1 (upstream of Mist1) may 
promote complete maturation of ImChief cells. ImChief cells could be transfected with 
Xbp1 to induce maturation. It is possible that this overexpression will push the ImChief 
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cells to a mature state that could then lead to transdifferentiation into SPEM. This study 
would greatly support the findings in the Mist1 null mice. Furthermore, if Xbp1 
expression does push ImChief cells to complete maturation, it may then be possible to 
study pepsinogen secretion mechanisms. While much progress has previously been made 
in understanding pepsinogen secretion, new studies have been difficult due to a lack of in 
vitro models with manipulation capabilities. Xbp1 overexpressing ImChief cells could 
renew efforts in this area and further understanding of the genes and factors that regulate 
pepsinogen secretion and how it is altered in disease.  
 These novel ImChief and ImSPEM cell lines can be utilized for investigations of 
any gene of interest involved in gastric homeostasis or metaplasia. In addition, these in 
vitro models can be used to discern the specific factors from the complex network 
involved in the induction and progression of metaplasia in the stomach. Studies 
investigating the inflammatory response in metaplasia must sort out the influences from 
several different sources (i.e. types of immune cells such as neutrophils, macrophages, 
etc). Ongoing studies in our lab have suggested that macrophages are the key 
inflammatory cell for the induction of SPEM. Thus, macrophages would be a notable 
choice for co-culturing experiments with ImChief and ImSPEM cells. Resident 
macrophages in the normal stomach as well as circulating macrophages that infiltrate the 
gastric mucosa after L635 treatment or Helicobacter infections could be isolated. The 
isolated macrophages on ImChief and ImSPEM cells could be co-cultured to investigate 
their effects in a controlled and less variable environment. Cells could be cultured in the 
same plate to analyze the necessity of direct interaction or in opposing compartments of 
transwells for paracrine signaling investigations. If an effect is detected through paracrine 
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signaling, a cytokine array may be used to elucidate the factors secreted into the media. 
This framework could also investigate possible feedback loops from chief cells, such as 
signals the chief or SPEM cells relay back to macrophages or other cell types. 
Inflammatory cells are not the only avenue of exciting co-culturing studies. Upon 
the eradication of Helicobacter infection, the gastric mucosa reverts to normal lineages 
(Matsumoto et al. 2005; Nishizawa et al. 2007). This reversal was also observed 14 days 
after cessation of DMP-777 of L635 administration(Nomura et al. 2004c). It is presumed 
that parietal cells, once they begin to repopulate the gastric glands, resume directing the 
differentiation of chief cells. As no increase in cell death is observed during this reversal, 
it is inferred that SPEM cells can revert into chief cells. Thus, a primary parietal cell 
culture model could be isolated and co-cultured with ImSPEM cells. Utilizing established 
protocols, parietal cells remain viable for up to one week (Chew et al. 1989; Soroka et al. 
1993; Agnew et al. 1999). If parietal cells are the driving force for SPEM reversal to 
chief cells, one would expect ImSPEM cells to decrease SPEM markers and begin 
expressing differentiated chief cell markers, such as Mist1. Furthermore, if ImSPEM cells 
did begin reverting to chief cells, it could by theorized that a secreted factor from parietal 
cells acts upon the ImSPEM cells causing upregulation of chief cell differentiation genes. 
Novel parietal cell secreted factors may be identified through this avenue. Additionally, 
transcriptional profiling of the actively reverting cells may reveal novel genes that are 
upregulated to drive chief cell differentiation. Identification of novel genes involved in 
the maturation of chief cells will contribute to our understanding of chief cell homestasis 
as well as their transdifferentiation into SPEM. Conversely, from previous DMP-777 
studies, it has been theorized that the dying parietal cells secrete factors that could signal 
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chief cells to transdifferentiate. Thus, while normal functioning parietal cells may be able 
to reverse ImSPEM cells, dying parietal cells may push ImChief cells to SPEM. Again, 
these studies could be completed using isolated primary parietal cells in combination with 
ImChief cells. 
Other immortalized gastric cell lines 
 Many co-culturing experiments could be proposed with the novel ImChief and 
ImSPEM cell lines. As mentioned above, many experiments of interest would involve 
frequent isolation of new parietal cells. An alternative to continuous replenishment is to 
develop an immortalized parietal cell line. We have had success using the Immortomouse 
to develop a chief cell line and a SPEM cell line. While SPEM cells have an innate 
proliferative ability, chief cells were thought to be post-mitotic. Thus, chief cells were 
originally thought to be difficult to culture and that immortalization would not be 
possible. The establishment of the ImChief cell line has refuted this theory. Similarly, a 
parietal cell line has conventionally been thought to be too difficult to develop. However, 
with the availability of the Immortomouse and an H/K ATPase Cre ERT2 transgenic 
mouse (Xiao et al.) (parietal cell specific expression), an enriched GFP expressing 
parietal cell population could be sorted, isolated, and cultured. Preliminary observations 
from the development of the ImSPEM cell line suggest that an immortalized parietal cell 
culture may be possible. During the development of the ImSPEM cell line, a few 
subclones expressed H/K ATPase transcripts, even after several passages. Initially, these 
cells were of no interest as we focused on establishing a SPEM cell line. Therefore, we 
actively reduced and ultimately eliminated these cells from the cultures. Establishing a 
parietal cell line would not only bolster future studies of the ImChief and ImSPEM cell 
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lines, but also provide a novel in vitro model system for studying trafficking and acid 
secretion. Ultimately, an aspiration would be to have an immortalized cell line of each of 
the major gastric fundic cell lineages (parietal cell, mucous neck cell, chief cell, and 
SPEM cell). With all of these cell lines available, a multitude of molecular mechanism 
and co-cultures could be investigated. Interest in culturing enteroids and organoids 
continues to increase; but, establishing protocols for sustained culturing for gastric 
lineages has proven difficult. If Immortomouse lines of parietal cells, mucous neck cells, 
and chief cells were all available, they could be studied in a 3D matrix such as Matrigel 
that may provide an in vitro system for studying gastric gland dynamics. 
Possible interactions and roles of MMP12 in SPEM induction and progression 
 Initial characterization of ImSPEM cells grown in 3D Matrigel revealed cystic 
structures. While this finding presents a novel system to investigate polarization in SPEM, 
an atypical occurrence was found. When grown in Matrigel, ImSPEM cells degraded the 
Matrigel such that it could no longer retain its shape. Because ImSPEM cells were shown 
to properly function and secret HE4, we theorized that ImSPEM cells could secrete other 
factors that may degrade the surrounding matrix, such as matrix metalloproteinases 
(MMP’s). From our comparison of acute SPEM lineages, we found Mmp12 transcription 
was upregulated in L635 induced SPEM. Mmp12 has been linked to emphysema and 
other inflammatory diseases in the lung (Molet et al. 2005). In fact, Mmp12 deficiency 
resulted in macrophages being unable to degrade extracellular matrices and invade tissues 
(Shipley et al. 1996). Recent studies have also suggested cooperative interaction between 
MMP12 and neutrophil elastase (Shapiro et al. 2003). In the lung, it appears that 
neutrophil elastase (NE) activates MMP12 and degrades the tissue inhibitor of 
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metalloproteinase-1 (TIMP1) (a MMP12 inhibitor). From this data, we have hypothesized 
that MMP12 is a pro-inflammatory protein that is partially responsible for the prominent 
influx of macrophages and thus advanced stage of L635 induced SPEM. Furthermore, 
Mmp12 transcription was also upregulated in DMP-777 induced SPEM. However, 
neutrophil elastase inhibition by DMP-777 may block NE from activating MMP12 and 
inhibiting TIMP1. Future studies could explore the interaction between MMP12 and NE 
as well as their role in inflammation. Neutrophil elastase null mice and Mmp12 null mice 
could be treated with L635 and analyzed for the activation of NE or MMP12. These 
studies could provide insight into novel interactions between immune cells as well as 
identify specific factors and their mechanisms that contribute to the inflammatory 
influence on SPEM. 
Longitudinal analysis of inflammation in Helicobacter infections 
 Because inflammation is such an important part of the metaplastic progression in 
the human stomach, many investigations have attempted to elucidate pathways involved 
in the complex inflammatory network. Helicobacter infections in mice remain the 
primary model for studying effects of chronic inflammation in SPEM and SPEM-IC. 
However, Helicobacter infections can be problematic due to inefficient colonization and 
lengthy incubation periods (six months) without confirmation of infection. Many diseases 
in other organs are also associated with inflammation, and research in these tissues has 
led to development of analysis techniques for presence and degree of inflammation. 
These tools allow the researcher to longitudinally study the progression of inflammation 
in a disease model of interest. For example, positron emission tomography (PET) 
imaging with [18F]fluorodeoxyglucose (FDG-PET) has been used to follow the 
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inflammatory burden in cystic fibrosis patients (Chen et al. 2006b). The use of such a tool 
to evaluate the presence and amount of inflammation in the stomach of Helicobacter 
infected mice would allow researchers to closely track the dynamics of inflammation in 
the stomach without having to euthanize a mouse. It would also allow earlier detection of 
failed colonization, thus saving time and resources. Longitudinal analysis of the 
inflammatory load in the stomach may also provide unique insights into correlations 
between the amount and length of time of the inflammatory response to the stage of 
metaplastic progression (SPEM or SPEM-IC). For example, the amount of inflammation 
may be a stronger influence on metaplastic progression than the length of time of 
inflammation. Furthermore, these imaging techniques may lead to a more profound 
understanding of the dynamic progression of metaplasia and the association with 
inflammation. 
Conclusion 
  There are many exciting directions and possibilities for future studies 
investigating metaplasia of the stomach. The future studies described above allow for the 
greatest impact on our understanding of gastric homeostasis and metaplastic progression. 
Overall, the work presented here has identified novel markers of metaplasia, established a 
new model of SPEM progression, developed indispensible in vitro models, and 
determined the intrinsic chief cell characteristics required for transdifferentiation into 
SPEM.  
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APPENDIX A 
 
SUPPLEMENTAL TABLES 
Supplemental Table 1. Upregulated and downregulated transcripts in Pan-SPEM.  
List of transcripts upregulated or downregulated in all three SPEM models compared to 
WT. 
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Supplemental Table 2. Upregulated and downregulated transcripts in Acute SPEM.  
List of transcripts upregulated or downregulated in DMP-777- and L635- induced SPEM 
as compared to WT. 
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Supplemental Table 3. Upregulated and downregulated transcripts in SPEM with 
Inflammation.  List of transcripts upregulated or downregulated in L635- and H.felis-
induced SPEM as compared to WT. 
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Supplemental Table 3 cont. 
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Supplemental Table 4. Upregulated and downregulated transcripts in Specific to 
SPEM with Inflammation.  List of transcripts upregulated or downregulated in L635- 
and H.felis-induced SPEM as compared to DMP-777-induced SPEM. 
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Supplemental Table 5. Upregulated and downregulated transcripts in SPEM with 
Chronic Inflammation.  List of transcripts upregulated or downregulated in H.felis-
induced SPEM as compared to the other 3 groups (WT, DMP-777, and L635). 
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Supplemental Table 6. Quantitative RT-PCR primer sequences.  Specific primer 
sequences are listed with the concentrations used for qRT-PCR experiments. 
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APPENDIX B 
 
ALTERED GASTRIC CHIEF CELL LINEAGE DIFFERENTIATION IN 
HISTAMINE-DEFICIENT MICE 
Appears as: Nozaki, K.*, Weis, V.*, Wang, T.C., Falus, A., and Goldenring, J.R. Altered 
gastric chief cell lineage differentiation in histamine-deficient mice. Am J Physiol 
Gastrointest Liver Physiol. 2009;296:G1211-G1220. 
*co-first authors 
 
Abstract 
The orderly differentiation of cell lineages within gastric glands is regulated by a 
complicated interplay of local mucosal growth factors and hormones. Histamine secreted 
from enterochromaffin-like cells plays an important role in not only stimulated gastric 
acid secretion but also coordination of intramucosal growth and lineage differentiation. 
We have examined histidine-decarboxylase (HDC)-deficient mice, which lack 
endogenous histamine synthesis, to evaluate the influence of histamine on differentiation 
of fundic mucosal lineages and the development of metaplasia following induction of 
acute oxyntic atrophy. Stomachs from HDC-deficient mice and wild-type mice were 
evaluated at 8 wk and 12 mo of age. DMP-777 was administrated orally to 6-wk-old mice 
for 1 to 14 days. Sections of gastric mucosa were stained with antibodies against Mist1, 
intrinsic factor, H/K-ATPase, trefoil factor 2 (TFF2), chromogranin A, and Ext1 and for 
the cell cycle marker phospho-histone H3. HDC-deficient mice at 8 wk of age 
demonstrated a prominent increase in chief cells expressing Mist1 and intrinsic factor. 
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Importantly Mist1-positive mature chief cells were present in the midgland region as well 
as at the bases of fundic glands, indicating a premature differentiation of chief cells. Mice 
dually deficient for both HDC and gastrin showed a normal distribution of chief cells in 
fundic glands. Treatment of HDC-deficient mice with DMP-777 led to loss of parietal 
cells and an accelerated and exaggerated emergence of mucous cell metaplasia with the 
presence of dual intrinsic factor and TFF2-expressing cells throughout the gland length, 
indicative of the emergence of spasmolytic polypeptide-expressing metaplasia (SPEM) 
from chief cells. These findings indicate that histamine, in concert with gastrin, regulates 
the appropriate differentiation of chief cells from mucous neck cells as they migrate 
toward the bases of fundic glands. Nevertheless, histamine is not required for emergence 
of SPEM following acute oxyntic atrophy. 
 
Introduction 
In the normal gastric fundic mucosa, progenitor cells located in the upper gland 
neck give rise to four types of epithelial cells including pepsinogen-secreting zymogenic 
chief cells, acid-producing parietal cells, and two types of mucous cells, namely surface 
mucous cells and mucous neck cells. These lineages differentiate from three second-order 
progenitor cells, prepit, preparietal, and preneck cells (Karam et al. 1993b; Karam et al. 
1993c; Karam et al. 1993d). Prepit cells give rise to surface mucous cells, which migrate 
toward the lumen and secrete trefoil factor family 1 and mucin 5 types A and C. Parietal 
cells differentiate from preparietal cells and in mice most of these acid-secreting cells 
migrate toward the base. The mucous neck cells differentiate from preneck cells and 
secrete spasmolytic polypeptide/trefoil factor 2 (TFF2) and MUC6. As mucous neck cells 
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migrate toward the bases of fundic glands, they redifferentiate into zymogenic chief cells, 
which secrete both pepsinogen and intrinsic factor in rodents (Karam et al. 1993d). The 
prezymogenic cells display granules showing features intermediate between those of neck 
cells and zymogenic chief cells (Karam et al. 1993d; Ramsey et al. 2007). Importantly, 
the transition between mucous neck cells and chief cells occurs without an intermediate 
transiently amplifying cell and appears to involve the induction of the expression of the 
transcription factor Mist1 (Ramsey et al. 2007). 
Recent investigations have noted the critical influence of intrinsic mucosal growth 
factors on the differentiation of fundic cell lineages. A number of studies have suggested 
that gastrin, released from antral G cells, leads to the expansion of parietal cell lineages 
(Neuburger et al. 1972; Koh et al. 1997). Gastrin is also the major driver for the 
expansion of surface cell lineages in hypergastrinemic states (Nomura et al. 2005b). 
Similarly, elevation of transforming growth factor (TGF)-α, normally secreted by parietal 
cells, surface cells, and enterochromaffin-like (ECL) cells, leads to a marked expansion 
of surface cells and a reciprocal decrement in the differentiation of lineages in the deep 
glands (i.e., parietal cells, chief cells, and mucous neck cells) (Dempsey et al. 1992; 
Bockman et al. 1995; Sharp et al. 1995; Goldenring et al. 1996). Parietal cells secrete a 
number of other growth factors including the EGF receptor ligands, amphiregulin (Abe et 
al. 1997), heparin-binding EGF (Murayama et al. 1995), as well as sonic hedgehog 
(Zavros et al. 2007). Loss of parietal cells leads to a number of alterations in gastric 
lineages including an inhibition of mucous neck cell to chief cell differentiation as well as 
transdifferentiation of chief cell in spasmolytic polypeptide-expressing metaplasia 
(SPEM) (Nomura et al. 2005b; Nam et al. 2007; Nozaki et al. 2008). The loss of either 
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gastrin (Nomura et al. 2005b) or amphiregulin (Nam et al. 2007) or attenuation of EGF-
receptor signaling (Ogawa et al. 2006) leads to accelerated emergence of SPEM 
following acute oxyntic atrophy. Thus loss of intrinsic growth factors may lead to global 
alterations in intramucosal signaling that are necessary for the normal response of the 
mucosa to injury or lineage loss. 
Fundic endocrine cell lineages can also influence through release of hormones 
such as somatostatin and histamine. Somatostatin-deficient mice develop hyperplastic 
polyps (Zavros et al. 2005). H2-histamine receptor knockout mice develop a hypertrophic 
gastropathy with marked foveolar hyperplasia (Ogawa et al. 2003). Furthermore, 
previous investigations of mice with targeted deletion of histidine decarboxylase (HDC), 
the key enzyme for the production of histamine, have shown an increase in ECL cell 
numbers and expansion of parietal cells that appear small and less mature (Nakamura et 
al. 2004). Although previous investigations have suggested that parietal cell-derived 
influences are required for maturation of chief cells (Li et al. 1996), no investigations 
have identified particular paracrine influences that promote chief cell differentiation. We 
have now sought to characterize the lineage changes in HDC-deficient mice in more 
depth. Our studies have revealed a previously unrecognized marked increase in chief cell 
numbers in HDC-deficient mice. HDC-deficient mice showed a pattern of premature 
differentiation of mucous neck cells into mature chief cells in the neck region of the 
fundic glands. However, dual knockout mice deficient in both histamine and gastrin 
showed an amelioration of the premature chief cell differentiation phenotype. The chief 
cells that differentiated in neck region still appear to be susceptible to transdifferentiation 
into SPEM following acute oxyntic atrophy. All of these results indicate that the process 
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of chief cell differentiation from mucous neck cells is regulated by the combined 
influence of both histamine and gastrin. 
 
Materials and methods 
 
Animals 
HDC-deficient mice were genotyped as previously described (Ohtsu et al. 2001) 
(primers used were sense, 5′-GAG CAC TGT CAG CGA ATC CAC-3′; wild-type allele 
antisense, 5′-GGC CGT GAG ATA AGC GTG ACC-3′; and HDC-deficient allele 
antisense, 5′-TGG GAT TAG ATA AAT GCC TGC TCT-3′). Gastrin-deficient mice 
were genotyped as previously described (Nomura et al. 2005b) (primers used were wild-
type allele sense, 5′-TCC ATG CCT CTT TGT TGT TG-3′; gastrin-deficient allele sense, 
5′-TCG TCA AGA AGG CGA TAG-3′; and antisense, 5′-CCA GAG GTA AAG GGC 
TGA CCA G-3′). HDC-deficient mice and gastrin-deficient mice were crossed, and dual 
HDC/gastrin-deficient mice (HDC−/−/Gastrin−/−) were established by genotyping. 
HDC-deficient mice and Balb/c mice (Jackson Laboratories, Bar Harbor, ME) were 
euthanized at 6 wk, 2 mo, 6 mo, or 12 mo of age. HDC−/−/Gastrin−/− dual knockout 
mice were euthanized at 8 wk of age. DMP-777 (a gift of DuPont Pharmaceuticals), 
formulated in 0.5% methylcellulose, was administrated orally to 6-wk-old mice (6 per 
group) as a gavage once daily at 350 mg/kg per day. Stomachs were excised and opened 
along the greater curvature and fixed with 4% paraformaldehyde and embedded in 
paraffin for immunohistochemical analysis. All breeding and procedures were performed 
under Vanderbilt University IACUC-approved animal protocols. 
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Immunohistochemical analysis 
Excised stomachs embedded in paraffin were used for immunohistochemistry 
analysis. Deparaffinized sections were pretreated with antigen retrieval using Target 
Retrieval solution (Dako Cytomation, Glostrup, Denmark) or Trilogy antigen retrieval 
solution (Cell Marque, Austin, TX) at 120°C for 15 min, followed by immediate cooling 
using iced water. Sections were then treated with 2% blocking serum and incubated with 
the primary antibody overnight at 4°C. Immunostaining was performed with the 
following primary antibodies: murine monoclonal immunoglobulin M (IgM) anti-TFF2 
(a gift from Sir Nicholas Wright; Cancer Research, London, UK; 1:1,000), rabbit anti-
Mist1 (a gift from Dr. Jason C. Mills; Washington University, St Louis, MO; 1:2,000), 
murine monoclonal anti-H/K-ATPase (a gift from Dr. Adam J. Smolka; Medical 
University of South Carolina, Charleston, SC; 1:100,000), rabbit anti-chromogranin A 
(Zymed Laboratories, San Francisco, CA; 1:500), rabbit anti-exostoses 1 (Ext1; 
ProteinTech, Chicago, IL; 1:1,000), murine monoclonal anti-phospho-histone H3 (Cell 
Signaling Technology, Danvers, MA; 1:1,000), and rabbit anti-intrinsic factor (a gift 
from Dr. David Alpers; Washington University; 1:2,000). For immunohistochemistry 
with detection with diaminobenzidine, the sections were incubated with biotinylated 
secondary antibody followed by horseradish peroxidase-conjugated streptavidin. 
Chromogen was developed with diaminobenzidine (BioGenex Laboratories, San Ramon, 
CA). For immunohistochemistry with alkaline-phosphatase detection, the sections were 
incubated with biotinylated secondary antibody followed by alkaline phosphatase-
conjugated avidin-biotin complex. Chromogen was developed with Vector Red Substrate 
(Vector Laboratories, Burlingame, CA). All sections were counterstained with Meyer's 
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hematoxylin. For immunofluorescence analysis, Cy3-goat anti-mouse IgM antibody, 
Cy5-goat anti-mouse IgG antibody (Jackson ImmunoResearch, West Grove, PA), and 
Alexa488 goat anti-rabbit IgG (Invitrogen, Carlsbad, CA) were used, and ProLong Gold 
Antifade Reagent with DAPI (Invitrogen) was used for nuclear counterstain and 
mounting medium. Sections were viewed and photographed on a Zeiss Axiophot 
microscope equipped with an AxioVision digital imaging system (Zeiss, Jena, Germany) 
or a FluoView FV1000 confocal microscope system (Olympus, Tokyo, Japan). 
For quantitation of early maturation of chief cells, numbers of cells expressing only 
intrinsic factor cells between the first and last TFF2-staining mucous neck cells were 
determined for 10 glands in dual-labeled sections from three animals in each group (wild-
type, HDC-deficient, and dual HDC/gastrin-deficient mice). Statistically significant 
differences were determined by a Student's t-test. 
For quantitation of cell numbers, well-oriented sections from three animals from 
each group (wild-type,days 0, 1, 3, 7, and 14 of treatment; HDC knockout, days 0, 1, 3, 7, 
and 14 of treatment) were analyzed. Three gland units from the lesser curvature of the 
fundic mucosa, in each slide, were counted under fluorescent microscope (Zeiss). The 
average and standard deviation for cell numbers for each cell type were determined, and 
statistically significant differences were analyzed by Mann-Whitney U-test. 
 
Results 
HDC-deficient mice have prominent increases in ECL cells. 
Previous investigations of HDC-deficient mice demonstrated mucosal 
hypertrophy with increases in parietal cells and ECL cells (Nakamura et al. 2004). We 
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observed a similar pattern of hypertrophy in the mucosa of all HDC knockout mice with a 
prominent increase in mucosal height in 8-wk-old animals (Figure 34, A and B). We 
noted a prominent increase in ECL cells marked by both chromogranin A (Figure 
34, C and D) and Ext1 staining (Figure 34, E and F). Whereas ECL cells in wild-type 
mice were distributed more toward the bases of fundic glands, in HDC-deficient mice the 
ECL cells were distributed more broadly along the gland length. Nevertheless, we did not 
observe any instances of either nodular or linear hyperplasia patterns. 
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Figure 34. Characterization of the fundic mucosa of histidine-decarboxylase (HDC)-
deficient mice. A: fundic mucosa of untreated wild-type mouse at 6 wk old (hematoxylin 
and eosin, H&E), which has normal architecture of fundic glands. B: fundic mucosa of an 
untreated 6-wk-old HDC-deficient mouse (H&E), which showed increased numbers of 
small parietal cells and chief cells. C and D: cells were triple stained for chromogranin A 
(green), trefoil factor 2 (TFF2) (red), and H/K-ATPase (blue). E and F: cells were tripled 
stained for exostoses 1 (Ext1) (green), TFF2 (red), and H/K-ATPase (blue). C and E: in 
wild-type mice, chromogranin A and Ext1-expressing endocrine cells were located 
mostly in the bases of fundic glands. D and F: in contrast, HDC-deficient mice showed 
increased numbers of endocrine cells that were distributed throughout the fundic gland 
length. Magnification bars: A and B = 160 μm; C–F = 40 μm. 
 
HDC-deficient mice show a pattern of premature chief cell differentiation. 
In examining the fluorescence stains for lineages in 8-wk-old mice, it became 
clear that, in addition to the broader distribution of ECL cells, there were significant 
alterations in other lineages. Most notably, there appeared to be two zones of TFF2-
expressing mucous neck cells (Figure 35). The mucous neck cells in both zones were 
morphologically normal, but there also was a zone of intermediate cells that did not stain 
for TFF2; also, not all of these cells were accounted for by H/K-ATPase-expressing 
parietal cells (Figure 35E). We therefore investigated whether the intervening cells might 
be differentiated chief cells by assessing staining with antibodies against intrinsic factor 
(Figure 36), which is only expressed the zymogen granules of mature chief cells (Ramsey 
et al. 2007). In wild-type mice, intrinsic factor-expressing chief cells were observed only 
at the bases of glands, completely separate from TFF2-expressing mucous neck cells in 
the midgland (Figure 36, A–C). As noted previously, this phenotype is consistent with the 
differentiation of mucous neck into chief cells during migration toward the bases of 
glands (Karam et al. 1993d; Ramsey et al. 2007). In contrast, in 8-wk-old HDC-deficient 
mice, intrinsic factor-expressing chief cells were noted in both the midgland and at the 
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bases of fundic glands (Figure 36,D–F). This pattern of early chief cell differentiation 
was confirmed using staining for Mist1, a transcription factor, which is only expressed in 
mature chief cells (Figure 38). Supplemental information for this article is available at 
the American Journal of Physiology Gastrointestinal and Liver Physiology website. To 
quantitate this alteration in cell differentiation along the gland axis, we determined the 
number of intrinsic factor-positive cells lying between the first and last TFF2-expressing 
mucous neck cell in fundic glands from wild-type and HDC-deficient mice. Figure 
37 demonstrates that, although few mature chief cells expressing intrinsic factor were 
identified within the mucous neck cell zone in wild-type mice, many mature chief cells 
were observed within the mucous neck cell region in HDC-deficient mice. 
We also examined whether the mucosal phenotype could be explained by 
reactivation of mucosal progenitor cells. Figure 39 demonstrates that phospho-histone 
H3-expressing progenitor cells in both wild-type and HDC-deficient mice were only 
observed in the neck region of fundic glands. Similar results were also observed with Ki-
67 staining (data not shown). These results suggested that a population of chief cells was 
maturing prematurely in the midgland region in the fundic mucosa of HDC-deficient 
mice. 
160 
 
 
161 
 
Figure 35. Characterization of TFF2-positive cells in HDC-deficient mice. A–D: 
sections of stomach from 8-wk-old wild-type and HDC-deficient [HDC knockout (KO)] 
mice were stained with antibodies against TFF2 (red), and nuclei were visualized with 
DAPI (blue). In the wild-type mice, TFF2 stained the mucous neck cells in the neck 
region (A, B). However, in HDC-deficient mice, TFF2-positive cells were located in two 
layers, not only in the neck region, but also deeper in the gland toward the base, forming 
two layers of TFF2-positive cells in the fundic glands (C, D). The two layers of TFF2-
positive cells in HDC-deficient mice were separated from each other by a layer of 
nonstaining cells. E and F: HDC-deficient mouse fundic sections were stained for H/K-
ATPase (green) and TFF2 (red). Note that parietal cells account for only some of the cells 
between the mucous neck cells. Magnification bars: A, C, and E = 40 μm; B, D, and F = 
20 μm. 
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Figure 36. Aberrant location of intrinsic factor-positive mature chief cells in HDC-
deficient mice. Sections of fundic mucosa from wild-type, HDC−/− and HDC−/− × 
gastrin−/− mice were immunostained for intrinsic factor (green) and TFF2 (red) along 
with DAPI staining of nuclei (blue). In the wild-type mice (A–C), intrinsic factor was 
positive in the cytoplasm of mature chief cells at bases of fundic glands. However, in 8-
wk-old HDC knockout mice (D–F), intrinsic factor-positive cells were widely located 
along the fundic gland length in both the neck region and at the bases. In the dual 
HDC−/−× gastrin−/− mice (G–I), intrinsic factor-labeling mature chief cells were again 
predominantly located at the bases of fundic gland, deep to the mucous neck cell layer. 
Magnification bars: A, B, D, E, G, and H = 40 μm; C, F, and I = 20 μm. 
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Figure 37. Premature maturation of chief cells in HDC-deficient mice. Intrinsic factor 
expression in mature chief cells within the neck region was assessed in sections stained 
for both intrinsic factor and TFF2 as in Figure 36. Neck region mature chief cells were 
counted as intrinsic factor-expressing cells located between the first and last TFF2-
expressing mucous neck cells in each gland. Results are shown for mean cell numbers ± 
SD (*P < 0.01). Gas, gastrin. 
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Figure 38. Aberrant location of Mist1 positive mature chief cells in HDC-deficient 
mice. Sections of fundic mucosa from wild type, HDC-/- and HDC-/- X gastrin-/- mice 
were immunostained for Mist1 (green), TFF2 (red) and H/K-ATPase (blue). In the wild 
type mice (A-C), Mist1 was positive in the nuclei of mature chief cells at bases of fundic 
glands. However, in 8-week-old HDC knockout mice (D-F), Mist1 positive cells were 
widely located along the fundic gland length in both the neck region and at the bases. In 
the dual HDC-/- X gastrin-/- mice (G-I), Mist1-labeling mature chief cells were again 
predominantly located at the bases of fundic gland, deep to the mucous neck cell layer. 
Magnification bars: A,B,D,E,G,H = 40 μm; C,F,I = 20 μm. 
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Figure 39. Characterization of mitotic cells in HDC-deficient mice. Sections of fundic 
mucosa from both wild type and HDC-deficient mice were stained with antibodies 
against phospho-Histone H3 (red) and counterstained with DAPI (blue). Both wild type 
(A,B) and HDC-deficient (C,D) mice showed phospho-Histone H3 staining cells in the 
neck region. Although the number of labeled cells in HDC-deficient mice was elevated, 
no proliferating cells were noted in the mid-gland or at the bases of fundic glands in 
either wild type or HDC-deficient mice. Magnification bars: A,C = 50 μm; B,D = 10 μm. 
 
 
The secretion of histamine and gastrin are coregulated in the gastric mucosa to 
provide control of acid secretion. Previous investigations have determined that HDC-
deficient mice have profound hypergastrinemia (Tanaka et al. 2002; Nakamura et al. 
2004). Therefore, to analyze the influence of gastrin on the phenotype in histamine-
deficient mice, we also examined the fundic mucosa of mice dually deficient in both 
histamine and gastrin (HDC−/− × gastrin−/− mice). In these dual knockout mice, we 
observed a normal distribution of lineages. Mucous neck cells were located in the 
midgland region distinctly separated from intrinsic factor-expressing chief cells that were 
located predominantly in the deep gland region (Figure 36, G–I). Although occasional 
intrinsic factor-expressing mature chief cells were still observed in the midgland, the 
cross of the HDC-deficient mice onto the gastrin knockout background significantly 
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ameliorated the phenotypic aberrations in the HDC-deficient mice as reflected by a 
decrease in intrinsic factor-expressing cells in the mucous neck cell zone of fundic glands 
(Figure 37). Similar results were also seen with Mist1 staining (Figure 38). These results 
indicate that the premature maturation of chief cells accrued from the coordinate 
influences of both a loss of histamine and hypergastrinemia. 
Effects of acute parietal cell loss in HDC-deficient mice. 
We have previously noted that acute loss of parietal cells using treatment with 
oral gavage of DMP-777 leads to mucous cell metaplasia through transdifferentiation of 
chief cells into SPEM. Following acute parietal cell losses, we observed marked increases 
in gastrin  (Goldenring et al. 2000; Nomura et al. 2005b), and, because gastrin strongly 
stimulates histamine release, one would expect to observe elevated levels of tissue 
histamine release. Whereas we have recently demonstrated that loss of either gastrin or 
amphiregulin can promote the formation of SPEM  (Nomura et al. 2005b; Nam et al. 
2007) , the influence of histamine in promotion of metaplasia has not been examined. We 
therefore administered DMP-777 to HDC-deficient mice for 1–14 days (Figure 40). As 
with wild-type mice, DMP-777 elicited a rapid loss of parietal cells that was maximal by 
3 days of treatment (Figure 40A). Although HDC-deficient mice showed almost twice the 
number of intrinsic factor-labeling chief cells compared with wild-type mice before 
treatment, in both groups we observed only small changes in intrinsic factor-expressing 
cells with DMP-777 treatment. We have previously noted that the appearance of cells 
expressing both intrinsic factor and TFF2 is the best reflection of the induction of SPEM 
following acute oxyntic atrophy  (Nomura et al. 2005b; Nam et al. 2007) . In HDC-
deficient mice treated with DMP-777, the appearance of dual labeling cells was 
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accelerated, and a significantly greater number of dual-expressing cells was observed in 
the HDC-deficient mice at all days of treatment. Figure 41 demonstrates that, although 
intrinsic factor-expressing chief cells were present in the untreated HDC-deficient mice, 
few cells were observed with dual staining for intrinsic factor and TFF2 (Figure 41C). In 
contrast, in DMP-777-treated HDC-deficient mice, dual intrinsic factor/TFF2-labeling 
cells were observed along the entire length of the fundic glands (Figure 41, F and I). 
These results suggest that histamine is not required for development of metaplasia 
induced by acute parietal cell loss. In addition, the findings indicate that chief cells that 
have matured prematurely in the neck region also can develop into metaplastic SPEM 
cells. 
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Figure 40. Alterations in cell lineages in HDC-deficient mice following acute atrophy 
oxyntic atrophy with DMP-777. Wild-type (solid bars) and HDC-deficient (open bars) 
mice were treated with DMP-777 for 0 to 14 days, and H/K-ATPase-staining parietal 
cells (A), intrinsic factor staining cells (B) and dual intrinsic factor (IF)/TFF2-staining 
cells (C) were quantitated. *P < 0.05 vs. wild-type (same treatment). #P < 0.05 vs. day 
0 (untreated control). 
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Figure 41. Characterization of fundic gland morphology in untreated or DMP-777-
treated HDC-deficient mice. Sections of HDC-deficient mouse fundus from untreated 
(A–C) and DMP-777 treated (D–I) mice were stained for intrinsic factor (green), TFF2 
(red), and H/K-ATPase (blue in G–I). As noted for Mist1 staining, the untreated HDC-
deficient mice showed a marked increase in intrinsic factor-labeling chief cells 
throughout the length of the fundic glands. Little overlap with TFF2 labeling was 
observed except in the neck region. In contrast, after 14 days of treatment with DMP-777 
to induce parietal cell loss, a large number of the intrinsic factor cells were also 
immunoreactive for TFF2 (D–F). Higher magnification of cells at the base of one gland 
showed that dual expressing cells show immunoreactivity for TFF2 and intrinsic factor in 
separate granules, a characteristic of spasmolytic polypeptide-expressing metaplasia cells. 
Magnification bars: A–F, 40 μm; G–I, 20 μm. 
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Older HDC-deficient mice show hyperplastic and metaplastic changes in the mucosa. 
Previous investigations have reported that 9-mo-old HDC-deficient mice can 
develop hyperplastic changes in the fundus  (Nakamura et al. 2004). We also examined 
HDC-deficient mice at over 1 yr of age. We did observe that all older mice showed 
regions of hyperplastic polyps along the greater curvature containing numerous parietal 
cells, chief cells, and mucous neck cells (Figure 43). Nevertheless, in 20% of the mice, 
we also observed other regions, especially along the lesser curvature, which showed 
marked mucous cell metaplasia with glands dominated by mucous cells that were reactive 
for both diastase-resistant periodic acid-Schiff (PAS) and Alcian blue (Figure 42, A–D). 
We have previously noted this phenotype in some forms of SPEM, and indeed the 
mucous cell metaplasia was strongly positive for TFF2 (Figure 42E). In contrast with the 
hyperplastic polyps on the greater curvature, these glands contained few parietal cells 
(Figure 42F). Chromogranin A-labeled ECL cells were observed along the gland length 
intermixed with the metaplasia (Figure 42, G and H). These results indicate that chronic 
absence of histamine in HDC-deficient may lead to global changes of both hyperplasia 
and metaplasia. 
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Figure 42. One-year-old HDC-deficient mice showed metaplastic lesions. Sections of 
stomach from 1-yr-old HDC-deficient mice were examined by hematoxylin and eosin 
staining (A and B) or Alcian blue/periodic acid-Schiff (AB-PAS) (C and D) 
histochemical staining. Twenty percent of 1-yr-old mice showed mucous cell metaplasia 
that was dually positive for both PAS and Alcian blue in areas along the lesser curvature. 
Immunostaining of these metaplastic lesions showed strong staining of the mucous 
metaplasia for TFF2 (E) and relatively few H/K-ATPase immunoreactive parietal cells 
(F) that were extremely small. G and H: ECL cells were also interspersed in metaplastic 
glands stained with antibodies against chromogranin A (green), TFF2 (red), and H/K-
ATPase (blue). Magnification bars: G, 40 μm; H, 20 μm. 
 
 
 
Figure 43. Hyperplastic polyps in HDC-deficient mice. (A) Immunohistochemical 
staining for H/K-ATPase (Alkaline phosphatase-Vector Red) (B) Immunofluorescence 
staining for H/K-ATPase (green) with nuclear counterstain with DAPI (blue). (C) 
Immunofluorescence staining against TFF2 (red) and Intrinsic Factor (green) with DAPI 
nuclear counterstain (blue). Along the greater curvature of all one year-old HDC-
deficient mice, we observed hyperplastic polyps with expansion of parietal cell numbers. 
At the bases of glands in hyperplastic areas staining was observed for parietal cells (H/K-
ATPase), chief cells (intrinsic factor) and mucous neck cells (TFF2). Magnification bar = 
20 μM. 
 
Discussion 
Investigations over the past several years have led to the realization that cell 
lineage differentiation in fundic gastric glands is critically influenced by both hormonal 
factors as well as intrinsic mucosal growth factors. Intramucosal growth factors may have 
variable influences that are spatially heterogeneous as cells migrate from the progenitor 
zone in the neck to regions in the deeper glands. In particular, mucous neck cells 
differentiate initially in the neck from preneck cells and undergo a further differentiation 
into chief cells as they migrate toward the gland base (Karam et al. 1993d). Importantly, 
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mucous neck cell redifferentiation into chief cells occurs without any proliferating cell 
intermediate although a morphological prezymogenic cell can be identified (Karam et al. 
1993d; Ramsey et al. 2007). Maturation of chief cells requires the expression of the 
transcription factor Mist1, and loss of Mist1 leads to a failure of complete differentiation 
of zymogenic cells in the deep glands (Ramsey et al. 2007). As chief cells migrate toward 
the base, they come under the influence of secreted paracrine factors from other lineages 
including parietal cells and ECL cells. These factors include a number of EGF receptor 
ligands and sonic hedgehog from parietal cells, as well as histamine and other growth 
factors secreted from ECL cells. A number of studies have indicated that the loss of 
parietal cells can alter the full differentiation of chief cells (Bockman et al. 1995; Li et al. 
1996). However, the present investigation suggests that endocrine and intrinsic mucosal 
histamine production also have important influences on the differentiation of chief cells. 
Indeed, loss of histamine led to premature differentiation of chief cells in the neck region, 
before full migration to the base. The effects of histamine loss were also dependent on 
elevation of gastrin because breeding of HDC-deficient mice onto the gastrin-null 
background led to an amelioration of the premature chief cell differentiation phenotype. 
All of these results support the concept that the orchestration of fundic gland cell lineage 
differentiation requires a complex and coordinated influence of intrinsic and extrinsic 
growth factors. 
Few studies have addressed the role of histamine as a regulator of gastric cell 
proliferation and differentiation. Previous investigations have suggested that histamine 
can regulate the proliferation of ECL cells (Modlin et al. 1996). Pharmacological 
inhibition of the H2-receptor leads to inhibition of acid secretion and elevated levels of 
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gastrin but is not associated with alteration in chief cell lineages. Similarly, knockout of 
the H2-histamine receptor leads to marked elevations in gastrin as well as increases in 
TGF-α and massive foveolar hyperplasia (Nakamura et al. 2004). This phenotype has 
been compared with that for transgenic overexpression of TGF-α, which also leads to 
massive foveolar hyperplasia  (Bockman et al. 1995; Sharp et al. 1995; Goldenring et al. 
1996; Nomura et al. 2005a). 
Nevertheless, these mice do not show alterations in chief cell differentiation as 
seen in the HDC-deficient mice. All of these mice, as well as other models associated 
with hypergastrinemia, do not demonstrate early differentiation of chief cells (Minegishi 
et al. 2007). Importantly, because all of these models elevate gastrin, they would also be 
expected to raise histamine secretion. Thus most models of hypergastrinemia are likely 
dual models for hypergastrinemia with elevated histamine release (Figure 44). It is 
interesting to note that, although alterations in chief cell differentiation are not observed 
in hypergastrinemic insulin-gastrin transgenic mice at an early age, these mice do go on 
at a later age to develop SPEM and gastritis cystica profunda (Wang et al. 2000). In the 
HDC-deficient mouse, the gastric mucosa experiences hypergastrinemia in the absence of 
histamine (Nakamura et al. 2004) (Figure 44B). Interestingly, our studies have shown 
that the phenotype of premature differentiation and maturation in chief cells in the fundic 
gland neck was substantially ameliorated in dual HDC- and gastrin-deficient mice. These 
results suggest that the phenotype observed in HDC-deficient mice results from an 
imbalance in the influences of histamine and gastrin. Since a similar phenotype is not 
apparently observed in H2-receptor knockout mice (Ogawa et al. 2003; Minegishi et al. 
2007), it seems likely that the loss of histamine may lead to alterations in signaling 
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through another histamine receptor. Perhaps the most likely candidate for this action 
would be through the H3-histamine receptor. The H3-histamine receptor is an 
autoreceptor on ECL cells and may regulate coordinated release of other ECL cell-
paracrine factors (Kidd et al. 1996; Grandi et al. 2008). Alternatively, the loss of 
histamine secretion may in turn change the secretory pattern of other growth factors from 
parietal cells. In any case, these results again suggest that loss of one paracrine regulator 
such as histamine in the stomach can lead to global effects on amine, peptide, or growth 
factor secretion through various feed back loops. Disruption of these signaling loops 
alters the balance of lineage differentiation within gland units. 
 
 
Figure 44. Model for regulation of chief cell differentiation by histamine and 
gastrin. A: most models of hypergastrinemia also elicit elevations in histamine. Thus, as 
in the normal gastric mucosa of wild-type mice, there is a balance of gastrin and 
histamine. B: in the HDC-deficient mice, hypergastrinemia exerts its effects in the 
context of an absence of histamine, leading to the observed premature differentiation of 
chief cells in the gland neck. In mice deficient for both histamine and gastrin, the balance 
is restored and chief cell lineage differentiation is normalized. 
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Previous studies have shown that acute oxyntic atrophy from treatment with the 
parietal cell-toxic compound DMP-777 leads to a rapid rise in serum gastrin and marked 
alterations in mucosal dynamics, leading to the emergence of SPEM  (Goldenring et al. 
2000; Nomura et al. 2005b; Nozaki et al. 2008). We have previously noted that SPEM 
developed more rapidly following DMP-777 treatment in gastrin- or amphiregulin-
deficient mice (Nomura et al. 2005b; Nam et al. 2007) . Similarly, in HDC-deficient mice, 
acute oxyntic atrophy led to more rapid induction of SPEM and a greater amount of 
metaplasia within glands. The latter finding likely accrued from the increased baseline 
numbers of mature chief cells in the fundic glands of HDC-deficient mice. Accumulating 
evidence suggests that SPEM arises from both transdifferentiation of mature chief cells 
into mucous cell metaplasia as well as an arrest of mucous neck cell differentiation into 
chief cells (Nam et al. 2007; Nozaki et al. 2008). The results presented here indicate that 
mature Mist1-expressing chief cells, regardless of their position in the fundic glands of 
HDC-deficient mice, can undergo transdifferentiation manifested by dual expression of 
both intrinsic factor and TFF2 in separate granules within SPEM cells. Thus the ability to 
undergo transdifferentiation into mucous cell metaplasia appears to be an intrinsic 
characteristic of mature chief cells. Interestingly, whereas mucosal hyperplasia was the 
most characteristic pathological finding in older HDC-deficient mice, 20% of mice over 1 
yr of age also showed metaplastic polyps along the lesser curvature. Thus it is possible 
that the expansion of the chief cell population may predispose over time to the 
development of oxyntic atrophy and metaplasia. 
In summary, whereas previous investigations in HDC-deficient mice had 
documented age-dependent fundic mucosal hyperplasia, the present studies document 
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that the absence of intramucosal histamine production also leads to a remarkable 
premature differentiation in chief cells from mucous neck cells. HDC-deficient mice 
demonstrate a phenotype of increased mature chief cells located throughout the gastric 
gland. Although gastrin appears necessary for the development of this phenotype, it is 
does not appear to represent the sole mediator because hypergastrinemia alone does not 
elicit such an effect on chief cell differentiation. The small size of parietal cells suggests 
that they also do not undergo complete maturation (Nakamura et al. 2004). It appears 
likely that the combination of hypergastrinemia without histamine leads to an alteration 
in intramucosal signaling that regulates the timely differentiation of lineages as they 
migrate down the fundic glands. 
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